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Abstract
Cell migration towards a chemical cue (chemotaxis) underlies a variety of physiological
processes, including embryonic development and the immune response. This mode of mi-
gration is also hijacked by metastatic cancer cells that use this process to enter blood or
lymphatic vessels to enable growth of secondary tumours at other sites within the body.
Using a novel cell migration assay we sought to determine the molecular mechanisms by
which vesicle traﬃcking regulates chemotactic invasion. In particular we focused upon
the inter-dependency of growth factor receptor signalling and traﬃcking.
We use this assay to show that the large GTPase dynamin is necessary for epidermal-
growth factor (EGF)-dependent migration in the breast cancer cell line MDA-MB-231
and a pancreatic cancer cell line PDAC. By following this result with RNAi studies we
found clathrin-mediated endocytosis, but not caveolar endocytosis, to be necessary for
migration in MDA-MB-231 cells.
Inhibiting dynamin in MDA-MB-231 cells not only inhibited migration but resulted in
an elongated phenotype of the cells. This and the current literature led us to investigate
whether focal adhesion disassembly during chemotactic invasion occurred through endo-
cytosis of integrins. Using total internal reflection fluorescence (TIRF) microscopy we
found no significant colocalisation of focal adhesion markers with markers of endocytosis
and found inhibiting endocytosis to have no eﬀect on the number or localisation of focal
adhesions.
We next investigated colocalisation between the EGF receptor (EGFR) and markers of
endocytosis in migrating cells and found a high degree of colocalisation with clathrin,
but not with caveolin. Inhibiting endocytosis led to a build-up of receptor at the front
of the cell and time-lapse imaging revealed that events of clathrin-mediated endocytosis
are polarised to the front of migrating cells. Thus during EGF-directed chemotactic in-
vasion of human breast cancer derived cells, EGFR endocytosis is polarised to the front
of migrating cells and occurs via clathrin-mediated endocytosis.
We then went on to analyse the exocytic traﬃcking of EGFR during chemotactic in-
vasion, and observed polarisation of EGFR exocytosis events towards the front of mi-
grating cells. We also found significant colocalisation of EGFR with Rab11, a marker
of the long-loop recycling pathway, whereas only a small amount of colocalisation was
seen with NPY, a marker for the biosynthetic secretory pathway.
Finally we use fluorescent lifetime imaging-fluorescence resonance energy transfer (FLIM-
FRET) microscopy to show that cells migrating in an EGF-dependent manner have
i
increased signalling of Scr and Akt Biosensors, compared to those not in an EGF envi-
ronment. We also observed that this signalling was further increased upon inhibition of
endocytosis. These experiments begin to investigate the link between endocytosis and
signalling, an area not yet very well studied.
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Chapter 1
Introduction
1.1 Metastasis
The spread of cancer cells from a primary tumour to other locations within the body
is known as metastasis. This process is strongly associated with a poor prognosis and
chance of survival; as such the prevention of metastasis is a key target for therapeutic
intervention (Sporn, 1997).
Prior to the onset of metastasis tumour cells undergo epithelial-mesenchymal transition
(EMT). A complex set of morphological and phenotypic changes occur which ultimately
lead to the loss of adherens junctions, an increased expression of proteases and increased
migratory ability (Hanahan and Weinberg, 2011). These newly acquired characteristics
are key to the process of metastasis, for which a tumour cell must first detach itself
from surrounding cells through the disruption of adhesions. The second stage is termed
intravasation and involves degradation of the extracellular matrix (ECM), through the
production of matrix metalloproteinases, and migration of the tumour cell into a nearby
blood or lymphatic vessel (Coussens and Werb, 1996; Wyckoﬀ et al., 2000). Extrava-
sation occurs when a tumour cell exits the blood stream in order to form a secondary
tumour site; cells must then seek to colonise the new site in order for metastasis to be
successful (Figure 1.1; Hanahan and Weinberg 2011).
Particular primary tumours often have a higher likelihood to metastasize to a specific
site, for example tumours of the colon have a higher propensity of metastasizing to
1
Figure 1.1: Model of metastasis. Firstly, cells separate from the primary tumour before
secreting proteases to degrade the ECM and vessel wall of a nearby blood or lymphatic
vessel. Tumour cells then migrate towards the blood or lymphatic vessel before entering,
in a process termed intravasation. Tumour cells leave the circulation by extravasation
and form secondary tumour sites elsewhere in the body.
2
the liver rather than any other organ (Pathak et al., 2010). Primary breast cancer
tumours are most likely to metastasize to the lung, liver or bones but metastasis has
been observed in many other organs as well as multiple organs at once (Weigelt et al.,
2005). Chemotactic cues play a role in the homing of tumour cells to particular sites of
secondary tumour formation (Hiratsuka et al., 2006).
The process of directed cell migration to a source of chemoattractant is known as chemo-
taxis and is vital to the intravasation and extravasation stages of metastasis. Conse-
quently a thorough understanding of this process is needed to provide novel targets for
anti-metastatic therapies (Condeelis et al., 2005).
1.2 Chemotaxis
Chemotaxis is triggered by the binding of chemoattractant molecules to cell surface re-
ceptors (e.g. epidermal growth factor (EGF) binding to its receptor (EGFR; Bagorda
et al. 2006). Activation of such receptors results in a complex signalling cascade that
leads to polarisation of the cell in the direction of migration, increased contractility and
subsequent directed motility (Bagorda and Parent, 2008). Chemotaxis is vital during
embryonic development and the immune response but is also utilised by tumour cells to
enable metastasis of the primary tumour to other areas of the body. A large number
of studies on the chemotactic process focus on the amoebae Dictyostelium discoideum
that is able to chemotactically respond to a gradient of cyclic adenosine monophosphate
(cAMP) of less than 2% diﬀerent across the length of its body (Mato et al., 1975). Amaz-
ingly, the chemotactic mechanisms of this single-celled organism are remarkably similar
to those of mammalian leukocytes that diverged from Dictyostelium during evolution
approximately one billion years ago (Pollard and Borisy, 2003). This serves to demon-
strate how fundamental the process is to all living systems and also allows research in
model organisms such as Dictyostelium to be translated to that of mammalian cells.
The present report serves to introduce the process of chemotaxis as has been elucidated
3
in various cell types using a number of experimental systems.
1.2.1 Membrane organisation during chemotaxis
The initial response upon the sensing of a chemoattractant is for the cell to polarize
and to extend protrusions in the direction of migration (Lauﬀenburger and Horwitz,
1995). Such protrusions can be large, sheet-like extensions called lamellipodia or the
more spike-like filopodia (Figure 1.2). The polymerisation of actin provides the driving
force for these protrusions (Welch and Mullins, 2002). Actin can either be monomeric (G
actin) or filamentous (F actin). Polymerisation of monomers leads to formation of actin
filaments which grow largely from their barbed ends (Welch and Mullins, 2002). The
driving force for this polymerisation comes from the actin-related protein 2/3 (Arp2/3)
complex, a 7 subunit complex able to polymerise actin by binding to existing filaments
and nucleating new filaments at a 70  angle to the exisiting filament (Machesky et al.,
1994). The Arp2/3 complex is in turn activated by a set of proteins called nucleation
promoting factors (NPFs; Machesky et al. 1994). These NPFs are a highly diverse
set of proteins and as such may serve to diﬀerentially regulate the function of Arp2/3
depending on the upstream factors at the time (Welch and Mullins, 2002). The or-
ganisation of actin is diﬀerent within these two types of membrane extension; this dif-
ference may allow the extensions to have distinct roles in migration. Lamellipodia are
broad in width but usually quite thin structures and contain highly cross-linked den-
dritic actin filaments. The Rho family GTPase Rac is involved in actin nucleation in
lamellipodia and is thought to be acted on upstream by the NPF WAVE (WASP-family
verprolin-homologous protein; Miki et al. 1998; Welch and Mullins 2002). As stated,
filopodia are thinner spike-like structures and contain tightly packed bundles of paral-
lel actin. The regulation of filopodia appears to be by an interaction between Cdc42
and WASP (Wiskott–Aldrich syndrome protein)/N-WASP leading to the activation of
Arp2/3 which in turn causes actin nucleation (Kim et al., 2000; Welch and Mullins,
2002). Another diﬀerence noted between lamellipodia and fliopodia is the turnover of
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Figure 1.2: Model of a chemotaxing cell. After sensing an extracellular cue by recep-
tors on the cell surface, membrane extensions form in the direction of the chemotactic
gradient. Nascent adhesions form in the region of the lamellipodium and are either disas-
sembled or mature first to focal complexes and then mature further into focal adhesions.
Focal adhesions form the site of contact between the ECM and actomyosin bundles and,
as such, are the region of traction force generation to enable the cell to migrate. Small
Rho GTPases and other signalling molecules are polarised during migration in order to
localise migration specific activities to particular regions of the cell. Figure inspired by
Parsons et al. 2010, Figure 1.
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actin within the structures: actin filaments within lamellipodia appear to be undergoing
constant turnover compared to that within filopodia which appear much more stable
(Mallavarapu and Mitchison, 1999).
1.2.2 Amplifying the gradient
Cells have the ability to respond to very shallow gradients of chemoattractant and in or-
der to do this the gradient needs to be amplified by the cell (Ridley et al., 2003). This am-
plification involves phosphoinositide-3 kinase (PI3K) and phosphatase and tensin homo-
logue (PTEN), and cells with altered activity of these molecules are unable to migrate di-
rectionally along a gradient (Devreotes and Janetopoulos, 2003). PI3K is involved in the
production of phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) and phosphatidylinositol-
(3,4)-bisphosphate (PI(3,4)P2); PTEN is involved in the breakdown of these two phos-
pholipids. In non-migrating cells PI3K is found in the cytosol whereas PTEN is located
at the plasma membrane. Upon application of a chemoattractant a rearrangement oc-
curs which sees PI3K polarise to the front of the migrating cell and PTEN more to
the sides and the posterior of the cell (Funamoto et al., 2002). Such strict localisation
of these two proteins following addition of chemoattractant results in PIP3 quickly be-
coming polarised at the front of the cell providing a method for amplification of small
chemoattractant gradients (Devreotes and Janetopoulos, 2003).
There is evidence to suggest that PIP3 has a role in regulating sites of actin protrusion
in the migrating cell (Funamoto et al., 2002). Experiments abrogating PI3K activity
prevent such actin structures from properly forming, conversely inhibiting PTEN causes
excess and unwanted actin polymerisation within the cell (Devreotes and Janetopoulos,
2003; Iijima and Devreotes, 2002).
1.2.3 Rho proteins in cell migration
The Rho family of GTPases have a variety of important roles in cell migration, partic-
ularly in the formation and regulation of lamellipodia and filopodia, as already men-
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tioned, and also in the establishment of cell polarity (Machesky and Hall, 1997; Welch
and Mullins, 2002; Ridley et al., 2003). Rho GTPases cycle between active GTP-bound
and inactive GDP-bound states by the action of guanine nucleotide exchange proteins
(GEFs) and GTPase activating proteins (GAPs), Rho guanine nucleotide dissociation
inhibitors (RhoGDIs) also add another level of complexity to their regulation. In GTP-
bound active states Rho GTPases interact with a number of eﬀectors including activators
of the Arp2/3 complex, which, as mentioned previously, is crucial for the initiation of
actin polymerisation (Etienne-Manneville and Hall, 2002). Rho proteins with particular
importance to the formation of lamellipodia and filopodia are RhoG, Cdc42 and Rac1
(Ridley et al., 2003; Murali and Rajalingam, 2013). The role of RhoG in the process
of lamellipodia formation appears to be upstream of Rac; it has been shown to activate
RacGEFs thereby indirectly leading to Rac activation (Katoh et al., 2006). Following
its activation Rac1 is able to activate WAVE leading to actin polymerisation through
the action of the Arp2/3 complex (Eden et al., 2002).
Cdc42 is involved in the formation of filopodia through interaction with WASP (Welch
and Mullins, 2002). While this claim is backed up by studies including those in Cdc42-
null mouse embryonic fibroblasts which are unable to form filopodia (Yang et al., 2006),
conflicting evidence has been found in other migratory models such as a study in Cdc42-
null embryonic stem cells derived from fibroblastoid cells which were able to form filopo-
dia as normal (Czuchra et al., 2005). More work therefore needs to be done to fully
elucidate the role of Cdc42 in filopodia formation; perhaps other small GTPases of the
Cdc42 family or wider Rho family are involved in the process in certain cases.
A polarized phenotype needs to be maintained in order to achieve directed migration.
Cdc42 plays an important role in the creation and maintenance of such polarity (Ridley
et al., 2003). Work showing the involvement of Cdc42 in the process includes experi-
ments in macrophages using a dominant-negative form of the protein. In this case cells
were still able to migrate and form an axis of polarity; however the axis was not oriented
in the direction of the chemotactic gradient (Allen et al., 1997). This points to an im-
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portant role for Cdc42 in interpreting external cues as to the direction of the gradient
and hence controlling polarity of the cell. Cdc42 is active towards the leading edge of
migrating cells (Itoh et al., 2005) and is involved in determining where protrusions form
at the front of the cell (Srinivasan et al., 2003). Is has also been shown to have an
eﬀect on localisation of the Golgi and the microtubule organising centre (MTOC) to-
wards the front of the cell, thereby influencing traﬃc and microtubule formation in this
area (Palazzo et al., 2001). Positive feedback loops have been suggested to be involved
in the activation of Cdc42 towards the front of migrating cells, including one involving
the kinase p21-activated kinase1 (PAK1), which is also a downstream target of Cdc42.
G-protein coupled receptors (GPCRs) at the cell surface can be activated by the binding
of chemoattractants, this in turn activates PAK1 which can cause Cdc42 activation, pro-
viding a mechanism for increased Cdc42 activation at the leading edge (Li et al., 2003).
The Rho GTPase Rac also has wider roles in the activation and maintenance of actin
polymerisation at the leading edge of migrating cells, many of these mechanisms appear
to involve feedback loops (Eden et al., 2002). As with Cdc42, activation of Rac1 is
localised to the front of the cell, this is likely to be due to the production of PIP3 in this
area by the highly localised activation of PI3K; PIP3 in turn leads to localised activa-
tion of a number of Rac GEFs (Welch et al., 2003). One positive feedback loop stems
from further activation of PI3K by Rac at the plasma membrane, thereby ensuring its
own sustained activation in this area (Welch et al., 2003). A second positive feedback
loop occurs from the activation of Rac by microtubules and in return the stabilisation
of microtubules by Rac (Waterman-Storer et al., 1999; Rodriguez et al., 2003). A third
mechanism of localised Rac activation comes from activation of Rac by integrins, thereby
ensuring Rac activation at the leading edge which in turn enables clustering of integrins
to the lamellipodia completing a third feedback loop (Kiosses et al., 2001; Burridge and
Wennerberg, 2004).
The role of defining the ‘tail’ area of a migrating cell appears to be mediated by Rho.
Rho and Rac inhibit each other’s activity meaning that suppression of Rho would occur
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at the front of the cell where Rac is activated (Sander et al., 1999). Similarly, Rho would
inhibit Rac activity at the back of the migrating cell therefore preventing lamellipodia
formation in this area of the cell (Worthylake and Burridge, 2003; Sander et al., 1999).
Rho activity in the lagging edge of cells is thought to stabilise microtubules which in
turn enables focal adhesion turnover at the back of the cell, again keeping processes at
the front of the cell distinct from those at the back (Rodriguez et al., 2003).
1.2.4 Integrins and adhesions in cell migration
Integrins are key to the process of cell migration; they are the anchors that allow the
stabilisation of protrusions by linking them to the ECM. Integrins also have valuable
roles when it comes to signalling, with the ability to participate in outside-in as well
as inside-out signalling (Hynes, 2002). More details will be presented about integrin
traﬃcking at later stages of this report, for now focus will be on their direct role in the
mechanics of migration.
Integrins are transmembrane proteins that bind to ligands in the ECM, such as colla-
gen and fibronectin. The outdated view of adhesion formation was that ligand binding
caused conformational changes within the integrins which leads to clustering and ul-
timately to the formation of larger adhesion complexes (Ridley et al., 2003). A more
recent standpoint is that the process of their formation depends largely on actin, and
in fact inhibiting actin polymerisation prevents the formation of new adhesions (Choi
et al., 2008; Vicente-Manzanares et al., 2009). An updated view consists of nascent
adhesions containing a small number of adhesion proteins forming in the protruding
lamellipodium in a manner dependent on polymerised actin, this complex can then ei-
ther undergo quick turnover or can become stabilised by integrins and go on to form a
larger adhesion complexes (Figure 1.2; Parsons et al. 2010; Vicente-Manzanares et al.
2009). Such larger complexes, termed focal adhesions, contain a complex array of pro-
teins including integrins, paxillin, talin, focal adhesion kinase (FAK) and ↵-actinin,
amongst others (Parsons et al., 2010), and in fact more than 150 proteins have been
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found to be adhesion-associated in some way (Huttenlocher and Horwitz, 2011). The
large number of proteins involved serves to highlight the complexity and multifaceted
role of focal adhesions within cells.
Focal adhesions serve as an important signalling hub, transferring information between
the ECM and the internal actin-based protrusions. This signalling can also aid in po-
larisation of the cell, since focal adhesions form at the front of migrating cells. In fact,
integrin specific activation of protein kinase A at the leading edge of migrating cells has
been shown to be an important early factor in the migratory process (Lim et al., 2008).
Focal adhesions act as sites for traction enabling cell movement. The traction force is
provided by the interaction of myosin II and actin with the ECM via the intermediate
proteins of the adhesion complex, including talin and ↵-actinin. In this way the ad-
hesions are seen as the ‘molecular clutch’ of the cell (Vicente-Manzanares et al., 2009;
Huttenlocher and Horwitz, 2011). The activity of myosin II is regulated by phosphoryla-
tion of myosin light chain (MLC) by either MLC kinase or Rho kinase and this activation
of myosin II results in cell contractility and the application of tension at focal adhesion
sites (Ridley et al., 2003; Riento and Ridley, 2003) .
Disassembly of adhesions can occur both at the front and the rear of migrating cells. At
the front focal complexes which do not mature into focal adhesions are disassembled as
new adhesion complexes form at the leading edge (Broussard et al., 2008). A complex
interaction between focal adhesion kinase (FAK) and Src as well as regulators of Rac
appears to underlie adhesion turnover at the front (Ridley et al., 2003). At the rear of
the cell myosin II may be involved in the disassembly of the mature focal adhesions and
many of the proteins necessary for disassembly at the front also appear to be required
for disassembly at the rear of migrating cells (Ridley et al., 2003). There also seems to
be a role for intracellular calcium levels, perhaps in the activation of calpain, a protease
which is involved in cleavage of focal adhesion components (Glading et al., 2002).
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1.2.5 Vesicle traﬃcking in chemotaxis
In order to control the directionality and magnitude of migration the availability of
chemoattractant receptors and cell adhesion molecules on the cell surface must be care-
fully regulated. The availability of these molecules depends heavily upon the process of
vesicle traﬃcking, meaning that in order to fully understand chemotaxis, vesicle traf-
ficking must be taken into account (Fletcher and Rappoport, 2010).
Three main vesicle traﬃcking pathways control the composition of the plasma mem-
brane; endocytosis, endosomal recycling and exocytosis. The interplay between these
pathways is pivotal to the process of chemotaxis in order to control the protein and lipid
composition of the cell surface. Endocytosis is important for the down-regulation of
receptor signalling by internalisation of such receptors (Doherty and McMahon, 2009).
Recycling and exocytosis are needed to provide the correct amount and cell surface local-
isation of receptors and cell adhesion molecules for the control of cell motility. For each of
these cellular traﬃcking pathways there are a number of routes, some of which are cargo-
or cell-type specific. Endocytosis includes the well-characterised clathrin-mediated en-
docytosis pathway, but also less well understood but nevertheless important pathways
such as caveolar endocytosis (Hommelgaard et al., 2005; Doherty and McMahon, 2009).
Endosomal recycling includes immediate return of proteins to the cell surface following
endocytosis (short-loop recycling), and the long-loop recycling pathway via the perinu-
clear recycling compartment (PNRC; van der Sluijs et al. 1992; Ullrich et al. 1996).
Polarised vesicle traﬃcking has been suggested as important for the promotion of cell
migration, however this area has many conflicting ideas and it is not yet clear which
vesicle traﬃcking pathways are involved (Sheetz et al., 1999). Using a wound healing
system it has been suggested that in migrating cells clathrin-mediated endocytosis takes
place in the middle-to-front area of the cell (Fletcher and Rappoport, 2010). Conversely,
caveolar endocytosis is polarised towards the rear of the cell and endocytic recycling ap-
pears polarised to the leading edge of migrating cells (Fletcher and Rappoport, 2010).
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This polarisation, however, may diﬀer in diﬀerent cell types and experimental systems.
1.2.6 Model for chemotaxis
Piecing together the above information and findings allows a picture to be built of what
we currently know about migration and chemotaxis. Firstly environmental chemoattrac-
tants bind to cell surface receptors initiating a signalling cascade; these can be through
GPCRs or growth factor receptors (Bagorda et al., 2006). The signalling cascade results
in the localised activation of GEFs for Rho GTPases. The activation of Rac and Cdc42
by their GEFs results in the activation of WASP/WAVE proteins, which in turn leads
to activation of the Arp2/3 complex (Miki et al., 1998; Kim et al., 2000; Welch and
Mullins, 2002). Arp2/3 initiates branched actin polymerisation, stimulating the forma-
tion of membrane protrusions in the direction of migration (Burridge and Wennerberg,
2004). Cdc42 is also involved in the activation of PI3Ks that serve to concentrate the
amount of PIP3 to the leading edge of the cell where it acts to amplify the gradient
(Devreotes and Janetopoulos, 2003). An axis of polarity exists in the migrating cell
controlled by Cdc42. This protein serves a number of functions related to cell polarity
including orientation of the Golgi and MTOC (Ridley et al., 2003; Palazzo et al., 2001).
Activities of Rac and Rho are also polarised in the migrating cell whereby Rac’s acti-
vation at the front inhibits Rho and the converse occurs at the rear (Worthylake and
Burridge, 2003; Sander et al., 1999). Stabilisation of protrusions occurs via interaction
with focal complexes that link them to the ECM. These focal complexes/adhesions also
serve as traction points over which the cell moves (Huttenlocher and Horwitz, 2011).
1.3 Endocytosis
As mentioned above, for correct migration, cells need to be able to control the com-
position of the plasma membrane. Endocytosis is the process of internalising plasma
membrane lipids and proteins (Doherty and McMahon, 2009). This internalisation takes
place in vesicles that bud from the membrane and, once inside the cell, are traﬃcked to
12
intracellular compartments for sorting. For growth factor receptors at the plasma mem-
brane endocytosis can have opposing eﬀects: endocytosis can lead to down-regulation
by degradation, or can lead to the maintenance of signalling by delivering the receptor
to a compartment where the ligand is detached and the receptor recycled (Doherty and
McMahon, 2009). Endocytosis has been found to be a route of cellular entry for cer-
tain viruses and so is a focal point for studies hoping to prevent spread of these viruses
(Doherty and McMahon, 2009; Thorley et al., 2010). There are many mechanisms of en-
docytosis involving the action of a large array of proteins, however this introduction will
concentrate on the two most highly studied methods of endocytosis: clathrin-mediated
endocytosis and caveolar endocytosis.
1.3.1 Clathrin-mediated endocytosis
First observations of clathrin-mediated endocytosis date back 50 years to the study of
yolk protein uptake by insect oocytes (Roth and Porter, 1964), although at the time of
this study researchers did not know the identity of the coat protein. Since this study
the coat protein has been identified as clathrin and the process of clathrin-mediated
endocytosis has been studied in numerous cell types (Pearse, 1976). Clathrin-mediated
endocytosis is now widely established as the main route for internalisation in eukaryotic
cells.
Clathrin
In clathrin-mediated endocytosis the internalising vesicle is surrounded by a lattice of
clathrin. The lattice is made up of clathrin triskelia, which each contain three clathrin
heavy chains (CHCs), in an arrangement with their legs radiating out from a central
hub, shown in Figure 1.3 (Kirchhausen and Harrison, 1981). Each CHC unit consists
of eight repeats of a clathrin heavy chain repeat (CHCR0-8), these make up the re-
gions known as the ankle, distal leg, knee and proximal leg of the structure (Ybe et al.,
1999; Brodsky, 2012). Connected to CHCR0 by a linker region is the terminal domain
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Figure 1.3: Diagram showing the domain structure of a clathrin triskelion
Figure 1.4: Diagram showing the four subunits of AP2. Subunits the ↵ and   have both
a trunk domain and flexible linker. Approximate positioning of the medium and small
subunits are also shown.
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(TD; Wilbur et al. 2005). The TD can bind to a number of diﬀerent adaptor/accessory
proteins via four interaction sites contained within its sequence (Ter Haar et al., 2000;
Miele et al., 2004; Lemmon and Traub, 2012). A further adaptor protein binding site has
been mapped to the region in the ankle domain between CHCR1 and CHCR2 (Knuehl
et al., 2006). Each CHC is associated with a clathrin light chain (CLC; Kirchhausen
and Harrison 1981). This interaction is mediated by three tryptophan residues in the
CLCs (Chen et al., 2002). The functions of the central hub include aiding CLC binding,
trimerisation and lattice formation (Blank and Brodsky, 1986, 1987; Näthke et al., 1992).
The diameter of the clathrin lattice ranges from 60 – 200 nm but can vary greatly de-
pending on species and the cargo being transported (Crowther et al., 1976; McMahon
and Boucrot, 2011). Clathrin coat assembly occurs by crosslinking of triskelia, a process
facilitated by the action of adaptor protein (AP) complexes. Clathrin triskelia lie ap-
proximately 20 nm away from the vesicle contained within the coat, the link between the
two being formed of interactions between the CHCs and AP complexes (Kirchhausen,
2000).
Adaptor protein 2
Adaptor protein 2 (AP2) is a tetrameric complex thought to function as the main adaptor
protein for clathrin-mediated endocytosis. It is analogous to AP1 and AP3 which have
functions in vesicle formation from sites other than the plasma membrane. The 200 kDa
AP2 complex is made up of four subunits as shown in Figure 1.4: two large subunits,
↵ and  2, which each contain a trunk joined by a flexible linker to an appendage, a
medium subunit (µ2) and a small subunit ( 2; Kirchhausen 1999). The roles of AP2
in clathrin-mediated endocytosis include the initial binding to the plasma membrane
and recruitment of clathrin, binding to and incorporation of cargo into the vesicle and
recruitment of other proteins necessary for the endocytic process (Collins et al., 2002).
Targetting of AP2 to the plasma membrane occurs by its binding to membrane lipids,
especially PIP2 (Gaidarov et al., 1996). This interaction requires phosphorylation of
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the Thr-156 residue on the µ2 subunit of AP2 which causes a conformational change
within AP2 revealing an additional site for PIP2 binding and cargo molecule binding
sites, increasing interactions between the adaptor complex and the membrane (Olusanya
et al., 2001; Collins et al., 2002). AP2 is able to bind clathrin through interaction with its
 2 appendage domain and also a clathrin box motif in the hinge region of its  2 subunit
(Ter Haar et al., 2000; Owen and Evans, 1998). AP2 predominantly binds cargo proteins
with specific motifs: those containing tyrosine-based motifs (Yxx ), which it binds via
the C-terminal of its µ2 domain, and those containing dileucine motifs (D/ExxxLL)
which it binds via its µ2 or  2 subunits (Ohno et al., 1995; Rodionov and Bakke, 1998;
Rapoport et al., 1997).
There is a large array of proteins involved in clathrin-mediated endocytosis. To discuss
fully the function of the key players it becomes necessary to discuss clathrin-mediated
endocytosis in terms of the five stages which make up the process, those are: initiation,
cargo incorportation, membrane bending, scission and uncoating. Figure 1.5 also shows
these stages in the form of a diagram.
Coated pit initiation
The longstanding view of coated pit initiation begins with AP2 binding to PIP2 at the
plasma membrane, from here it can bind to cargo molecules, recruit more AP2 and
also recruit clathrin (Doherty and McMahon, 2009). This view was challenged recently
by Henne and colleagues who published that a protein complex including Fer/Cip4 ho-
mology domain-only (FCHO) proteins 1 and 2, EGFR pathway substrate 15 (Eps15)
and intersectin was responsible for coated pit initiation in clathrin-mediated endocy-
tosis (Henne et al., 2010). Using spinning disk confocal microscopy they showed that
FCHO1/2 could be detected at sites of coated pit formation prior to the recruitment
of clathrin or AP2 and that coated pit formation failed when the FCHO1/2 proteins
were knocked-down by RNA interference (RNAi). They also showed that the number of
clathrin-coated pits which formed on the plasma membrane correlated with the number
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of FCHO1/2 molecules present in the cell. From this they concluded that FCHO1/2, in
complex with intersectins and Eps15 was the initiator of clathrin-coated pit formation
(Henne et al., 2010).
Data from other groups has, however, conflicted with this viewpoint (Cocucci et al., 2012;
Umasankar et al., 2012). Cocucci and colleagues were able to recapitulate some of Henne
et al.’s results using the same methods of experimental design and image acquisition.
However, when they used a highly sensitive total internal reflection fluorescence (TIRF)
microscopy method with single fluorophore sensitivity they found that in FCHO1/2
knock-down cells AP2-containing pits were forming but were mostly short-lived (<10 s)
and abortive (Cocucci et al., 2012). From this they concluded that FCHO1/2 proteins
are necessary for clathrin-mediated endocytosis but are not involved in initiation of the
pit, rather they are necessary for its stabilisation (Cocucci et al., 2012). In the study
by Umasankar et al. they used a genetics approach with zebrafish predicting that if
FCHO1/2’s function was vital to pit formation interfering with FCHO1/2 expression
would give a similar phenotype to interfering with AP2 expression (Umasankar et al.,
2012). Results showed that knock-down of AP2 in the developing embryos was lethal at
later stages of embryogenesis, however this was not the case with knock-down of FCHO1
which showed embryos with more developed dorsal regions and under developed ventral
regions. This, along with other results, led the group to conclude that FCHO proteins
could not be directly responsible for pit formation, although they must have some role
in the endocytic process (Umasankar et al., 2012).
The aforementioned study by Cocucci et al. also involved detailed imaging of fluorescent
clathrin and AP2 at early stages of endocytosis, they then used modelling software to
come up with predictions about the stoichiometries of these molecules during endocy-
tosis (Cocucci et al., 2012). They found that one event corresponding to the arrival of
clathrin and AP2 is followed very quickly by another such event and that in each case
the most likely stoichiometry was one clathrin to two AP2 molecules. They discussed
that if AP2 were to bind alone the dwell time would most likely not be long enough
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for any further interactions to take place, similarly short-lived interactions would occur
if only a single AP2-clathrin complex interacted with the plasma membrane. However,
the binding of two AP2 molecules and clathrin to the plasma membrane creates a much
stronger contact due to the increased number of AP2-PIP2 interactions and AP2-cargo
interactions, leading to a longer dwell time at the plasma membrane, therefore increas-
ing the likelihood of interaction with more clathrin and AP2 (Cocucci et al., 2012). As
mentioned previously PIP2 is indispensible for the initial binding of AP2 molecules to
the plasma membrane as shown by a number of studies (Boucrot et al., 2006; Zoncu
et al., 2007; Antonescu et al., 2011).
Cargo incorporation
AP2 is the main protein known to be involved in cargo sorting into clathrin-coated
vesicles. AP2 binds to cargo such as receptor tyrosine kinases (RTKs) in the plasma
membrane containing either tyrosine-based or dileucine motifs, as mentioned previously
(Ohno et al., 1995; Rodionov and Bakke, 1998; Collins et al., 2002). In addition to
AP2 other adaptor proteins exist which regulate incorporation of specific cargo proteins.
There has been much controversy over whether these proteins act independently of AP2
or whether AP2 is still necessary for clathrin-mediated endocytosis in these cases. Ex-
amples of such include arrestins for the internalisation of GPCRs; Disabled protein 2
(Dab2) and Autosomal recessive hypercholesterolemia protein (ARH) for low density
lipoprotein receptor (LDLR) endocytosis; and epsin as an adaptor for ubiquitinated
cargo, amongst others (Benmerah et al., 1996; Traub, 2003).
The evidence that AP2 was not needed to form clathrin-coated pits in all cases comes
largely from RNAi experiments looking into the eﬀect knock-down of one or more sub-
units of AP2 had on endocytosis (Motley et al., 2003; Keyel et al., 2006; Maurer and
Cooper, 2006; Hinrichsen et al., 2003). Such experiments showed that knock-down of
AP2 subunits was able to prevent transferrin endocytosis but was unable to completely
halt endocytosis of LDLR or EGFR. However, a more recent study by Boucrot et al.
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sought to identify whether these results could be substantiated or were likely an arte-
fact of experimental procedure. Boucrot and colleagues pointed out that in most cases
of AP2 subunit knock-down there was still some AP2 left in the cells and investigated
the theory that while there was clearly a massive reduction in the number of form-
ing clathrin-coated vesicles perhaps those that were still forming contain this residual
AP2 and were therefore sites of clathrin-mediated endocytosis (Boucrot et al., 2010).
Through their own experiments they showed that only a small number of clathrin spots
remained on the cell surface following RNAi against AP2, but importantly all AP2 spots
contained clathrin and all clathrin spots contained AP2 (Boucrot et al., 2010). Another
point the Boucrot et al. study sought to test was whether LDLR internalisation could
occur following AP2 knock-down as had been shown in previous studies (Motley et al.,
2003; Keyel et al., 2006; Maurer and Cooper, 2006). Experimental procedures in some
of the previous studies had allowed cells to cool to 4 C which would prevent endocytosis
while ligand binding to the surface receptors was still able to occur, before warming
to 37 C to allow endocytosis (Motley et al., 2003; Keyel et al., 2006). When this ex-
periment was repeated by Boucrot and colleagues at physiological temperature of 37 C
throughout the experiment LDLR internalisation was inhibited in a way comparable to
transferrin uptake (Boucrot et al., 2010). Consolidating all these results led the group to
postulate that AP2 is necessary for clathrin-coat formation in all cases and that taking
experimental procedure into account when analysing results is very important. These
results corroborate with others such as Huang and colleagues who undertook internal-
isation experiments at a physiological 37 C to show a role for AP2 in endocytosis of
EGFR, thereby showing how valuable correct experimental procedure is in such studies
(Huang et al., 2004).
The necessity for AP2 in the process of clathrin-mediated endocytosis is backed up by
other more recent studies (Aguet et al., 2013; Cocucci et al., 2012). The current view
is that alternative adaptor proteins bind to AP2 and therefore work cooperatively with
AP2. Alternative adaptors are likely to be necessary for tissue specificity of the en-
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docytic process, for example since the liver needs to take up large amount of LDLR,
ARH is present in hepatocytes to facilitate its incorporation into vesicles (Traub, 2003;
Doherty and McMahon, 2009).
Membrane bending
Clathrin polymerisation itself is able to allow membrane deformation but calculations
previously showed this was unlikely to be enough to cause vesicle formation (Nossal,
2001). Various proteins known to be recruited to sites of clathrin-coated pit formation
are thought to be involved in the bending of the membrane. The protein epsin has
been identified as being involved in membrane deformation during clathrin-coated pit
formation, as well as a possible role as an adaptor protein (Ford et al., 2002). The
epsin N-terminal homology (ENTH) domain allows epsin to bind PIP2, and therefore
be recruited to the plasma membrane. Once bound an amphipathic helix (known as
helix 0) contained within the protein’s N-terminal reverts to an ordered state allowing
its insertion into the cytosolic side of the plasma membrane (Ford et al., 2002). This
act causes membrane deformation by the pushing apart of lipid head-groups within the
plasma membrane.
Another set of proteins with importance in membrane deformation during endocytosis
are the Bin-Amphiphysin-Rvs (BAR) domain containing proteins which work by cre-
ating or stabilising membrane curvature (Mim and Unger, 2012). Endcoytosis of the
transferrin receptor has been shown to be dependent on this class of proteins and they
have been shown to cause tubulation of liposomes in vitro (Itoh et al., 2005). Re-
cruitment of these proteins mainly occurs by binding to phospholipids in the plasma
membrane (Daumke et al., 2014). The BAR domain of these proteins contains a three
helix coiled-coil which enables dimerisation of the protein; dimerisation can be either
homo- or hetero-dimerisation (Mim and Unger, 2012). The dimerised complex has a
so-called ‘banana shape’ structure that aids the hypothesis that these proteins allow
invagination simply by imposing their shape onto the membrane. These proteins also
21
have a high density of positively charged residues along their length which likely assist
in binding and shaping of the negatively charged membrane (Peter et al., 2004). BAR
domain containing proteins can be split up into several classes which diﬀer in the extent
of curvature they can mediate, whether this curvature is positive or negative and also in
the stage they are recruited to the forming clathrin-coated pit (Mim and Unger, 2012).
The aforementioned FCHO1/2 proteins contain F-BAR domains; these are recruited
early in clathrin-coated pit formation and are known to induce positive but only shallow
membrane curvature (Henne et al., 2010; Daumke et al., 2014).
Amphiphysin, endophilin and sorting nexin 9 (SNX9) are examples of BAR domain
containing proteins recruited to late stages of clathrin-coated vesicle formation (Doherty
and McMahon, 2009). In addition to their N-terminal BAR domains they have Src-
homology 3 (SH3) domains in their C-terminal which are important for interaction with
dynamin at the site of vesicle formation and therefore aid in targeting the protein to the
plasma membrane (Itoh et al., 2005). As well as the roles of inducing and/or stabilising
membrane curvature BAR domain containing proteins are predicted to have other im-
portant roles in clathrin-mediated endocytosis including acting as scaﬀolds involved in
the wider organisation of proteins involved in the internalisation process and recruitment
of actin polymerising proteins (Mim and Unger, 2012).
More recent studies have proposed alternate and conflicting mechanisms for how mem-
branes are deformed during endocytosis (Dannhauser and Ungewickell, 2012; Stachowiak
et al., 2012). The first study conflicts with the idea presented earlier, that clathrin is not
suﬃcient, by itself, to cause membrane deformation during endocytosis. The researchers
used a system containing lyposomes where they were able to control the composition of
each experimental system. Using this system they showed that when only clathrin and
a truncated version of epsin, only able to bind clathrin and the membrane (ie. not able
to bend membranes), were added to the liposome solution clathrin-coated vesicles were
able to form (Dannhauser and Ungewickell, 2012). The authors conclude that clathrin
is able to bend membranes to the necessary degree for vesicle formation. It is, how-
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ever, unknown whether such a mechanism would be suﬃcient for this process in vivo.
A second study, again conflicting with earlier ideas, proposed that membrane bending
could occur without the insertion of any proteins into the membrane, simply by over-
crowding of proteins in a particular region (Stachowiak et al., 2012). Giant unilamellar
vesicles (GUVs) were used in this study along with only the membrane binding portions
of epsin or AP180 (another molecule proposed to play a role in vesicle formation) to
allow membrane binding but not insertion into the membrane (Stachowiak et al., 2012).
Tubulation of the GUVs was evident in both cases and the group used it to conclude
that such ‘membrane crowding’ could aid membrane invagination (Stachowiak et al.,
2012). Once again, however, it is uncertain whether this so called ‘membrane crowd-
ing’ would be enough to cause membrane invagination in vivo and it is noted that the
concentrations of proteins in both of these above mentioned studies is too high to be
physiologically relevant (Kirchhausen, 2012).
Until some of these processes are tested in live cells and in vivo systems we cannot know
for sure the method of membrane curvature formation during clathrin-coat assembly.
Perhaps clathrin is suﬃcient to begin membrane curvature but curvature-sensing pro-
teins are necessary for later stages of pit formation to stabilise the curved region and
recruit membrane scission factors.
Vesicle scission
Dynamin is a large GTPase responsible for the scission event in clathrin-mediated en-
docytosis. Mammals have three dynamin isoforms but in non-neuronal cells the ubiqui-
tously expressed dynamin2 isoform has been shown to be the major isoform necessary
for clathrin-mediated endocytosis, hence this will be the main focus of discussion here
(Liu et al., 2008). Dynamin’s first appearance on clathrin-coated pits appears to be
during early stages of formation, however only a small amount is present at this time
(Aguet et al., 2013). Research suggests that early dynamin recruitment may be neces-
sary in order to pass a regulatory checkpoint; vesicles devoid of dynamin were found to
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be abortive at early stages, whereas dynamin-positive vesicles had lifetimes > 40 s, con-
sistent with a completed endocytic event (Aguet et al., 2013). Later in vesicle formation
there is a characteristic burst in dynamin activity consistent with its role in fission of
the vesicle from the membrane (Taylor et al., 2011).
Dynamin has five main domains in its structure: a proline-rich domain (PRD) in its C-
terminal for binding to SH3-containing proteins, a GTPase domain, a bundle signalling
element (BSE), a stalk and finally a pleckstrin homology (PH) domain for binding phos-
pholipids (Daumke et al., 2014). The stalk domain is able to self-assemble in a criss-cross
fashion via a hydrophobic interface to create an extended dimer (Faelber et al., 2011).
A second hydrophobic interface allows additional oligomer assembly. The BSE inter-
acts with the GTPase domain of the same dynamin molecule forming a flexible hinge
region. The stalk region also forms an interface with the PH domain and this is thought
to regulate oligomerisation in some way (Faelber et al., 2011). Oligomerised dynamin
assembles in a helix around the neck of a forming vesicle, whereas dimerisation occurs
between GTPase domains on adjacent rungs (Ferguson and De Camilli, 2012).
The actual mechanism of vesicle fission by dynamin remains to be fully explained. The
hydrolysis of GTP appears to be the essential factor (Marks et al., 2001). The con-
stricted arrangement of dynamin creates high curvature and stress at the neck of the
vesicle and interaction of the PH domain with acidic phospholipids in the plasma mem-
brane helps to stabilise the reaction (Bashkirov et al., 2008b; Ramachandran et al.,
2009). One mechanism suggests that GTP hydrolysis by a GTPase domain dimer leads
to movement of the BSE in such a way as to cause rotational sliding of the dynamin helix
rungs leading to constriction of the vesicle neck (Chappie et al., 2011). The reaction
is likely to be more complex than this and other studies have implicated longitudinal
tension, actin polymerisation and insertion of amphipathic helixes into the membrane
as other key factors in the process as well as pointing out that dynamin may respond
in diﬀerent ways depending on the curvature of the membrane lipids (Bashkirov et al.,
2008a; Boucrot et al., 2012; Daumke et al., 2014).
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As eluded to earlier there is a high degree of co-operativity between dynamin and BAR
domain proteins. The SH3 domains of amphiphysin and endophilin have been implicated
in the recruitment of dynamin by binding to its PRD. Endophilin has been shown to
be reciprocally involved in dynamin recruitment, whereby depletion of endophilin leads
to decreased dynamin recruitment and vice versa. Recent studies proposed conflicting
views on how the interaction between BAR domain proteins and dynamin aﬀects fission
(Meinecke et al., 2013; Neumann and Schmid, 2013). Neumann et al. used supported bi-
layers with excess membrane reservoir (SUPER) templates to show that N-BAR domain
containing proteins, such as amphiphysin and endophilin acted to increase eﬃciency of
the fission reaction but that this was not dependent on SH3-PRD interactions and that
these were in fact inhibitory to the fission process (Neumann and Schmid, 2013). They
further hypothesised that the positive eﬀect of N-BAR associated membrane bending
balanced with negative regulation by the SH3-PRD interaction allowed these proteins to
intimately regulate dynamin eﬃciency and vesicle fission (Neumann and Schmid, 2013).
Another study from 2013 used GUVs to test the relationship between BAR domain pro-
teins and dynamin (Meinecke et al., 2013). They found that dynamin and GTP had
to be present in addition to amphphysin or endophilin in order for tubulation of the
GUVs to occur, and that, in contrast to results from Neumann et al., this was highly
dependent on the interaction between the BAR domain protein and dynamin (Meinecke
et al., 2013; Neumann and Schmid, 2013). To fully appreciate the extent to which these,
and other, results mirror the physiological process more live cell studies are needed.
Vesicle uncoating
After a clathrin-coated vesicle has been internalised the clathrin coat must be removed
to allow the vesicle to fuse with intracellular membranes. The uncoating process requires
the proteins heat shock cognate protein 70 (Hsc70) and auxilin (McMahon and Boucrot,
2011). Following vesicle internalisation auxilin is recruited to the TD and ankle regions
of clathrin triskelia, allowing it to localise to the hub region of a neighbouring triskelion
(Fotin et al., 2004). Auxillin enables Hsc70 to bind via its J-domain (Ungewickell et al.,
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1995). For maximal disassembly the ratio of auxillin to Hsc70 appears to be one auxillin
and three Hsc70 per triskelion (Böcking et al., 2011). Disassembly of the coat occurs from
energy obtained through ATP hydrolysis by the ATPase activity of Hsc70 (Ungewickell
et al., 1995). Clathrin, along with accessory and adaptor proteins, is recycled for use
in further clathrin-mediated endocytosis, and the vesicle is now free to fuse with other
organelles within the cell (Young, 2007).
1.3.2 Caveolar endocytosis
Caveolae were first identified in mammalian cells as flask-shaped invaginations, 55 - 65
nm diameter in size, connected to the plasma membrane (Yamada, 1955). Since their
discovery caveolae have been shown to have a role in a number of cellular processes
including lipid regulation in adipocytes, signalling and mechanosensing (Parton and
Simons, 2007; Bastiani and Parton, 2010). These functions of caveolae are out of the
scope of this discussion and the focus will be on the role of caveolae in endocytosis.
Caveolin
The protein caveolin has been found to be indispensible for caveolae formation (Razani
et al., 2001). Caveolin has three family members: caveolin1 and caveolin2 are found
in non-muscle cells as well as smooth muscle, caveolin3 is expressed in skeletal muscle,
cardiac muscle and some smooth muscle (Drab et al., 2001; Way and Parton, 1996). In
their respective tissues caveolin1 and caveolin3 function similarly and are required for
caveolae formation, shown by loss of these isoforms leading to a loss of caveolae formation
(Drab et al., 2001; Galbiati et al., 2001). Caveolin2 is not thought to be necessary for
caveolae formation, although it often co-associates with caveolin1 (Razani et al., 2002).
Caveolin1 is able to oligomerise, and this appears necessary for caveolar formation. The
C-terminal of caveolin1 is palmitoylated, with three possible sites for this palmitoylation
identified, however this was found not to be necessary for the plasma membrane locali-
sation of caveolin1 (Dietzen et al., 1995; Monier et al., 1995). At the plasma membrane
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caveolin1 forms a hairpin structure and inserts into the plasma membrane, its N- and
C-terminals protrude into the cytoplasm. In particular cell types caveolae have been
observed to make up a third of the plasma membrane (Parton and Richards, 2003).
Requirements for caveolae
It has been estimated that 144 caveolin molecules are required to form one caveolae
(Pelkmans and Zerial, 2005). Regions of the plasma membrane enriched in caveolae also
contain higher than normal levels of glycosphingolipids, sphingomyelin and cholesterol
(Örtegren et al., 2004; Parton and Simons, 2007). Cholesterol has been reported to be
very important for caveolae structure and cholesterol depletion leads to flattening of
caveolae (Rothberg et al., 1992). Caveolae on the plasma membrane are found to be
highly stable structures and budding only occurs under particular stimuli (Pelkmans
et al., 2004). An interesting model for how caveolae form has become apparent (Parton
and Simons, 2007; Bastiani and Parton, 2010). Caveolin proteins are first synthesised in
the endoplasmic reticulum (ER) where they also undergo an initial stage of oligomeri-
sation (Monier et al., 1995). Transport to the Golgi occurs and exit from the Golgi
takes place along with further oligomerisation and association with lipid-raft domains
enriched with cholesterol and glycosphingolipids (Parton and Simons, 2007). These ‘ma-
ture’ caveolae can then fuse with the plasma membrane. The formation of these mature
structures and exit from the Golgi is dependent on cholesterol (Pol et al., 2005). The
ganglioside GM1 has also been shown to be important for caveolae maintenance at the
plasma membrane (Singh et al., 2010).
In endothelial cells dynamin has been shown to be important for endocytosis by cave-
olae; as in clathrin-mediated endocytosis it appears to localise to the neck of caveolar
vesicles (Oh et al., 1998; Nabi and Le, 2003). Additionally dynamin has been shown
to be important for caveolae internalisation in various cell types (Lamaze et al., 2001;
Puri et al., 2001; Nabi and Le, 2003). Phosphorylation of caveolin at residue Tyr-14
is also important for caveolar endocytosis and likely occurs by action of the kinase Src
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(Cao et al., 2002; del Pozo et al., 2005b; Hill et al., 2007). Other factors that appear to
be important for caveolar endocytosis include Src kinases, protein kinase C (PKC) and
actin (Bastiani and Parton, 2010). Imaging of Simian virus 40 (SV40) internalisation
showed recruitment of dynamin as well as a burst of actin polymerisation as the vesicle
internalised (Pelkmans et al., 2002).
Fairly recently another set of proteins, called cavins, were found to be necessary for
caveolae stabilization at the plasma membrane (Liu and Pilch, 2008). Interaction of
the four cavin family members into a 60-80 molecule complex is known as the ‘cavin
complex’ (Bastiani and Parton, 2010). Depletion of cavin-1 negatively impacts caveolae
formation and results in a flat plasma membrane, it also lead to degradation of caveolin1
(Hill et al., 2008). Caveolin recruits the cavin complex to the plasma membrane in a
cavin-1-dependent manner (Bastiani et al., 2009). The role of these proteins isn’t known
in detail but it appears they have some function in the stabilisation of caveolae at the
plasma membrane (Bastiani and Parton, 2010).
Roles for caveolar endocytosis
Controversy exists over the role of caveolar endocytosis in mammalian cells and many
studies have given conflicting results. Caveolar endocytosis has been noted as the inter-
nalisation route for glycosphingolipids and integrins as well as various pathogens (Bas-
tiani and Parton, 2010). The stimulation of caveolar endocytosis by glycosphingolipids
has been shown to cause clustering of  1-integrin and subsequent internalisation of the
adhesion protein (Sharma et al., 2004, 2005). Another interesting link between caveolar
endocytosis and integrins is that in adherent cells caveolin is found to be present in focal
adhesions, this serves sequester the caveolin in these structures preventing them from
forming caveolae at the plasma membrane (del Pozo et al., 2005a). When these cells
detatch from the ECM caveolin is free to promote caveolae formation at the cell surface
and mediate endocytosis (del Pozo et al., 2005a). Once internalised caveolae appear to
fuse with early endosomes in a manner dependent on Rab5 (Parton and Simons, 2007;
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Hayer et al., 2010). Interestingly, it has been shown that internalisation by the caveolar
route can lead to a diﬀerent fate than internalisation of the same molecule by clathrin-
mediated endocytosis; transforming growth factor beta (TGF ) receptor can enter cell
by both of these internalisation routes however entry by clathrin-mediated endocytosis
leads to sustained signalling whereas internalisation by caveolae leads to degradation of
the receptor (Di Guglielmo et al., 2003).
Some bacterial toxins and viruses have been shown to enter cells by caveolar endocytosis,
and as such derivatives of these molecules are often used to study the process. Fluo-
rescent or gold-tagged cholera toxin is often used, however under some circumstances
this molecule has been shown to enter cells by methods others than caveolar endocyto-
sis, making its use for the study of this process questionable (Torgersen et al., 2001).
Another maker often used is SV40, which has been shown to internalise via caveolae;
however, as with cholera toxin, SV40 has been shown to enter cells lacking caveolae,
yet again questioning its use as a marker for the caveolar endocytic pathway (Damm
et al., 2005; Ewers et al., 2010). Another caveat to using such markers for the study
of caveolar endocytosis is that antibodies and toxins are known to cluster receptors at
the sites of their binding which can lead to the formation of caveolae, or caveolae-like
transport intermediates, however this unlikely to represent the endogenous mechanism
for internalisation of these receptors (Rothberg et al., 1992).
There are clear links between the caveolar endocytic pathway and other raft-dependent
internalisation routes that require neither caveolin nor dynamin; for example the inter-
nalisation of SV40 can occur by either of these types of internalisation process (Pelkmans
et al., 2002; Damm et al., 2005). However, SV40 uptake is in fact decreased in cells con-
taining caveolae, thus caveolar endocytosis may represent a method of regulating uptake
of particular molecules (Damm et al., 2005). It seems like the presence of caveolin and
dynamin in the caveolar endocytic pathway is a method of adding regulation to raft-
dependent endocytosis.
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There is conflicting evidence about the role caveolar endocytosis plays in migration, with
groups many reporting opposing results. One group used caveolin1-deficient fibroblasts
to show that a lack of caveolin1 abrogated cell polarisation and directional persistency,
thereby pointing to the necessity of caveolin1 in these processes (Grande-García et al.,
2007). In a similar vein, Shatz et al. were able to show that inhibition of caveolin1 by
expressing dominant-negative versions of the protein lead to decreased cell migration
and invasion (Shatz et al., 2010). These results point to a possible tumour promoting
role for caveolin1. In contrast to this one group have shown that expression of caveolin1
inhibited lamellipodia formation in a breast cancer cell line (Zhang et al., 2000). Bonuc-
chelli and colleagues also point to a role for caveolin1 in tumour supression by showing
that a mutant version of caveolin1 is able to promote tumour cell migration and invasion
(Bonuccelli et al., 2009). It is clear from just these studies that the role for caveolin1
in cell migration and therefore metastasis is complex and more streamlined research is
needed before its role is fully elucidated.
1.4 Endosomal recycling and exocytosis
Endosomal recycling and exocytosis are integral to the process of cell migration (Figure
1.6 shows a simplified version of cargo traﬃcking through the endosomal system). They
are necessary to provide correct surface localisation of chemoattractant receptors and
adhesion molecules, as well as lipid membrane for membrane extension (Bretscher, 1996).
Once internalised vesicles fuse with early endosomes which have a pH of approximately
6.0 (Maxfield and Yamashiro, 1991), this causes some (but not all) ligand-receptor com-
plexes to dissociate (French et al., 1995). Endosomes and other membrane structures
within the cell are given identity by specific Rab GTPases and phosphoinositides; the
early endosome is marked by Rab5, and phosphatidylinositol-3-phosphate (Grant and
Donaldson, 2009). Over time the early endosome matures into a late endosome which
contains acid hydrolases, has a lower pH (5.0-6.0) and is marked by the loss of Rab5 and
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Figure 1.6: A simplified diagram of the endosomal system. After internalisation vesicles
fuse with early endosomes (black arrows) from where they can be recycled by the short-
loop recycling pathway (green arrows) or by the long-loop recycling pathway via the
PNRC (orange arrows). Alternatively cargo can be transported for degradation via the
late endosome (red arrows). Newly synthesised cargo can be traﬃcked from the Golgi
complex to the plasma membrane (purple arrows).
31
addition of Rab7 (Li et al., 2013; Poteryaev et al., 2010). Even further in the maturation
process late endosomes mature into lysosomes or fuse with pre-existing lysosomes which
have a lower internal pH of 4.5-5.0; cargo degradation occurs here (Mindell, 2012; Li
et al., 2013).
For cargo to avoid transport along the degradation route it must be re-routed before
it reaches the lysosome. Taking the transferrin receptor as an example, over 95% of it
leaves the early endosome before maturation occurs, pointing to the default route for
this receptor to involve recycling (Dunn et al., 1989; Maxfield and McGraw, 2004). Re-
cycling occurs either directly from the early endosome in a ‘short-loop’ recycling route,
or via the PNRC in a ‘long-loop’ recycling route (Grant and Donaldson, 2009; Maxfield
and McGraw, 2004). The short-loop recycling pathway is the route for the transferrin
receptor and various integrins (Jones et al., 2006). This pathway is dependent on Rab4
which appears to be involved in cargo sorting in this pathway (Daro et al., 1996; van der
Sluijs et al., 1992). When Rab4 is inhibited short-loop specific cargo ends up in jux-
tanuclear compartments, consistent with a re-routing of cargo via the long-loop pathway
(McCaﬀrey et al., 2001). The PNRC is a tubular structure localised in a juxtanuclear
region, transport to this compartment requires the proteins EDH4 and also the Rab11
eﬀector Rab11FIP5 (Sharma et al., 2008; Schonteich et al., 2008). Recycling back to the
plasma membrane from the PNCR is dependent on Rab11 and Arf1 and/or 6 (Ullrich
et al., 1996; Mohrmann and van der Sluijs, 1999; Jones et al., 2006).
Both recycling pathways are important for cell migration and chemotaxis. Integrins
internalised from adhesion complexes at the leading edge have been observed to route
to a juxtanuclear recycling compartment, and recycling vesicles are shown to trans-
port from this compartment to the front of cells (Jones et al., 2006). A role for the
Rab4-dependent route of recycling in migration is indicated by a decrease in directional
migration and ↵v 3 integrin recycling in NIH 3T3 fibroblasts following expression of
dominant-negative Rab4, suggesting a role for the short-loop pathway in the polarized
traﬃcking of this integrin to the leading edge of migrating cells (Woods et al., 2004;
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White et al., 2007). The Rab11-dependent long-loop recycling pathway also has a noted
role in cell migration. Expression of a dominant-negative Rab11 impairs random mi-
gration of MDCK cells and wound healing in the PtK1 epithelial cell type (Mammoto
et al., 1999; Prigozhina and Waterman-Storer, 2006). Interestingly, in the latter system,
the speed of migration appeared increased but the directionality was seriously reduced
using this inhibitor. As with the short-loop pathway, there is also evidence that the
long-loop pathway is involved in polarized traﬃcking of specific integrins (Caswell and
Norman, 2006). A third member of the Rab11 family, known as Rab25 or Rab11c, has
been found in epithelial cells (Goldenring et al., 1993). Overexpression of this Rab pro-
tein correlates with increased invasiveness and aggressiveness of some ovarian and breast
cancers, presenting a possible role for Rab25 in epithelial cell migration (Cheng et al.,
2004), however the situation remains controversial as Rab25 has also been reported to
act as a tumour suppressor in some cases (Cheng et al., 2006, 2010).
The importance of the traﬃcking of newly synthesised cargo has come to light in recent
years, particularly following the finding that the Golgi reorientates between the nucleus
and the leading edge in migrating cells of some cell types (Gotlieb et al., 1981; Yadav
et al., 2009). Disrupting post-Golgi secretion with Brefeldin A, which prevents transport
of newly synthesised protein from the ER, inhibits the formation of a polarised phenotype
and cell migration in Swiss 3T3 fibroblasts (Bershadsky and Futerman, 1994). However,
non-specific eﬀects caused by this inhibitor mean it is not ideal to use to directly study
post-Golgi transport. PKD is a protein found to be necessary for fission of cargo from
the Golgi (Liljedahl et al., 2001), this therefore provides a more specific target for study
of transport from this organelle. Abrogation of the pathway by use of dominant-negative
PKD in Swiss 3T3 fibroblasts showed decreased migration and suppression of lamellipo-
dia formation, highlighting the necessity of this pathway in cell migration (Prigozhina
and Waterman-Storer, 2004).
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1.5 Integrins and their traﬃcking
Integrins are adhesion molecules that make up a family of transmembrane proteins that
serve to connect cells to the ECM or other cells (Margadant et al., 2011). In this way they
are important mediators of signalling from the extracellular environment to intracellular
regions and vice versa. In mammals there are 18 integrin ↵ subunits and eight integrin
  subunits that are arranged into 24 diﬀerent heterodimers (Hynes, 2002). Roles for
integrins have been found in cell migration, proliferation and apoptosis amongst others
and deregulation of integrins has been observed in many cancers (Caswell and Norman,
2006). The polarisation of integrins is vital to enable directionality of migration point-
ing to a key role for vesicle traﬃcking in the regulation of integrins during this process
(Jones et al., 2006). Integrin heterodimers typically have two conformations: a bent
(or ‘inactive’) conformation and an open (or ‘active’) conformation (Bridgewater et al.,
2012). Factors that influence whether integrins are in the active or inactive conformation
include the binding of extracellular ligands such as fibronectin and collagen in a process
known as ‘outside-in’ signalling (Humphries et al., 2006), or the influence of intracellu-
lar factors such as the binding of the proteins talin or kindlins in a process known as
‘inside-out’ signalling (Legate et al., 2009).
The traﬃcking of integrins greatly influences their function in cells. Integrins in adhe-
sion complexes have been reported to be internalised by both clathrin-dependent and
clathrin-independent routes (Caswell et al., 2009). One integrin, ↵v 5, has been seen
to bind directly to clathrin and therefore its internalisation by clathrin-mediated endo-
cytosis is proposed (De Deyne et al., 1998).   integrin subunits contain NxxY motifs in
their cytoplasmic tails and so are predicted to bind clathrin adaptor proteins for entry
into the cell. The alternative adaptors Numb and Dab2 have been proposed to aid entry
of certain integrins via clathrin-mediated endocytosis and indeed Numb has been shown
to bind  1 and  3 integrins, with Dab2 known to associate and aid internalisation of  1
(Calderwood et al., 2003). Dab2 and AP2 have also been shown to localise at or near to
sites of focal adhesions at the time of their disassembly (Margadant et al., 2011). A cave-
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olar internalisation route has been proposed for some integrins. ↵2 1 has been shown
to internalise by a route dependent on caveolin which may also involve interaction of
the  1 tail with PKC (Upla et al., 2004). Other integrins have been shown to colocalise
to caveolae in certain cell types and some integrins, such as ↵v 3 and ↵5 1, are also
reported to enter cells by more than one endocytic route (Caswell et al., 2009). Evidence
against a direct role of integrin endocytosis as a method of focal adhesion disassembly
also exists (Gu et al., 2011; Fletcher et al., 2012).
Once internalised, integrins are traﬃcked in a Rab5-dependent manner to early endo-
somes (Caswell et al., 2009). The vast majority of integrins are quickly recycled; however
some do traﬃc to the lysosome for degradation (Margadant et al., 2011). Integrins not
destined for degradation are recycled either by the Rab4-dependent short-loop recycling
pathway or via the PNRC in a Rab11- and/or Arf6-dependent manner in a long-loop
recycling pathway (Jones et al., 2006). The Rab4-dependent recycling of ↵v 3 inte-
grin back to the cell surface requires direct interaction with PKD1 to enable correct
polarisation for cell migration and abrogation of this contact decreases persistency and
directionality of migrating fibroblasts (Woods et al., 2004; White et al., 2007). The acti-
vation of Rab4-dependent short-loop recycling appears to be mediated by growth factor
signalling meaning that signalling from the extracellular environment plays a large role
in the control of recycling and hence, function of integrins. There is also evidence that
the Rab11-dependent long-loop recycling process requires certain signalling pathways to
confer selectivity (Caswell and Norman, 2006). Particular roles for PKC", Akt and Arf6
have been have been found in the regulation of integrin traﬃc via the Rab11-dependent
pathway (Ivaska et al., 2002; Powelka et al., 2004; Roberts et al., 2004). The recycling
of  1 integrins by this pathway has been found to involve the phosphorylation of an
Arf6GAP which then physically associates with  1 integrins to promote their recycling
from the PNRC (Li et al., 2005).
Polarisation of integrin internalisation and recycling has been proposed to occur during
migration. Much evidence exists to show that focal adhesion disassembly, and there-
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fore presumably integrin internalisation, occurs at the rear of migrating cells (Bretscher
and Aguado-Velasco, 1998; Laukaitis et al., 2001; Webb et al., 2004; Broussard et al.,
2008). This would likely allow retraction of the cell rear and traﬃcking of integrins
to the leading edge for use in more adhesion complexes. However, in some cases it has
been observed that rather than internalise the integrins are left bound to the substratum
(Regen and Horwitz, 1992). Some evidence also suggests integrin endocytosis actually
occurs at the front of cells in the region behind the lamellipodia and evidence for this
includes visualisation of polarised endocytosis in this region and localisation of sorting
endosomes towards the leading edge (Rappoport and Simon, 2003; Caswell et al., 2009).
Although this is not direct evidence for polarised endocytosis of integrins at the leading
edge visualisation of one particular integrin, ↵5, has mapped its internalisation to this
region (Laukaitis et al., 2001). Perhaps integrin endocytosis can take place at diﬀer-
ent regions of the cell depending on cell type and migratory system. Recycling via the
PNRC appears to take place at the rear of the cell where it then travels back to the cell
front along a similar route to newly synthesised material from the Golgi (Laukaitis et al.,
2001; Schmoranzer et al., 2003). Numerous studies have shown that inhibiting integrin
recycling blocks cell migration providing evidence that their traﬃcking is involved in the
migratory process (Powelka et al., 2004; Yoon et al., 2005; Fan et al., 2004; Caswell and
Norman, 2006). These recycling processes most likely contribute to the polarisation of
integrins in migrating cells; indeed disruption of recycling by inhibition of Rab4 or PKD1
prevents localisation of ↵v 3 integrin to the leading edge of fibroblasts (Woods et al.,
2004). This requirement for PKD1 suggests that vesicles involved in integrin recycling
may be regulated in a similar way to vesicles derived from the Golgi, since this process
also requires PKD1 (Caswell and Norman, 2006).
As mentioned previously integrins are the link between the ECM and the actin cytoskele-
ton and therefore are the regions of traction force generation during cell migration. An-
other role for integrins during migration has emerged in the control of Rho signalling
(Caswell et al., 2009). It has been shown that high levels of ↵v 3 integrin and low ↵5 1
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supports active Rac at the front of cells leading to a stable lamellipodium and persistent
directional migration (Danen et al., 2005; White et al., 2007). Switching the expression
of these two integrins increases Rho signalling and leads to random migration. In cells
such as NIH3T3 fibroblasts that express both these integrin heterodimers diﬀerences in
their traﬃcking is used to control the balance of Rho and Rac during migration (White
et al., 2007).
A role for integrins in the traﬃcking of RTKs has become apparent. It was discovered
that ↵v 3 integrin inhibition could lead to a decrease in cell migration and angiogen-
esis in vitro and so this integrin was targeted for anti-cancer therapies (Nisato et al.,
2003; Maubant et al., 2006). Unfortunately the inhibitors appeared to have little eﬀect
in more physiological studies and it was subsequently shown that inhibiting ↵v 3 was
stimulating a Rab4-dependet recycling route for the VEGFR2 which led to its traﬃcking
back to the plasma membrane, whereas under non-inhibitory conditions this receptor
was usually degraded in a ligand-dependent manner (Reynolds et al., 2009). Another
eﬀect inhibiting this particular integrin has is to recruit Rab-coupling protein (RCP) to
the cytoplasmic tail of integrin  1. This interaction in turn leads to association of RCP
with EGFR promoting the recycling of both ↵5 1 intergin and EGFR to the plasma
membrane, increasing EGFR signalling to Akt, thereby increasing tumour cell invasive-
ness (Caswell and Norman, 2008). We can therefore see that certain integrins play an
important role in preventing tumour cell invasion by preventing traﬃcking processes
that would drive invasion.
1.6 The EGFR family
EGFR is of particular importance to this report as all chemotaxis research undertaken
in this project has utilised EGF as the chemoattractant. The EGFR family of tyrosine
kinase receptors has roles in many vital and varied processes within the cell. These pro-
cesses range from cell diﬀerentiation and proliferation to the regulation of metabolism
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and cell motility (Arkhipov et al., 2013). The EGF receptor family of tyrosine kinase
receptors consists of four members: EGFR (also known as ErbB1), ErbB2 (also known
as Her2/Neu), ErbB3 and ErbB4. EGF was discovered when it was shown to be a regu-
lator of mouse eyelid opening and to cause growth of cultured human cells (Cohen, 1997,
2004). Previous to this EGF had already been shown to be important for breast devel-
opment, and subsequent studies showed that EGFR mutations led to impaired breast
development in mice (Cohen, 1997). Research following these studies led to the discovery
of the first receptor of the family, EGFR. Structurally, the EGFR family of receptors
consist of a ligand binding extracellular region (containing four distinct domains), a sin-
gle transmembrane region and a C-terminal region containing the kinase activity of the
receptor and a long regulatory tail region (Arkhipov et al., 2013).
The EGFR family functional unit is as a dimer, which can be either heterodimeric or
homodimeric (Lemmon et al., 1997; Schlessinger, 2002). ErbB2 is the preferred partner
for all other family members as it contains a larger interaction loop than the other mem-
bers which readily enables dimerisation (Eccles, 2011). Including splice varients, there
are 13 known ligands for members of the EGFR family, of which EGF and TGF↵ are
the main ligands that bind EGFR (Harris et al., 2004; Eccles, 2011).
Following ligand binding to an EGFR family member conformational changes occur to
expose interaction regions of the receptor. These changes are suﬃcient to allow recep-
tor dimerisation to occur to form either a homodimer or a heterodimer (Schlessinger,
2002). Dimerisation allows the kinase domain of one monomer to be stabilised by the
cytoplasmic region of the other monomer, enabling the kinase domain to achieve an
active conformation. The active kinase domain is subsequently able to access tyrosine
residues on the other monomer resulting in receptor transphosphorylation (Riese et al.,
2007; Foley et al., 2010). These phosphorylation sites serve to create docking regions
for the binding of proteins containing either Src-homology 2 (SH2) or phospho-tyrosine
binding (PTB) domains which includes many proteins involved in both signalling and
receptor internalisation (Normanno et al., 2006). The binding of particular proteins and
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the aﬃnity to which they bind is influenced by which particular receptors are present
in the dimer (Schulze et al., 2005). The signalling cascade following receptor activation
can lead to activation of a multitude of proteins including Akt, extracellular signal-
regulated kinase (ERK) and Janus kinase/signal transducers and activators of tran-
scription (JAK/STATs) (Figure 1.7 shows some of the signalling pathways EGFR is
known to act through). The receptor is therefore linked to many vital cellular processes
such as cell survival, proliferation, diﬀerentiation and migration (Yarden et al., 2001).
1.6.1 EGFR in breast cancer
All four members of the EGFR family have been reported to be overexpressed to some
degree in breast cancer (Eccles, 2011). The term ‘triple-negative’ is used to describe
breast tumours lacking the oestrogen receptor↵, the progesterone receptor and ErbB2
(Korsching et al., 2008). These tumours are generally associated with a high degree of
metastasis and poor prognosis, and a high level of them (50-70%) are found to be EGFR
expressing (Burness et al., 2010). Recent transcriptome analysis has found oestrogen
receptor↵-negative breast cancers to contain increased levels of EGFR family ligands
including TGF↵ and NRG2  as well as proteins necessary for ligand maturation, when
compared to oestrogen receptor↵-positive breast cancers (Foley et al., 2010). This ob-
servation points to a potential role for autocrine EGFR signalling in the potency of these
tumours. EGFR expression has also been shown to be higher in patients where distant
and nodal metastases are found (Foley et al., 2010).
For tumours to metastasise they first need to stimulate the growth of blood vessels by
angiogenesis. The most potent pro-angiogenic factor is VEGF. One mechanism for the
production of this growth factor is via EGFR/ErbB2 signalling resulting in Akt sig-
nalling and subsequently upregulation of VEGF (Eccles, 2011). In this way overexpres-
sion/overactivation of EGFR can be seen to promote angiogenesis leading to increased
tumour survival.
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Figure 1.7: Ligand binding to EGFR can activate a multitude of signalling pathways
leading to a number of diﬀerent cellular responses including cell migration. Pathways
here are simplified and in reality include cross talk between pathways, positive and
negative feedback and other proteins not included in this diagram.
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EGFR and ErbB2 are seen as key players in the process of tumour cell migration. Identi-
fication of disseminated tumour cells from the blood and bone marrow are an indication
of poor prognosis; a high proportion of the time these cells also express EGFR/ErbB2,
even if the primary tumour does not (Braun et al., 2001; Eccles, 2011). This observa-
tion points to a major role for the EGFR signalling pathway in the metastatic process.
The bone presents a major site for breast cancer metastases to appear. A positive feed-
back loop has been described whereby breast tumour cells promote bone destruction
and this in turn aids tumour growth (Guise et al., 1996). EGFR signalling has been
implicated in this cycle; breast tumour cells that reach the bone release EGF which acts
on EGFR-expressing osteoclasts acting to disrupt the balance of RANKL and osteopro-
tegerin (which regulate osteoclast activity; Gilmore et al. 2008; Foley et al. 2010). This
disruption enhances osteoclast-mediated destruction of bone which, in turn, leads to a
release of growth factors that stimulate tumour growth and invasion.
1.6.2 Therapeutic targeting of EGFR
Multiple approaches have been taken in the targeting of EGFR family members as a
treatment for breast cancer; these include antibody-based therapies, gene therapy, RNAi
and even vaccines (Eccles, 2011). Many of the therapeutics in current clinical trials are
used to target tumours with ErbB2 amplification by preventing receptor dimerisation –
trastuzumab and pertuzumab fall under this category (Baselga and Swain, 2010; Eccles,
2011). Antibodies directed specifically to EGFR include cetuximab and panitumumab,
but neither has yet been shown to be an ideal treatment against EGFR-positive breast
cancer (Burness et al., 2010). Inhibitors of the kinase activity of EGFRs have also been
trialled with varying success. Selective inhibitors of EGFR kinase activity, erlotinib and
gefitinib, have little eﬀect when used alone, but are currently being trialled in combina-
tion with other cytotoxic agents (Eccles, 2011). Neratinib, a compound shown to bind
and prevent the kinase activity of EGFR, ErbB2 and ErbB3, is showing some positive
results in trials, alone and in combination with other drugs (Colombo et al., 2010). As
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well as therapies targeted directly to the receptors, components of the downstream sig-
nalling pathways also represent targets for anti-cancer therapies for tumours using the
signalling pathways for survival and growth (Eccles, 2011).
1.6.3 EGFR internalisation and traﬃcking
There is conflicting evidence over which route of internalisation EGFR takes and what
its fate is following internalisation. In particular, there is evidence for both clathrin-
dependent and clathrin-independent routes of internalisation which are in dispute by
many groups (Sorkina et al., 2002; Motley et al., 2003; Hinrichsen et al., 2003; Huang
et al., 2004; Sigismund et al., 2005; Johannessen et al., 2006; Orlichenko et al., 2006; Rap-
poport and Simon, 2009). Using RNAi Huang et al. showed that knocking down CHC
reduced the amount of EGFR endocytosis to 25% of that of control cells (Huang et al.,
2004). Two papers previously published conflicted with these new results by showing
that knocking-down components of AP2 has very little eﬀect on EGFR endocytosis (Mot-
ley et al., 2003; Hinrichsen et al., 2003); this therefore points to a clathrin-independent
pathway for EGFR entry, or at least a clathrin-dependent AP2-independent pathway.
However, as discussed earlier, the ligand binding stage of this internalisation assay was
conducted at 4 C and likely does not represent the physiological situation (Motley et al.,
2003; Keyel et al., 2006; Huang et al., 2004; Boucrot et al., 2010). In 2009 Rappoport
and Simon demonstrated the necessity of clathrin and AP2 in EGFR endocytosis (Rap-
poport and Simon, 2009). Firstly, they imaged plasma membrane localised EGFR in
conjunction with fluorescently labelled clathrin or caveolin1 to show a much higher colo-
calisation of EGFR with clathrin than with cavelolin1, they also showed that EGFR
was recruited to pre-formed clathrin spots rather than stimulating the formation of new
clathrin clusters. Secondly, they depleted AP2 using RNAi and found a decrease in
the amount of EGFR internalisation taking place (Rappoport and Simon, 2009). Like
the Huang and Boucrot studies, internalisation assays in this paper were conducted at
a more physiological 37 C (Huang et al., 2004; Rappoport and Simon, 2009; Boucrot
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et al., 2010).
More conflicting evidence comes from work by Orlichenko et al. and Sigismund et al.
(Sigismund et al., 2005; Orlichenko et al., 2006; Sigismund et al., 2008). Orlichenko and
colleagues show evidence that EGFR signalling is responsible for the phosphorylation of
caveolin1 and leads to an increase in the number of caveolae present on the cell surface
(Orlichenko et al., 2006). However, viewing these results in context with other work led
the authors to postulate a situation where the EGFR is sequestered in caveolae until
EGF stimulation where it becomes exchanged into clathrin-coated pits (Orlichenko et al.,
2006). In 2005 Sigismund et al. concluded that at low concentrations of EGF, EGFR
is exclusively internalised by clathrin-mediated endocytosis whereas at higher (but still
physiologically relevant) concentrations a raft-dependent route, possibly caveolae, is in-
volved in the receptor’s internalisation (Sigismund et al., 2005). They state that at
the higher concentrations ubiquitination of the receptor becomes more substantial and
may be the switch between the two internalisation routes. In 2008 the group furthered
these results by suggesting that clathrin-mediated endocytosis of the EGFR leads solely
to its recycling back to the cell surface, and hence sustains the signalling capabilities
of the cell (Sigismund et al., 2008). They propose that this sustained signalling due
to clathrin-mediated endocytosis is pivotal to some highly important cellular processes
such as DNA synthesis. The clathrin-independent pathway of internalisation was shown
to lead to degradation of the receptor instead of recycling and was also shown at this
point to not be caveolae-dependent, as was thought by a number of groups citing this
paper (Sigismund et al., 2008).
The classic view of the role of internalisation of growth factor receptors was that it led
to attenuation of signalling via degradation of the receptor. However, a growing body
of evidence says that EGFR continues to signal for some time from endosomes (Mi-
aczynska et al., 2004; von Zastrow and Sorkin, 2007; Murphy et al., 2009). There is also
evidence that particular signalling pathways can be activated by EGFR signalling from
endosomes, making this type of signalling distinct from that which occurs at the cell
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surface (von Zastrow and Sorkin, 2007). Early studies showed that particular compo-
nents of EGFR signalling cascades, such as Grb2, Shc and Sos, could be found located
to endosomes following EGFR activation by EGF (Di Guglielmo et al., 1994). Another
group showed that using a dominant-negative form of dynamin to inhibit endocytosis of
the receptor led to decreased signalling of the MAPK signalling proteins ERK and p85
(a subunit of PI3K), pointing to the necessity of internalisation for certain signalling
pathways to occur (Vieira et al., 1996).
One role for endosomal signalling might be to provide some temporal regulation of sig-
nalling, for example TGF↵ quickly dissociates from EGFR once the complex has reached
early endosomes due to high sensitivity to changes in pH, whereas EGF does not dissoci-
ate so readily and can therefore increase the duration of signalling (French et al., 1995).
Another role for such signalling is likely to be in spatially arranging molecules such
that particular signalling cascades can be driven while unwanted events are prevented
(Miaczynska et al., 2004). A more recent study took advantage of two systems, one to
specifically stimulate plasma membrane EGFR signalling and one to specifically stim-
ulate endosomal EGFR signalling (Wu et al., 2012). Their results showed that EGFR
signalling from the plasma membrane led to a gradual and lasting activation of ERK in
the nucleus, whereas endosomal EGFR signalling led to fast and short-lived ERK activa-
tion (Wu et al., 2012). The consequence of this was phosphorylation of the transcription
factor c-fos only following plasma membrane activation of EGFR but not following en-
dosomal EGFR activation. Another recent study conflicts with those that have shown
roles for endosomal signalling of EGFR (Sousa et al., 2012). By using dynamin-deficient
fibroblasts they were able to show that plasma membrane localised active EGFR was
able to stimulate normal MAPK activation as well as increased phosphorylation of Shc
and sustained Akt activation (Sousa et al., 2012).
A role for late endosomes in EGFR signalling has also become apparent. Taub and col-
leagues were able to manipulate cells so as to relocalise late endosomes from their usual
juxtanuclear location to two diﬀerent localisations: the periphery of the cell or clus-
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tered very close to the nucleus (Taub et al., 2007). The first manipulation didn’t aﬀect
transport of the activated receptor to late endosomes but did slow down the degradation
process and in this way promoted prolonged activation of ERK and another MAPK, p38
(Taub et al., 2007). The manipulation that led to late endosomes clustered close to the
nucleus resulted in slow transport of active EGFR from early endosomes to late endo-
somes causing prolonged activation of the receptor, however the delayed traﬃc appeared
to decrease ERK activation (Taub et al., 2007). Taken together these results show that
the spatial regulation of receptor location is of importance to signalling and that late
endosomes, as well as early, also have a role to play in EGFR signalling.
The studies mentioned above use a wide variety of experimental procedure and investi-
gate EGFR internalisation in a number of diﬀerent cell types. Some of the diﬀerences
and conflicting evidence could therefore be said to be cell-type specific or dependent on
the particular experimental procedures used.
1.7 Chemotaxis assays
There are a wide variety of assays to aid the study of chemotaxis and cell migration.
The choice of assay depends on the questions being asked and the how the results are
to be collected. Described here are a few of the common chemotaxis assays as well as
their advantages and disadvantages. A diagram of the set up of three of the assays can
be seen in Figure 1.8.
1.7.1 Transwell assay
Transwell assays (or Boyden chambers) involve seeding cells into an insert with a porous
membrane separating this insert from the lower compartment (Boyden, 1962; Toetsch
et al., 2009). The lower compartment contains a chemoattractant to stimulate migration
of the cells through the pores in the membrane. After the assay cells can be stained and
those which have migrated can be quantified. Disadvantages of the assay include that
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Figure 1.8: A simple diagram of some common chemotaxis assays. A) shows the set-up
of a Transwell assay, B) a Dunn chamber and C) an under-agarose assay.
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it cannot be imaged as migration is occurring, therefore is only an endpoint assay, and
the chemoattractant gradient cannot be sustained for more than a few hours (Pouliot
et al., 2013).
1.7.2 Dunn chamber
Dunn chambers were developed as a better version of the early Zigmond chamber (Zicha
et al., 1991; Zigmond, 1977). They involve a slide with two precise circular chambers
etched into it, separated by a bridge; cells go in one chamber and chemoattractant in
the other (Pujic et al., 2009). Once a coverslip is placed on top the creation of a shallow
chemoattractant gradient between the chambers occurs. Cells migrating over the bridge
can be visualised by microscopy. As with the Transwell assay, the Dunn chamber is not
able to maintain its gradient indefinitely (Toetsch et al., 2009). The small dimensions
of the assay and requirement for the manual application of adhesive mean it is also not
particularly user friendly.
1.7.3 Under-agarose assay
This assay involves punching wells into an agarose gel to which cells and chemoattractant
can be added (Heit and Kubes, 2003). A gradient diﬀuses from the chemoattractant well
and cells migrate in this direction. After several hours of migration the agarose can be
removed allowing for visualisation of the migrated cells by microscopy. Adaptations also
allow live cell imaging during the assay (Heit and Kubes, 2003). This assay has the
flexibility of being able to study multiple chemoattractants at once (Khademhosseini,
2008).
1.7.4 Microfluidic chambers
Assays based on microfluidics allow precise control of fluids and therefore stable gradient
production (Whitesides, 2006). Usually, cells are first injected into the chamber before
the gradient is generated and then migration examined (Pujic et al., 2009). Advantages
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of this system are the precise and rapid control of the gradient, allowing changes during
experimentation. One disadvantage of these systems is the high sheer stress generated
on the cells, therefore making the system unusable for some cell types (Pujic et al.,
2009).
1.7.5 3D migration assays
3D assays are used to bridge the gap between migration and invasion studies, and can be
used to analyse how cells react to chemoattractant in more physiological environments.
There are a wide variety of 3D migration assays available. In some respects the Transwell
assay can be considered a 3D migration assay as it can be modified to introduce a 3D
matrix of ECM components that the cells have to crawl through while migrating along
the gradient (Brekhman and Neufeld, 2009). At the other end of the spectrum of 3D
migration assays there exist assays such as organotypic assays where ECM components
and fibroblasts are used to create a more physiologically relevant environment, media
below the matrix can contain a chemoattractant and fluorescence microscopy can allow
imaging of cells migrating through the matrix (Dawson et al., 2011; Nobis et al., 2013).
1.8 TIRF microscopy
When imaging the plasma membrane microscopic techniques such as epi-flourescence
and confocal microscopy are not ideal, as fluorescence originating from intracellular re-
gions can obscure visualisation of the plasma membrane. By exciting only the adherent
plasma membrane of cells TIRF microscopy (also known as evanescent wave or evanes-
cent field microscopy) is able to overcome this.
In epi-fluorescence the incident beam hits the colver-slip-sample interface straight on,
meaning that all fluorophores within the sample are excited to the same extent (Matthey-
ses et al., 2010). Confocal microscopy benefits from the use of a highly focussed laser
combined with a small pinhole just prior to the detector which enables optical sectioning
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of a sample (Amos and White, 2003; Pitkeathly et al., 2012). However, these sections
are approximately 10 times the size of those achieved by TIRF and due to the incident
light propagating through the whole sample images are still contaminated with out of
focus fluorescence.
In TIRF the incident beam hits this interface at an angle greater than the ‘critical angle’,
as defined by Snell’s law (Mattheyses et al., 2010; Pitkeathly et al., 2012). By altering
the incident angle in this way TIRF ensures that the excitation light is reflected back
into the cover-slip (rather than passing straight through). As this occurs, some incident
energy creates a standing wave called the evanescent field, which forms the TIRF excita-
tion field (Figure 1.9; Axelrod 1981; Mattheyses et al. 2010). The evanescent field decays
exponentially with distance from the interface, creating an imaging depth of approxi-
mately 60-100 nm. Since no light penetrates deeper into the cell only fluorophores at or
near to the plasma membrane are illuminated. Consequently, images from TIRF have
high signal-to-noise ratio, adding to the advantages of using TIRF as the microscopic
method of choice when imaging the plasma membrane (Axelrod, 1981).
The ability of TIRF to excite fluorophores within 100 nm of the plasma membrane
make it highly valuable for imaging the dynamics of molecules at or near to the cell
surface. Although confocal microscopy can reduce the background fluorescence relative
to epi-fluorescence microscopy, TIRF benefits from a smaller and more specific region of
illumination, thereby providing clearer information about fluorophores associated with
the plasma membrane.
1.8.1 Possible issues with TIRF microscopy
Due to the nature of TIRF the cell type being imaged must be adherent. One consider-
ation to keep in mind is that the refractive index of the cells being imaged must be less
than that of the numerical aperture of the objective lens (not a problem for most cell
lines; Mattheyses et al. 2010).
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Figure 1.9: A diagram to demonstrate TIRF microscope. If the illumination light hits
the coverslip-sample interface at an angle greater than the ’critical angle’ TIRF will
occur and an evanescent field will be created which decays exponentially with distance
from the coverslip.
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Ensuring that the incident angle is higher than the critical angle is also a major prob-
lem encountered by TIRF users. If light propagates into the sample the image appears
similar to an epi-fluorescence image rather than TIRF, wherein background fluorescence
will contaminate the image (Mattheyses et al., 2010). As a general rule if the image can
be focused in more than one ‘z’ plane then the incident angle is too low and must be
increased. A related problem is that the TIRF lasers can become misaligned, causing a
field of view which is half in and half out of TIRF, or the complete inability to obtain
TIRF.
As with all forms of microscopy photobleaching can be a problem. Due to the small ‘z’
area being excited photobleaching will occur only to those proteins which remain within
the excitation field (plasma membrane and plasma membrane-associated proteins). Sol-
uble proteins may be found to photobleach less as they move in and out of the TIRF
excitation field (Mattheyses et al., 2010). This uneven photobleaching found in TIRF
must be considered, so as to not draw incorrect conclusions from imaging (eg. in cases
where photobleaching can be mistaken for endocytosis).
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Chapter 2
Materials and Methods
2.1 Cell Culture
MDA-MB-231 cells (HPA) were incubated at 37 C in 5% (v/v) CO2. Cells were grown
in Dulbecco modified Eagle medium (DMEM; Lonza) supplemented with 10% fetal calf
serum (FCS; Biosera) and 1% Pen/Strep (Lonza). PDAC cells (Kurt Anderson, The
Beatson Institute, Glasgow) were maintained in the same conditions as MDA-MB-231,
with the addition of G418 antibiotic to the media for the stably transfected cell lines
(see below).
2.2 Transfection
For cDNA transfection 5 x 105 cells were plated in 35 mm dishes 24 hours prior to
transfection to give approximately 80% confluence. For each dish transfection mixes of
4 µg cDNA with 250 µl of serum free media (SFM; Lonza) and 10 µl of lipofectamine
2000 (LF2000; Invitrogen) with 250 µl of SFM were made up. After waiting 5 minutes
the LF2000-containing mix was added to the mix containing cDNA followed by a 20
minute incubation period. The mixture was then added dropwise to cells and the cells
were incubated for 3 hours before the media was replaced. Assays with these cells were
performed 24 or 48 hours post transfection (depending on the cDNA construct and
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assay).
For siRNA transfections 2 x 105 cells were plated in 35 mm dishes 24 hours prior to
transfection. For each dish transfection mixes of 3 µl of siRNA with 200 µl SFM and 3 µl
DharmaFECT1 transfection reagent (Invitrogen) with 200 µl SFM were made up. After
waiting 5 minutes the DharmaFECT1-containing mix was added to the mix containing
siRNA followed by a 20 minute incubation period. The mixture was then added dropwise
to cells and the cells. Assays with these cells were performed 72 hours post transfection.
2.3 Plasmid constructs
Table 2.1 provides details of researchers from whom cDNA plasmid constructs were
obtained.
Table 2.1
Construct Source
 3-integrin-GFP Prof. Jonathan Jones, Northwestern University Medical
School, Chicago, IL, USA.
Caveolin1-GFP Prof. Ari Helenus, Swiss Federal Institute of Technology, Zurich,
Switzerland.
Caveolin1-mRFP Prof. Ari Helenus, Swiss Federal Institute of Technology, Zurich,
Switzerland.
Clathrin-dsRed Prof. Thomas Kirchhausen, Harvard Medical School,
Boston, MA, USA.
EGFR-GFP Dr. Alexander Sorkin, University of Pittsburgh, PA, USA.
GFP-clathrin Dr. Alexandre Benmerah. Institure Cochin, Paris, France.
NPY-mRFP Dr. Jyoti Jaiswal, George Washington University, Washington,
DC, USA.
Rab11a-mCherry Prof. Marino Zerial, Max Planck Institute of Molecular Cell
Biology and Genetics, Dresden, Spain.
mRFP-paxillin Dr. Maddy Parsons, King’s College London, London, UK.
PKD(K618N)-GFP Prof, Vivek Malhotra, The Centre for Genomic Regulation,
Barcelona, Spain.
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2.4 siRNA sequences
The non-silencing control (NSC) siRNA was a ON-TARGETplus Non-targeting pool
designed for use in mouse, rat or human cell lines. The ↵-adaptin siRNA was custom
made with target sequence 5’-AAGAGCAUGUGCACGCUGGCCA-3’ as used in pre-
vious studies (Motley et al., 2003; Huang et al., 2004; Rappoport and Simon, 2009).
The caveolin1 siRNA was a SMARTpool ON TARGETplus Human Cav1 siRNA from
Dharmacon containing a pool of 4 siRNAs targeted to human cavolin1 (Auciello et al.,
2013).
2.5 Bacterial transformation
If transforming from a previous cDNA preparation 1 µg of DNA was used, if dissolving
DNA from filter paper, as little water as possible was added to dissolve the DNA oﬀ
the paper and 3 µl of this was used. The DNA was added to 50 µl of MAX Eﬃciency
DH5↵ Competent Cells (Invitrogen) before being incubated for 30 minutes on ice. The
competent cells were then heat shocked to 42 C for 45 seconds in a water bath before
being put back on ice for 2 minutes. 500 µl of Luria Broth (LB; Sigma; Supplementary
methods 1) was added to the competent cells and they were then incubated with shaking
for 1 hour at 37 C. Following incubating 150 µl was pipetted and spread onto an LB
agar plate (Supplementary methods 2) containing antibiotic (kanamycin or ampicillin,
depending on the resistance present in the particular plasmid being prepped). Plates
were inverted and incubated overnight at 37 C. The following day two single colonies
were picked using a pipette tip and placed in a 15 ml Falcon tube containing 2 ml LB
plus 2 µl kanamycin or ampicillin. These were incubated with shaking at 37 C for 8
hours. Following this incubation 100 µl was taken from the Falcon tube and added to
100 ml of LB plus 100 µl of kanamycin and ampicillin. These were left shaking overnight
at 37 C. The LB-bacteria liquid was split into two 50 ml Falcon tubes and centrifuged
at 5000 rpm at 4 C for 15 minutes. The supernatant was subsequently discarded and
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the Qiagen Plasmid Maxi Kit (Qiagen) protocol followed for DNA purification. Purified
DNA was dissolved in 1 ml ultrapure water and the concentration calculated using a
spectrophotometer.
2.6 Creating stably transfected cell lines
To first establish a concentration of G418 that kills PDAC cells after by one week post
plating cells were plated into a 24 well plate. After 24 hours, when the cells had achieved
confluency, media containing diﬀering concentrations of G418 (Sigma) was added to
duplicate wells. The concentrations ranged from 0-1.4 mg/ml. Media was changed and
cells were observed every 2-3 days in order to find the lowest concentration that kills all
the cells after one week of G418 exposure. In this case the optimal concentration was
found to be 0.8 mg/ml. For making the stable cells lines cells were transfected with the
desired plasmid containing G418 resistance and the following day the media was changed
to that containing 0.8 mg/ml G418. Cells were cultured in the G418-containing media
for the whole course of experiments utilising them.
2.7 Western blotting
Western blot analysis was used to quantify the knockdown of siRNA constructs. Briefly,
cells were lysed in 1% Triton X-100 (Sigma) in phosphate-buﬀered saline (PBS; Lonza)
with protease inhibitors (Roche) and 3X sample buﬀer (Supplementary methods 3) was
added to a 2:1 ratio. Proteins were separated by SDS PAGE on a 12.5% acrylamide
resolving gel with a 4% acrylamide stacking gel (Supplementary methods 4), and then
transferred from the gel onto Immobilon-FL membrane (see Supplementary methods
5-8 for more information on solutions used). The membrane was blotted with primary
antibody overnight at 4 C and then with secondary antibody for 2 hours at room tem-
perature. Primary antibodies used were polyclonal rabbit anti-↵-adaptin (Invitrogen),
polyclonal rabbit anti-caveolin1 (BD Biosciences) and monoclonal mouse anti-tubulin
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(Sigma). Secondary antibodies used were anti-rabbit IRDye 800 and anti-mouse IRDye
680 (Li-Cor) for use in Odyssey. Quantification of knockdowns was done relative to
control tubulin using Odyssey software.
2.8 Agarose spot assay
Agarose spot assays were utilised to investigate chemotactic migration of the MDA-MB-
231 cells and PDAC cells (Wiggins and Rappoport, 2010). A 0.5% solution agarose was
made using low melting point agarose (Invitrogen) in PBS. The solution was heated to
boiling point, mixed thoroughly and allowed to cool to 45 C. Microcentrifuge tubes were
made up containing 10 µl PBS (for control) or 7 µl PBS + 3 µl EGF stock (1 mg/ml in
PBS; Bachem), to which 90 µl of the agarose solution was added. These were used to
plate 10 µl spots in 35 mm glass-bottomed dishes (MatTek Corporation). Dishes were
cooled to 4 C in a cold room for 5 minutes. After cooling 4 x 105 cells were plated in
each dish (same number of cells used for both MDA-MB-231 assays and PCDAC cell
assays). Dishes were incubated for 4 hours to allow cells to adhere before changing to cell
imaging media (see Section 2.13) with low (0.1%) serum content. Overnight time-lapse
imaging began directly after media change. TIRF imaging of migrating cells began 1
hour after media change to allow cells time to begin migrating.
For assays with EGF-containing media, the low serum media given after 4 hours con-
tained EGF at a concentration of 100 ng/ml.
For the Dynasore treatment assays the low serum media given after 4 hours contained
Dynasore (Sigma; 80 mM in dimethy sulphoxide (DMSO)) diluted to a final concentra-
tion of 80 µM. The control group was given media containing DMSO (Sigma) to the
equivalent volume as the Dynasore group.
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2.9 Transwell assays
Chemotaxis assays were carried out using 6 well Transwell plates (Corning Life Sciences)
containing 24 mm diameter semi-permeable membrane inserts with 8 µm pores. 2.6 ml
of media was added to each well. In wells receiving EGF treatment 1 µg/ml EGF was
also added. 5 x 105 cells were plated into each insert and the volume made up to 1.5
ml with media. The Dynasore group was treated with 80 µM in the media for both the
lower well and the insert. After 5 hours of incubation inserts were removed from the
plates, washed twice with PBS, and then fixed for 5 minutes in 4% Paraformaldehyde
(PFA; Electron Microscopy Sciences). After fixing, membranes were mounted into slides
using Vecta shield with DAPI (Vector Laboratories) to stain cell nuclei. Imaging was
done using a Nikon TE300 Inverted Epi-fluorescence microscope with a 40 x oil objective
lens (CFI Plan Apo 1.3 NA, Nikon).
2.10 Wound healing assay
For assessment of focal adhesion disassembly during wound healing cells were transfected
with siRNA 72 hours prior to wounding and cDNA 48 hours prior to wounding. 24
hours before wounding cells were replated into 35 mm glass-bottomed dishes to achieve
a confluent monolayer. Cells were wounded using a 200 µl pipette tip. For assessment of
migration following siRNA treatment cells were transfected with siRNA 72 hours prior
to wounding and then replated 24 hours before wounding onto glass-bottomed dishes.
Again, cells were wounded using a 200 µl pipette tip.
2.11 Endocytosis assays
Endocytosis assays were conducted to confirm the eﬀects of Dynasore treatment, ↵-
adaptin knockdown and caveolin1 knockdown on endocytosis. 24 hours before the assay
cells were plated onto cover slips in a 6 well plate. For assays with Dynasore each well was
rinsed with 2 ml SFM before incubation with 2 ml SFM containing the Dynasore at 80
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µM or the equivalent volume of DMSO for 30 minutes. A 10 minute incubation with just
SFM was used for assays utilising siRNA transfected cells. After this initial incubation
cells were then further incubated for 5 minutes with either Transferrin (Alexa Fluor R 
568 conjugate; Tf-AF568; Invitrogen) at 10 µg/ml or cholera toxin (Alexa Fluor R  555
conjugate; CTx-AF555; Invitrogen) at 1 µg/ml in 2 ml SFM. After incubation Tf568
wells were washed with acid PBS twice followed by a PBS wash; CTx555 wells were
washed twice with SFM followed by a PBS wash. Cover slips were fixed in 4% PFA for
5 minutes, before two final PBS washes. Cover slips were fixed to slides using ProLong
Gold (Invitrogen) before being imaged and analysed.
2.12 Exocytosis assays
Exocytosis assays were used to determine the eﬀect of Dynasore on traﬃcking from the
Golgi apparatus to the plasma membrane. Cells were transfected with either an neu-
ropeptide Y (NPY)-mRFP alone or NPY-mRFP and PKD dominant negative (PKD(K618N)-
GFP) together. Transfected cells were plated onto cover slips in a 6 well plate 24 hours
before the assay. Wells were washed with 2 ml SFM and then treated with 2 ml SFM
containing either the Dynasore to a concentration of 80 µM or the equivalent volume of
DMSO for 30 minutes. After incubation wells were washed twice with 2 ml PBS and
then fixed in 2 ml 4% PFA for 5 minutes. Cover slips were then fixed to slides using
ProLong Gold before being imaged and subsequently analysed.
2.13 Imaging and image analysis
All live cell imaging made use of cell imaging media (10 mM Hepes (Sigma), 9.7 g
Hank’s Balanced Salt Solution (Life Technologies) in 1 l dH2O, pH 7.4) with the re-
quired amount of serum dependent upon the experiment (0.1% FCS for agaose spot
assay, 5% for wound healing; Jaiswal et al. 2002).
For analysis by region cells were split into front, middle and back using an axis perpen-
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dicular to the spot edge (see Chapter 3 for more information on this analysis).
2.13.1 Endocytosis and exocytosis assays and Transwell assays
Imaging was achieved using a Nikon TE300 Inverted Epi-fluorescence microscope with
a 40 x oil objective lens (CFI Plan Apo 1.3 NA, Nikon). Using a Red/Green/Blue
multiband emission filter with excitation changed the desired colour (depending on the
fluorophore being used) using a Ludl filter wheel. Random fields of view from the slides
were imaged. For endocytosis and exocytosis assays analysis was done using ImageJ
software which allowed the drawing of a region of interest around the cell. Increasing the
contrast in brightfield images allowed accurate detection of the cell edge and switching
to the fluorescent image allowed a reading of the mean fluorescence intensity within
that cell to be displayed by Image J software (see Figure 2.1). Average background
fluorescence was measured by selecting regions where no fluorescence could be seen and
these values were taken away from the cell fluorescence values. For Transwell assays
simply the number of cells which had migrated through the membrane were counted in
each field of view.
2.13.2 Agarose spot assay: Overnight time-lapses
Overnight brightfield time-lapse imaging was done on a Nikon eclipse Ti inverted micro-
scope using a 10x air objective lens (CFI Plan Fluor 0.3 NA, Nikon). The microscope was
situated inside an Okolab incubator set to 37 C. The microscope system was controlled
by NIS elements AR. Regions around each spot were randomly selected for imaging;
generally two regions per spot. Images were taken every 10 minutes for 14 hours. For
counting number of cells migrated or distance migrated perpendicular to spot edge the
counting/measuring tools in NIS elements (version 3.1) were used. NIS elements man-
ual tracking software was used for all cell tracking analysis (see Figure 2.2). Cells were
chosen randomly for analysis but if at any point there was uncertainty over where a cell
had migrated too e.g. because it had migrated in very close proximity to other cells,
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Figure 2.1: Representative images of analysis of endocytosis and exocytosis assays. Con-
trast of brightfield images could be increased to ensure accurate drawing around the edge
of the cell. Image J software allowed quantification of mean fluorescence intensity within
each region.
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Figure 2.2: Images to show cell tracking analysis. A) Representative image cells after 14
hours timelapse. Using NIS Elements software cells can be manually tracked by clicking
on the cell in question in each frame of the timelapse. B) This image shows the track
produced from one cell and also details the distance measurements which would be used
for both ‘distance from edge’ and ‘distance from origin’ measurements.
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that analysis was ended and not counted and another cell was chosen to replace it. 100
cells were tracked per condition.
2.13.3 Agarose spot assay: TIRF imaging
Live cell TIRF imaging was performed using Nikon A1-R Ti TIRF system within in the
Nikon eclipse Ti inverted microscope with a 60x oil objective lens (CFI TIRF Apo 1.49
NA, Nikon). The microscope was situated inside an Okolab incubator set to 37 C. The
microscope system was controlled by NIS elements AR. All GFP constructs were excited
with the 488 nm lines of an Argon-Ion laser 457-514 nm. All RFP, dsRed or mCherry
constructs were excited with a green diode 561 nm laser. Image analysis was done using
NIS elements (version 3.1 or higher).
2.13.4 Colocalisation analysis
Colocalisation of  3-integrin and clathrin
Live cell TIRF imaging took place, imaging every 2 minutes for a total of 40 minutes.
All  3-integrin-GFP-labelled focal adhesions were circled in the green channel before
assessing the proportion that colocalised with clathin-dsRed in the red channel. A
technique whereby the eﬀect of shifting one channel relative to another one pixel at a
time and determining the eﬀect of this on the Pearson’s correlation coeﬃcient was also
used in this case to look at colocalisation by another method (Rappoport and Simon,
2003; Jones et al., 2014). In addition kymographs were made to assess the colocalisation
between  3-integrin-GFP and clathrin-dsRed and also paxillin-mRFP and clathrin-GFP.
Here a line was drawn across a 10 µm region of interest and a kymograph across this
region for 40 minutes was generated using NIS elements software.
Colocalisation of EGFR and clathrin or caveolin1
Static TIRF images were taken of live cells migrating into EGF spots. For colocalisa-
tion analysis of clathrin-dsRed or caveolin1-mRFP with EGFR-GFP 50 EGFR-positive
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structures in the green channel were circled, the number of these corresponding to a
clathrin/caveolin1-positive structure in the red channel was then recorded (see Figure
2.3 for representation of this colocalisation analysis). To assess random colocalisation,
the same 50 circled regions were moved slightly so that they corresponded to regions
where EGFR-GFP was not present; the number of these control regions which corre-
sponded to a clathrin/caveolin1-positive structure was recorded as the control value.
Colocalisation of EGFR and NPY or Rab11
Static TIRF images were taken of live cells migrating into EGF spots. NPY-mRFP or
Rab11a-mCherry-positive structures were circled in the red channel. Those correspond-
ing to EGFR-GFP-positive structures in the green channel were recorded. To assess
random colocalisation, the same circled regions were moved slightly so that they cor-
responded to regions where NPY-mRFP or Rab11a-GFP was not present; the number
of these control regions which corresponded to an EGFR-GFP-positive structure was
recorded as the control value.
2.13.5 Internalisation intensity profile
To create the intensity profile of a clathrin- and EGFR-positive structure disappearing
from the TIRF field a region of interest was drawn around the structure in both the red
and green channels. The instensity of this region of interest was measured over the time
course of the disappearance. Background intensity of each frame was taken away and
this value was divided by the area of the region to give intensity per unit area for both
the clathrin and EGFR clusters.
2.13.6 Cluster size analysis
For analysis of the apparent size of EGFR-GFP or clathrin-dsRed clusters the area cal-
culation tool in NIS elements was used. Cluster were excluded from analysis if there
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Figure 2.3: Representative image colocalisation analysis. Using EGFR-GFP and
clathrin-dsRed colocalisation analysis as an example: clusters of EGFR were drawn
around in the GFP image (increasing image brightness as necessary to accurately view
each cluster), switching to the dsRed image allowed analysis of whether the EGFR
clusters colocalised with a clathrin cluster. In the above image the arrows show repre-
sentative cluster which would be viewed as colocalised.
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were too close to another cluster to accurately see the edge and also in regions of ex-
cessive fluorescence possibly not stemming from cluster at the plasma membrane (eg.
fluorescence from the Golgi region). To draw around clusters, channel brightness was
increased to ensure entire cluster region was analysed (see Figure 2.4 for a representative
image of this analysis).
2.13.7 Clathrin internalisation analysis
For MDA-MB-231 cells live cell TIRF imaging was done with  400 ms exposure time
(corresponding to 2.5 frames per second) for one minute time-lapses. For analysis of in-
ternalisation events we looked for instances where clathrin-dsRed disappeared from the
evanescent field to indicate an internalisation event, as previously described (Rappoport
and Simon, 2003). The disappearance of clathrin from the evanescent field was taken
to be due to endocytosis only if it was not due to photobleaching, if it occurred rapidly
(within 10 frames of imaging) and if it did not reappear in the evanescent field within
10 frames of its disappearance. Analysis was done in relation to the front, middle and
back of migrating cells.
For PDAC cells live cell TIRF imaging was done with  200 ms exposure time (corre-
sponding to 5 frames per second) for one minute time-lapses. In the case of MDA-MB-231
cells the clathrin was generally static for the whole time-lapse or else it internalised. In
PDAC cells it appeared that the majority of clathrin was highly dynamic and moving
in a manner that suggested it was travelling along microtubules. Previously it has been
suggested that clathrin can move along microtubules prior to internalisation (Rappoport
et al., 2003b; Ezratty et al., 2009), so we analysed both the number of clathrin clusters
disappearing from the TIRF field as well as the number of these dynamic clathrin clus-
ters. Analysis was done in relation to the front, middle and back of migrating cells.
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Figure 2.4: Representative image of cluster size analysis. In NIS Elements softare bright-
ness of images was increased to ensure the most accurate region could be drawn around
the cluster. NIS Element analysis software was able to analyse the area of regions se-
lected.
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2.13.8 Focal adhesion disassembly analysis
During a wound healing assay live cell TIRF imaging of paxillin-mRFP in cells at the
edge of the wound took place. Regions of interest were drawn around focal adhesions
and intensity over time was monitored. The time from when the focal adhesion was
at its brightest until its intensity decreased to background was recorded as disassembly
time.
2.13.9 Wound closure analysis
For overall assessment of migration following wounding areas of the wound were imaged
by brightfield imaging using a Nikon eclipse Ti inverted microscope using a 10x air
objective lens (CFI Plan Fluor 0.3 NA, Nikon). Imaging took place from the point of
wounding for 14 hours, acquiring images every 15 minutes. Analysis using NIS elements
software involved drawing a line along the edge of the wound at the start and the end
of the time-lapse, then measuring the distance between these two lines as a number of
points to give the average distance of wound closure over the course of the time-lapse,
which could then be converted to average closure per hour.
2.13.10 Fusion analysis
For the verification of fusion events methods described by Schmoranzer and colleagues
were used (Schmoranzer et al., 2003). TIRF microscopy was used to image time-lapses
with EGFR-GFP as the cargo for vesicle fusion. Firstly, putative fusion events were
identified by examining the time-lapse for instances of high fluorescent intensity appear-
ing at the plasma membrane, before a decrease in fluorescence as the vesicle contents
diﬀuse in the plasma membrane. To verify fusion events two analytical methods were
used, the first being a line scan method using NIS elements line scan tool. A line scan
was drawn across the fusion area to measure the intensity of fluorescence in each pixel
along the time during the fusion process. A graph was produced plotting pixel number
against fluorescent intensity with each time point represented by a diﬀerent line. A true
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fusion event would have a sharp peak followed by the peak decreasing and widening as
the vesicle contents fuse and then diﬀuse laterally in the plasma membrane. The second
analysis method used was the draw a circular region of interest around the fusing vesicle
for each frame of the fusion and measure the fluorescence intensity of the region in each
frame. As area increases the intensity should first increase as the vesicle is coming into
closer proximity with the membrane and fusing with the membrane. At later stages the
area of the fluorescence intensity should increase but the total intensity should remain
fairly constant as the contents are diﬀusing within the plane of the plasma membrane.
2.13.11 FLIM-FRET imaging
Fluorescence lifetime imaging (FLIM) imaging took place at the Beatson Institute for
Cancer Research, Glasgow. FLIM measurements were achieved using a Lambert Instru-
ments fluorescent attachment on a Nikon Eclipse TE2000-U inverted microscope using
a 60x objective and a filter block with a 436/20 excitation filter, a T455LP dichroic
mirror, and a 480/40 emission filter. For FLIM-FRET a modulated 445 nm LED light
source was used for FLIM-FRET frequency domain measurements. Fluorescein (10 µM
in 0.1 M Tris-CL, pH   10) was used as a reference with known fluorescent lifetime
of 4 ns. Donor lifetime was analysed using LI-FLIM software (version 1.2.10, Lambert
Instruments). Regions of interest could be selected for lifetime measurements of a whole
cell or regions within a cell.
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Chapter 3
Investigating the role of vesicle
traﬃcking in chemotactic invasion
3.1 Introduction
As mentioned previously, the process of directed cell migration towards a source of at-
tractant is known as chemotaxis and is vital to the intravasation and extravasation stages
of metastasis (Condeelis and Segall, 2003). Chemotaxis is triggered by the binding of
chemoattractant molecules to cell surface receptors (e.g. EGF binding to its receptor)
(Bagorda et al., 2006). Activation of such receptors results in a complex signalling
cascade that leads to polarisation of the cell in the direction of migration, increased
contractility and subsequent directed motility (Bagorda and Parent, 2008).
In order to fully control important aspects of migration cells must have the ability to
regulate surface localisation of both chemoattractant receptors and adhesion molecules.
The process of vesicle traﬃcking aﬀords the cell such control and therefore must be
taken into account for a detailed understanding of cell migration (Fletcher and Rap-
poport, 2010). As previously mentioned vesicle traﬃcking can be split into three main
pathways (endocytosis, endosomal recycling and exocytosis) each of which is split further
into sub-pathways (eg. short-loop recycling and long-loop recycling as two sub-pathways
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in the wider traﬃcking process of endosomal recycling). Here we concentrate specifically
on endocytosis and aim to elucidate the endocytic transport routes necessary to MDA-
MB-231 cells migrating towards EGF.
Many assays exist to study cell directed cell migration, from Dunn chambers and Tran-
swell assays, to more recently developed assays such as the Insall chamber (Zicha et al.,
1991; Boyden, 1962; Muinonen-Martin et al., 2010). In the present study we use a rel-
atively new assay which is simple and cheap to perform and allows for use in multiple
microscopy set-ups. Figure 3.1 depicts a diagram of the agarose spot assay from the view
of the user. For more information about the agarose spot assay please refer to Wiggins
and Rappoport 2010 or Section 2.8. In this chapter we aim to further characterise
the assay and then use it to investigate the importance of endocytosis in EGF-directed
chemotactic invasion of MDA-MB-231 cells.
3.2 Results
3.2.1 Characterisation of the agarose spot assay
To study the response of cells to the chemoattractant EGF we employed a chemotactic
invasion assay in which cells migrate into an agarose spot containing EGF (hereafter re-
ferred to as EGF spots; Wiggins and Rappoport 2010). Further characterisation of the
assay was necessary to rule out that chemokinesis could be the cause of migration. Con-
trol experiments were undertaken using agarose spots containing PBS (hereafter referred
to as PBS spots) to represent an unstimulated condition. The same condition with the
addition of EGF to the media was used to stimulate chemokinesis (hereafter referred to
as chemokinetic control), in order to compare the migration seen in this condition with
that seen into EGF spots.
Data obtained from 14 hour brightfield time-lapses of these control conditions includes
the number of cells which migrated into the spot area, as well as the distance migrated,
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Figure 3.1: Diagram of the agarose spot assay; side-on view and a view from above.
The assay is done in 35mm glass-bottom dishes. Depicted in blue are the agarose spots,
four of which can fit comfortably in one dish. The close-up views show cells around the
agarose spots and those migrating under the spots.
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the average velocity of migrating cells and the directionality of the migrating cells. As
expected the number of cells which had migrated into the agarose spots was significantly
higher for those containing EGF than PBS (Figure 3.2). In the case of the chemotactic
control the number of cells which had migrated was intermediate to these results indi-
cating that the EGF in the media is able to stimulate migration but not to the same
extent as the EGF spots themselves (Figure 3.2).
In order to determine whether cells not in the direct vicinity of the agarose spots were
aﬀected by chemoattractant cells were tracked using NIS elements tracking software to
ascertain the velocity and total path length over the course of the time-lapse. Cells
away from the spots in dishes with PBS or EGF spots were not significantly diﬀerent
from one another in terms of distance migrated and average velocity, but the cells of
the chemotactic control migrated significantly further and faster than the other two
conditions (Figure 3.3A). This therefore suggests to us that cells undergo chemokinesis
when in EGF media but that the EGF from the agarose spots does not aﬀect cells in
regions away from the spots in this chemokinetic way.
Similar tracking analysis was applied to cells migrating into the agarose spots. Results
indicate that cells migrate much further and faster into EGF spots than PBS spots,
even when EGF is present in the media of the PBS spot dishes as in the chemotactic
control (Figure 3.3B). When comparing velocity of cells tracked from inside and outside
the agarose spots it is evident that there is no real diﬀerent between cells of the PBS
spots and cells of the chemotactic control, however a significant increase is seen in the
average velocity of those cells with EGF spots (Figure 3.3C). This indicates that the
EGF in the agarose spots is causing directed migration within the spot, and that any
migration seen as a result of EGF in the media is as a result of chemokinesis rather than
chemoattractant-directed migration. The distance migrated by cells in the chemotactic
control is much lower inside the agarose spot than out of it, suggesting that the agarose
spot itself poses a physical barrier to normal migration. This result adds to the point
that EGF spots stimulate migration into them as these cells travel significantly further
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Figure 3.2: Migration of MDA-MB-231 cells into PBS and EGF spots and PBS spots
with EGF-containing media. A) Representative images taken from the start point and
end point of 14 hour time-lapses in control experiments. The top panel shows migration
into a PBS spot, the middle shows migration into an EGF spot and the bottom panel
shows migration into a PBS spot with EGF present in the surrounding media. The line
denotes the edge of the agarose spot. All scale bars are 50 µm. B) Graph to show the
total number of cells migrated in the three conditions. n = 3 experiments with a total
of 24 spots analysed per condition. Error bars represent standard error of the mean,
significance determined by one way ANOVA followed by Tukey’s post-test, ** denotes
p-value < 0.01, *** denotes p-value < 0.001.
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Figure 3.3: Graphs to show the total path length and the average velocity of migrating
MDA-MB-231 cells both away from (A) and in the agarose spot (B). In (A) it can be
seen that cells away from the spot in dishes containing PBS and EGF spots do not
migrate significantly diﬀerently from one another, but that those in the chemotactic
control migrate significantly further and faster. When looking at cells migrating into
agarose spots in (B) it can be seen that both the distance migrated and velocity of
cells is significantly increased only for those migrating into EGF spots, compared to the
other two conditions. (C) compares the velocity data from the graphs on the right of
(A) and (B) in order to directly compare the aﬀect the spot has on the average velocity
of migration. n = 3 experiments with a total of 35 cells analysed per condition. Error
bars represent standard error of the mean, significance determined by one way ANOVA
followed by Tukey’s post-test, ‘ns’ denotes p-value   0.05 (not significant), ** denotes
p-value < 0.01, *** denotes p-value < 0.001.74
in the spots even with this barrier to overcome.
Control time-lapses were also used to establish the overall direction of migration taken
by cells within agarose spots. For later analyses following TIRF imaging we wanted
to split cells into regions of front, middle and back. For this analysis it would not be
possible to tell the direction that the cell was travelling in as this imaging involved taking
short rapid time-lapses or static images, and were therefore not over a long enough time
course to view the direction of migration at the time of imaging. From observation it
was also noted that the migrating MDA-MB-231 cells do not always have a well-defined
lamellipodia region, therefore we also have to discount this as a way of identifying the
front of the cells.
One theory was to assume the cells were travelling perpendicular to the spot edge and
use this axis to assign the front, middle and back of migrating cells. We decided to
investigate this assumption further in order to decide whether this was a satisfactory
method of splitting the cell into regions. We used two methods to calculate the trajectory
of migrating cells with regards to the perpendicular. In each case we noted the position
of the cell when it entered the agarose spot and the position at the end of the time-
lapse. We then drew a line perpendicular to the edge of the agarose spot at the time
the cell was at the spot edge (green line in Figure 3.4) and another straight line from
the cell’s start position to its end position (blue line in Figure 3.4). We then measured
the angle between these two lines. In our first method our aim was to see whether cells
have a propensity to travel to the left or right of the perpendicular axis or straight on
into the spot. For this reason we recorded angles to the right as positive numbers and
angles to the left as negative; in the diagram in Figure 3.4A we would therefore record
the angle of the red cell as +10  and the angle of the blue cell as -30 . Repeating this
analysis over 91 cells gave us an average angle of +5.04  with a standard error of the
mean (SEM) of 2.20  showing that overall the cells have a very slight deviation to the
right of the perpendicular and that the spread of the data is low. The second method
aimed to test the directionality of cells regardless of whether it was to the right or the
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Figure 3.4: A diagram of a field a view of an agarose spot with trajectories for two
migrating cells. The diagram shows how the angles were measured to determine how
far cells travelled from a perpendicular axis at their start point. The perpendicular is
shown by a green line and the actual overall direction of the cell shown by a blue line.
n = 3 experiments with a total of 91 cells analysed.
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left of the perpendicular, so the values from diagram in Figure 3.4 would simply be
10  and 30 . Repeating this analysis over 91 cells gave us an average angle of 16.97 
with an SEM of 1.38 . In this way the cells are migrating slightly oﬀ course from the
perpendicular but not to a large degree and the spread of the data is low. This data
supports observations by Wiggins et al. who noted that the movement of cells into
agarose spots was ‘progressive and directed’ (Wiggins and Rappoport, 2010). For later
analysis involving establishing the front, middle and back of migrating cells splitting
the cell into these regions was achieved using a line perpendicular to the edge of the
agarose spot and dividing this into three equal lengths. Where stated, analyses were
then normalised to the area of each region to account for their diﬀerent sizes.
3.2.2 Inhibition of dynamin-dependent mechanisms of endocy-
tosis decreases chemotactic invasion
Dynamin2 is a large GTPase shown to be vital for both clathrin-mediated and caveolar
routes of endocytosis (Hill et al., 2001; Nabi and Le, 2003). Dynasore is a small molecule
inhibitor of dynamin and was used to inhibit dynamin-dependent endocytosis in the
chemotactic invasion assay (Macia et al., 2006). We tracked cells exposed to Dynasore
in 14 hour time-lapses to elucidate the necessity for these routes of endocytosis on EGF-
directed cell migration. In order to establish the success of our inhibition strategy we
analysed how eﬃciently Dynasore inhibited the internalisation of transferrin and Cholera
toxin Subunit B (as markers of clathrin-mediated endocytosis and caveolar endocytosis,
respectively; see Figure 3.5).
Tracking data from 14 hour time-lapses of cells treated with Dynasore showed a signif-
icant decrease in the number of cells able to migrate into the EGF spots as well as the
total path length migrated, the distance from the origin and the average velocity (see
Figure 3.6). Interestingly, Dynasore also aﬀected the elliptical factor of cells (as found
by measuring the longest axis of the cell and measuring the width at the middle point
77
Figure 3.5: Endocytosis controls for Dynasore treatment. A) Representative images of
Tf568 (left panels) and CTx555 (right panels) endocytosis ligands in MDA-MB-231 cells
treated with DMSO (as control) or 80 µm Dynasore (to inhibit endocytosis). Ligand
uptake was allowed to occur for 5 minutes before excess ligand was washed oﬀ and cells
were fixed. Scale bars are 50 µm. B) Graph of transferrin uptake showing 60% inhibition
in cells treated with Dynasore and graph of Cholera toxin uptake showing 52% inhibition
in cells treated with Dynasore. n = 3 experiments with a total of 60 cells analysed per
condition. Error bars represent standard error of the mean, significance determined by
two-tailed unpaired student’s t-test. *** denotes p-value < 0.001.
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of the length, then dividing the width by the length to give a number between 0 and
1, where 1 would be a perfectly round cell), causing them to become significantly more
elongated (Figure 3.6). However, Dynasore had no eﬀect on the directionality of the
migrating cells as calculated either by the distance of the cell from its origin divided by
its total path length or by the straight line distance of the cell perpendicular to the edge
of the agarose spot divided by the distance from its origin (Figure 3.6).
In combination with the agarose spot assay we also used Transwells as another means
of testing the eﬀect of Dynasore on EGF-directed migration. Transwells are an end-
point chemotaxis assay that allows the production of a gradient of chemoattractant
between an upper and lower well separated by a membrane. Cells travel towards higher
chemoattractant concentrations by crawling through pores in the membrane to the lower
surface of the membrane and can then be visualised by staining and using fluorescent mi-
croscopy. The results of this assay corroborated those of our agarose spot assay, namely
that migration was inhibited by 94% in the presence of the drug when compared with
the control condition (see Figure 3.7).
Although the above data suggest that inhibition of dynamin-dependent endocytosis pre-
vents chemotactic invasion, such a conclusion cannot be drawn from this data alone.
Dynamin has roles in other cellular processes including exocytosis from the Golgi (Jones
et al., 1998), Dynasore treatment may therefore aﬀect other pathways in addition to
endocytosis. Exocytosis assays were used to assess the impact of Dynasore on exocytic
traﬃcking from the Golgi-apparatus. We utilised the secretory cargo neuropeptide Y
tagged to red fluorescent protein (NPY-mRFP) as a marker for PKD-mediated exocytic
traﬃc (Fletcher, 2012). Fluorescence intensity was measured in cells treated with DMSO
as a reference for NPY-mRFP intensity under normal traﬃcking conditions and this was
compared with Dynasore treated cells. We also made use of a dominant-negative form of
PKD (PKD(K618N)), which is a kinase dead mutant shown to inhibit vesicle production
at the trans-Golgi-network and fission of vesicles with the plasma membrane (Liljedahl
et al., 2001). This dominant-negative PKD was used as a comparison; if Dynasore was
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Figure 3.7: Dynasore inhibits MDA-MB-231 cell chemotaxis towards EGF in Transwells.
A) Representative images of cells on the Transwell membrane focussed on the underside
of the membrane. Scale bars are 50 µm. B) Quantification of cells migrated per field
of view following DMSO and Dynasore treatment. n = 3 experiments with a total of
  45 cells analysed per condition. Error bars represent standard error of the mean,
significance determined by two-tailed unpaired student’s t-test, *** denotes p-value <
0.001.
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to inhibit NPY-mRFP exocytosis we wanted to know whether this is to the same or a
lesser extent of the PKD dominant-negative.
Treatment of NPY-mRFP transfected cells with Dynasore increased NPY retention by
68% over control DMSO cells, to a level comparable to cells expressing a PKD dominant
negative (84% retention compared to control DMSO cells, Figure 3.8) Thus, in our sys-
tem Dynasore also has a significant inhibitory eﬀect on post-Golgi exocytic traﬃcking.
3.2.3 Clathrin-mediated endocytosis, but not caveolar endocy-
tosis, is required for EGF-directed cell migration
To more specifically inhibit endocytosis siRNAs were employed against proteins found
to be vital for clathrin-mediated and caveolar endocytosis. siRNA against ↵-adaptin
(a subunit of AP2) was used to inhibit clathrin-mediated endocytosis and was found
to give consistant knockdown with an average of 32% protein remaining (Figure 3.9A,
B). To specifically inhibit caveolar endocytosis siRNA against caveolin1 was used, this
construct consistently knocked-down caveolin1 with an average of 8% protein remaining
(Figure 3.9A, B). The ability of the siRNAs to inhibit transferrin uptake and Cholera
toxin Subunit B uptake, respectively, was also established (Figure 3.9C, D). Transferrin
uptake was inhibited by 45% under ↵-adaptin knockdown conditions, and Cholera toxin
uptake was inhibited by 50% under caveolin1 knockdown conditions.
Analysis of cells migrating into EGF spots showed the siRNA against ↵-adaptin signif-
icantly inhibited the number of cells able to migrate (Figure 3.10). The cells still able
to migrate showed a number of diﬀerences including a decrease in directionality and the
cells were slightly more rounded than control, however these diﬀerences were only small
compared to the earlier results with Dyansore treatment. Inhibition of caveolar endocy-
tosis by knockdown of caveolin1 had no eﬀect on the number of cells able to migrate and
no significant diﬀerences in most of the tracking parameters analysed (Figure 3.10). The
82
Figure 3.8: Inhibition of NPY-mRFP exocytic traﬃcking by Dynasore. NPY-mRFP
was transfected into MDA-MB-231 cells and used as a marker of exocytic traﬃcking.
DMSO treatment was used to assess normal traﬃcking, while cells also transfected with
dominant negative PKD (known to inhibit vesicle production at the Golgi) were used
to assess NPY-mRFP build up when its traﬃcking is inhibited. These controls could be
used to compare the eﬀect of Dynasore treatment on Golgi-derived traﬃcking. A) shows
representative images of NPY-mRFP under conditions of DMSO (negative control),
PKD-dominant negative (positive control) and Dynsore. B) Treatment with Dynasore
increased intracellular accumulation of NPY-mRFP to a level comparable to that of
the PKD dominant negative. n = 3 experiments with a total of 40 cells analysed per
condition. Error bars represent standard error of the mean, significance determined by
one way ANOVA followed by Tukey’s post-test, ‘ns’ denotes p-value  0.05, ** denotes
p-value < 0.01, *** denotes p-value < 0.001.
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Figure 3.9: Controls for ↵-adaptin and caveolin1 siRNA. A) Western blot of remaining
protein following treatment with non-silencing siRNA (NSC), ↵-adaptin siRNA and
caveolin1 siRNA. B) Graphs show the quantification analysis of protein knockdown. In
each case the NSC is normalised to 100% and percentage protein remaining is calculated.
Average amount of ↵-adaptin remaining was 32% in ↵-adaptin siRNA treated cells;
average amount of caveolin1 remaining in caveolin1 siRNA treated cells was 8%. n  
3 western blots per quantification analysis. Error bars represent standard error of the
mean, significance determined by two-tailed unpaired student’s t-test, *** denotes p-
value < 0.001. C) Representative images of Tf568 uptake in NSC ↵-adaptin siRNA
treated cells (left panel) and CTx555 uptake in caveolin1 siRNA treated cells (right
panel). D) Quantification of transferrin and Cholera toxin uptake; transferrin uptake
was inhibited by 45% in ↵-adaptin siRNA treated cells and Cholera toxin was inhibited
by 50% in caveolin1 siRNA treated cells. n = 3 experiments with a total of 60 cells
analysed per condition. Error bars represent standard error of the mean, significance
determined by two-tailed unpaired student’s t-test, *** denotes p-value < 0.001.
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Figure 3.10: ↵-adaptin siRNA inhibits MDA-MB-231 cell migration into EGF spots,
Cav1 siRNA does not inhibit MDA-MB-231 cell migration into EGF spots. A) Repre-
sentative images of cells treated with control siRNA, ↵-adaptin siRNA and caveolin1
siRNA after 14 hours migration into EGF spots. Line denotes edge of the agarose spot.
Scale bars 100 µm. B) Results of tracking cells over the course of the time-lapses. Pa-
rameters analysed were total number of cells migrated, total path length, distance from
origin, average velocity, elliptical factor and two measures of directionality. n = 4 ex-
periments with 100 cells analysed per condition. Error bars represent standard error of
the mean, significance determined by one way ANOVA followed by Dunnett’s post-test,
‘ns’ denotes p-value   0.05, * denotes p-value < 0.05, ** denotes p-value < 0.01, ***
denotes p-value < 0.001.
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caveolin1 knockdown cells did have a higher average velocity and distance from origin,
compared to control, but again these diﬀerences were only minor.
3.3 Discussion
The agarose spot assay was first developed by Wiggins and Rappoport as an inexpen-
sive, relatively simple assay for chemotactic invasion (Wiggins and Rappoport, 2010).
They showed that the assay could give highly reproducible results and that migration
into EGF spots was significantly higher than migration into control PBS spots. The
results of their preliminary studies, however, couldn’t rule out the possibility that EGF
was increasing chemokinesis of the cells in general and that it wasn’t specific to the cells
crawling under the spot. Control assays of PBS spots with EGF present in the sur-
rounding media were undertaken to stimulate chemokinesis and compare this condition
with those of PBS or EGF spots alone (Figures 3.2 & 3.3). The migration into these
chemotactic control was significantly slower and less far than migration into EGF spots,
but faster than those into regular PBS spots, indicating that the migration we observe
into EGF spots is in fact, not chemokinesis.
Analysis of the migration of cells not directly in the vicinity of the agarose spots also
took place (Figure 3.3A, C). It was found that cells in dishes with PBS or EGF spots
behave very similarly in terms of path length and velocity, suggesting that the EGF
aﬀects only cells close to the spot and does not seep out to cause chemokinesis of cells
further from the spot edge. The cells in the chemotactic control migrate much further
and faster than either of the other two groups when tracked in areas away from the spot,
providing further evidence that this mode of migration is chemokenesis.
On analysis of the directionality of cells migrating under the EGF spots it was found
that the average trajectory was 5.4  to the right of a perpendicular axis from the spot
edge, meaning overall the cells are migrating in a directional manner. If direction is dis-
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counted from this analysis the angle becomes 16.97  which is still only a minor deviation
from the perpendicular. Overall this result suggests that within the spots cells migrate
in a directional manner; and this can be used to establish front, middle and back regions
of the cell for later analysis.
The agarose spot assay was used to analyse migration of a large population of MDA-
MB-231 cells under various inhibitory conditions. We showed that Dynasore inhibits the
number of cells able to migrate as well as a number of other parameters analysed (Figure
3.6). However, we also showed that Dynasore aﬀected exocytosis in these cells, thereby
meaning we have to be cautious when interpreting results as a consequence of this drug
(Figure 3.8). With Dynasore aﬀecting exocytosis it is possible that the results we saw
were due to a decrease in receptors and adhesion molecules made available to the cell
surface through this inhibition, rather than due to a decrease in their internalisation.
From our results there is no way to distinguish between these possibilities. However, it
seems likely that both plasma membrane-based endocytic events as well as Golgi-derived
fission events would be necessary for migration and thus it can be stated that dynamin
is required for EGF-directed migration in our system.
We used siRNA to more specifically inhibit two endocytic pathways: ↵-adaptin siRNA
to inhibit clathrin-mediated endocytosis and caveolin1 siRNA to inhibit caveolar endo-
cytosis. In the case of ↵-adaptin siRNA we saw a large decrease in the number of cells
able to migrate but of those still able to migrate diﬀerences in the other parameters
measured were either small or non-existent. This was diﬀerent to the case of Dynasore
where large diﬀerences were seen in the total path length, velocity and other param-
eters. The ↵-adaptin protein knockdown in these cells was 68% meaning 32% of the
protein remained. We do not know whether this means that all cells had 32% of the
protein remaining or that 68% of cells were knocked down to 100% leaving 32% of cells
with no knockdown, or somewhere in between. Since the cells that still migrate aren’t
very dissimilar to control cells in most parameters we postulate that these represent a
population of cells unaﬀected or only partially aﬀected by the siRNA. It therefore seems
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that ↵-adaptin (and therefore clathrin-mediated endocytosis) is necessary for migration
of MDA-MB-231 cells.
In contrast to this caveolin1 knock-down had little eﬀect on any of the migratory param-
eters measured and so it seems likely that in our system clathrin-mediated endocytosis
but not caveolar endocytosis is necessary for MDA-MB-231 cell migration. However,
an argument must be made for a possible compensatory role for caveolin2 in migration
when caveolin1 is knocked-down. Caveolin2 is often thought of as unnecessary for caveo-
lar endocytosis and in fact caveolin2-null mice have been shown to form normal caveolae
(?). However, this does not fully discount a role for caveolin2 in caveolar formation
in all systems. Experiments in MDA-MB-231 cells have shown a role for caveolin2 in
tumour progression, specifically enhancing tumour proliferation and survival, though
this tumour promoting role was not linked to an ability to undergo caveolar endocytosis
(Shatseva et al., 2011). Other studies back-up the previously discussed lack of a role
for caveolin2 in caveolae formation. Sotgia et al. found that caveolin2 expression could
not rescue caveolae formation in caveolin1-null cells, but that caveolin1 or caveolin3 ex-
pression could (Sotgia et al., 2002). Conclusions drawn from other studies propose that
caveolin1 is necessary for transport of caveolin2 to the plasma membrane and that in
its absence, caveolin2 is simply degraded (Sowa, 2011). Taking the above into account,
a role for caveolin2 in caveolar endocytosis cannot be ruled out, therefore there is a
chance of a compensatory role for this protein when caveolin1 is knocked-down. In light
of the evidence, however, it seems likely then that by knocking down caveolin1 we were
preventing all caveolar endocytosis in our system and therefore our results show that in
MDA-MB-231 cells caveolar endocytosis is not required for EGF-directed migration.
3.4 Key chapter findings
• Our chemotactic invasion assay is specific for chemotaxis and not chemokinesis
and cells move directionally under the agarose spots.
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• Dynamin is necessary for EGF-directed migration of MDA-MB-231 cells in our
chemotactic invasion assay.
• Clathrin-mediated endocytosis is necessary for EGF-directed migration of MDA-
MB-231 cells in our chemotactic invasion assay, but caveolar endocytosis is not.
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Chapter 4
Clathrin mediated endocytosis is not
required for focal adhesion disassembly
in migrating MDA-MB-231 cells
4.1 Introduction
Research into the role of endocytosis during chemotactic invasion is currently limited.
Both chemoattractant receptors and focal adhesion components represent potential en-
docytic cargoes which are also likely to have roles in cell migration. Focal adhesions
serve as points of contact between the ECM and the actin cytoskeleton (Ridley et al.,
2003). Fully formed focal adhesions are complexes multiple proteins including those
which link the adhesion to actin, signalling proteins and integrins which link the actin
cytoskeleton to the ECM (Huttenlocher and Horwitz, 2011). Integrins are integral to
focal adhesions as they are membrane bound heterodimers that bind ECM ligands as
well as providing sites for binding of structural and signalling proteins that make up
the focal adhesion itself. Through interaction with myosin II via actin focal adhesions
serve as sites for traction force, thereby allowing the cell to move (Lauﬀenburger and
Horwitz, 1995; Sheetz et al., 1998; Beningo et al., 2001). Factors aﬀecting focal adhesion
dynamics, including their turnover, can aﬀect many aspects of migration.
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Endocytosis of integrins has been proposed as a mechanism of focal adhesion disassem-
bly under certain conditions (Fabbri et al., 2005; Panicker et al., 2006; Nishimura and
Kaibuchi, 2007; Caswell and Norman, 2008). Most  -integrin subunits have NXXY mo-
tifs in their cytoplasmic regions which points to an involvement of clathrin-mediated
endocytosis in their internalisation, however until recently little other evidence could be
gleamed that this motif does in fact aid internalisation of these integrins and even mu-
tating the motif was shown to have no eﬀect on the rate of internalisation of  -integrins
(Ylänne et al., 1995). More recently studies have found that a subpopulation of  1-
integrins which associate with the tetraspanin CD151 internalise via an AP2-dependent
route (Liu et al., 2007; Nishimura and Kaibuchi, 2007). However, there is much evidence
for clathrin-independent internalisation routes for the internalisation of integrins, with
studies linking particular integrins to caveolae (Caswell and Norman, 2008). Caswell
and Norman conclude that the types of internalisation pathways followed by integrins is
determined by multiple factors including the region of the cell the integrin is in, the mi-
gratory status of the cell and the method of detection of integrin internalisation (Caswell
and Norman, 2008).
During migration there is a need for focal adhesions to be present at the front of mi-
grating cells for the migratory traction force to control cell movement. Early work has
shown recycling of integrins from the rear of migrating cells as a way to provide integrins
to newly forming adhesions at the leading edge (Bretscher, 1989; Lawson and Maxfield,
1995; Pierini et al., 2000). Laukaitis and colleagues propose a model for endocytosis of
integrins to serve two functions; the first being internalisation of unliganded integrins
at the lamellipodial region and the second being internalisation at the cell rear followed
by traﬃcking to a PNRC (Laukaitis et al., 2001). The group also suggest that focal
adhesion disassembly is preceded by cleavage of the integrin-substrate complex from the
rest of the adhesion, a process which marks the initiation of disassembly.
Two papers from 2009 discuss a necessity for clathrin in integrin endocytosis, and thereby
focal adhesion disassembly, during cell migration (Chao and Kunz, 2009; Ezratty et al.,
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2009). The first study used human fibrosarcoma HT1080 cells to show colocalisation
between  1-integrin and components of the clathrin internalisation machinery and also
found that knockdown of dynamin2 on its own or DAB2 and AP2 together led to a
build-up of  1-integrins on the cell surface (Chao and Kunz, 2009). They postulate that
two NPXY motifs in the integrin bind to AP2 and DAB2 to enable its endocytosis by
the clathrin-mediated pathway. They also indicate that the lack of evidence of this motif
leading to internalisation of integrins thus far might be due to the necessity of integrin
activation to occur before this motif can bind endocytic machinery (Chao and Kunz,
2009). In the second study, using NIH3T3 fibroblasts, Gunderson’s group showed that
knocking down CHC led to an inhibition of focal adhesion disassembly of up to 80%
(Ezratty et al., 2009). They also used TIRF microscopy to show recruitment of clathrin
to  1-integrin-GFP as focal adhesions were disassembling, and in many cases clathrin
was seen to leave the TIRF field at the same time as  1-integrin punctae. Ezratty et al.
also point to a requirement for the alternative adaptor Dab2 (Ezratty et al., 2009).
In contrast to the two above mentioned studies in 2011 Gu et al. found integrin traﬃck-
ing to occur via circular dorsal ruﬄes (CDR) and marcopinocytosis as the adhesion was
being disassembled (Gu et al., 2011). The group showed  3-integrin to colocalise with
markers of CDR when fibroblasts were stimulated with platelet derived growth factor
(PDGF; Gu et al. 2011). The study was also expanded to other cell types and growth
factors (including EGF-stimulated MDA-MB-231 cells) and integrins were also found to
redistribute to CDRs in these situations. Gu et al. found this CDR-based internalisa-
tion of integrins to be dependent on brefeldin A-ADP-ribosylated substrate (BARS; a
molecule necessary for micropinocytosis) but independent of both clathrin and caveolin1.
The authors state that perhaps clathrin or caveolin1-dependent endocytosis of integrins
may represent a basal internalisation method for integrin internalisation but that under
growth factor stimulation macropinocytosis may be necessary to ensure correct integrin
internalisation and recycling (Gu et al., 2011). In a similar vein Fletcher et al. examined
focal adhesions during wound healing of MDCK epithelial cells (Fletcher et al., 2012).
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They saw no colocalisation between clathrin-dsRed and  3-integrin-GFP nor between
clathrin-GFP and paxillin-mRFP in migrating cells and also found no increase in the
number or size of focal adhesions present in migrating cells when clathrin-mediated en-
docytosis was inhibited using Eps15 EH29 mutant or caveolar endocytosis was inhibited
using Cav1Y14F mutant (Fletcher et al., 2012).
Here we aim to elucidate whether clathrin-mediated endocytosis is important for focal
adhesion turnover in MDA-MB-231 cells during EGF-directed migration.
4.2 Results
4.2.1 Colocalisation of endocytosis markers and focal adhesions
As shown previously in Figure 3.6 treating migrating cells with Dynasore to inhibit
dynamin causes a dramatic decrease in the number of cells able to migrate. Interestingly
those still able to migrate exhibit an elongated phenotype compared to control cells. This
elongated phenotype led us to postulate that a fault was occurring in the disassembly of
focal adhesions and therefore that perhaps clathrin-mediated endocytosis was involved in
their disassembly under normal conditions. Such necessity for clathrin in focal adhesion
disassembly has been observed in other cell types (as outlined previously) but has not
been universally observed.
To test this hypothesis of a role for clathrin in focal adhesion disassembly in migrating
MDA-MB-231 cells we used TIRF microscopy, a technique which allows illumination
of only fluorophores present within ⇠100 nm of the adherent plasma membrane (see
Figure 1.9). In this way we examined the colocalisation between clathrin-dsRed and  3-
integrin-GFP in cells migrating towards EGF in the agarose spot assay (Figure 4.1A).
 3-integrin-GFP expressing focal adhesions were circled and the proportion which also
contained clathrin was noted. Only 7.33% of focal adhesions could be seen to colocalise
with clathrin. We also investigated the eﬀect on Pearson’s correlation coeﬃcient of
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Figure 4.1: Clathrin does not colocalise with focal adhesions in MDA-MB-231 cells using
 3-integrin-GFP as the focal adhesion marker. A) Representative images with focal
adhesions circled in the  3-integrin-GFP image to assess colocalisation with clathrin-
dsRed. Scale bars are 10 µm. n = 3 experiments with a total of 30 cells analysed. B)
Pearson’s coeﬃcient of  3-integrin-GFP with clathrin-dsRed. Pearson’s coeﬃcient looks
at the amount of colocalisation between the two markers as one imaged is shifted relative
to the other one pixel at a time. Collaborative work with Emma Jenner is acknowledged
for the analysis of data used in this figure.
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shifting one channel relative to another one pixel at a time, which confirmed a lack of
colocalisation between the two (Figure 4.1; Rappoport et al. 2003a,b). We investigated
whether clathrin was being recruited to sites of focal adhesion disassembly after the
process had already begun. We produced a kymograph by assessing a 10 µm region
across two focal adhesions over time and saw no clathrin recruitment to the sites where
focal adhesions had previously been established (Figure 4.2).
The use of  3-integrin-GFP as our marker of focal adhesions was chosen for a number
of reasons. Firstly this integrin is known to be endogenously expressed in MDA-MB-231
cells, therefore adding physiological relevance to our studies. Secondly, the construct
itself has been shown to express normally with correct dimerisation with its integrin
partner ↵IIb and have normal surface expression levels (Plançon et al., 2001). Finally,
being membrane bound in focal adhesions means that integrins represent potential cargo
for endocytic machinery. However, we realise that this particular integrin may not be
present in all focal adhesions and thus we sought to repeat the above experiment using
a focal adhesion marker that binds intracellularly to other focal adhesion components
and thus is present in all focal adhesions. For this we chose paxillin-mRFP. In an iden-
tical experiment to those with  3-integrin-GFP we sought to examine the colocalisation
between paxillin-mRFP and clathrin-GFP in cells migrating in an EGF spot. Again,
we saw no colocalisation between these two markers and a kymograph showing focal
adhesions over time showed no recruitment of clathrin during or immediately after focal
adhesion disassembly (Figure 4.3).
An additional study was undertaken to further examine whether  3-integrin-GFP was
a valid marker for focal adhesions in our experimental system. We investigated colo-
calisation between  3-integrin-GFP and paxillin-mRFP to see the proportion of focal
adhesions  3-integrin-GFP was recruited to in migrating MDA-MB-231 cells. We found
all regions of paxillin-mRFP to contain  3-integrin-GFP and vice versa (Figure 4.4).
This leads us to conclude that, at least in our experimental system,  3-integrin-GFP
can be used to study focal adhesions and represent the whole focal adhesion population.
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Figure 4.2: Kymograph to show lack of colocalisation between clathrin-dsRed and  3-
integrin-GFP labelled focal adhesions in MDA-MB-231 cells. A 10 µm line was drawn
across two disassembling focal adhesions and a kymograph produced to show the de-
gree of clathrin and  3-integrin present within this region over time. The khymograph
demonstrated no co-localisation of clathrin with  3-integrin during focal adhesion dis-
assembly.
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Figure 4.3: Clathrin does not colocalise with focal adhesions in MDA-MB-231 cells
using paxillin as the focal adhesion marker. A) Representative images of paxillin-mRFP
and clathrin-GFP in migrating cells. Scale bars are 10 µm. n = 1 experiment, 20
cells imaged. B) Kymograph to show lack of co-localisation between paxillin-mRFP
labelled focal adhesions and clathrin-GFP over time. A 10 µm line was drawn across
two disassembling focal adhesions and a kymograph across this region demonstrated no
colocalisation of clathrin during focal adhesion disassembly.
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Figure 4.4: Colocalisation of focal adhesion markers in migrating MDA-MB-231 cells.
Representative image showing a high degree of colocalisation between paxillin-mRFP
and  3-integrin-GFP. Arrows denote the direction of migration. Scale bars are 10 µm.
n = 1 experiment, 20 cells imaged.
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Caveolar endocytosis was found not to be necessary for migration towards EGF in our
system, however some groups have shown it to be involved in integrin internalisation,
and therefore possibly also focal adhesion disassembly, in some cases (Caswell and Nor-
man, 2008). Thus we examined the potential for colocalisation between  3-integrin-GFP
and caveolin1-mRFP. We saw no colocalisation between the two and, as such (Figure
4.5), think it is unlikely that caveolar endocytosis could be involved in focal adhesion
disassembly during EGF-directed migration.
As a non-colocalisation based strategy to test for the involvement of endocytosis in fo-
cal adhesion turnover following Dynasore treatment we imaged paxillin-mRFP in cells
migrating in EGF spots. We examined the total number of focal contacts in migrat-
ing cells, assuming that if their disassembly was being prevented there would be an
increase in focal contact number, and found no overall increase (Figure 4.6A, B). We
also specifically examined the number of focal contacts present in the front, middle and
back regions of the cells in case there was a build-up in one particular region but found
that this was not apparent when looking at the total number present in each cell. We
counted the number in each region and normalised to the size of the regions (Figure
4.6C). No diﬀerences were seen in the number of focal adhesions present in any region
with Dynasore treatment leading us to conclude that endocytosis is not important for
focal adhesion disassembly in MDA-MB-231 cells in our EGF-directed migration system.
4.2.2 Focal adhesion disassembly time following inhibition of
clathrin-mediated endocytosis
As an alternative to using static images to assess focal adhesion colocalisation or number
we wanted to investigate whether an altered rate of focal adhesion disassembly occurred
when cells were treated with siRNA against ↵-adaptin to inhibit clathrin-mediated en-
docytosis. Our spot assay migration system posed a problem for this experiment, in
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Figure 4.5: Representative image showing a lack of colocalisation between caveolin1-
mRFP and  3-integrin-GFP in MDA-MB-231 cells. Arrows denote the direction of
migration. Scale bars are 10 µm. n = 1 experiment, 20 cells imaged.
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Figure 4.6: Dynasore does not cause redistribution of focal contacts during chemotactic
invasion of MDA-MB-231 cells. A) Representative images of paxillin-mRFP in cell
migrating towards EGF. Arrows denote the direction of migration. Scale bars are 10 µm.
B) Overall there is no significant increase in the number of focal contacts following 80 µm
Dynasore treatment. Data is normalised to the area of each cell to ensure comparison
between them. Error bars represent standard error of the mean, significance determined
by two-tailed unpaired student’s t-test, ‘ns’ denotes p-value   0.05. C) Quantification
of number of focal contacts in the front, middle and back regions of migrating cells.
Data is normalised to the area of each region to ensure comparison between regions of
diﬀerent sizes. n = 3 experiments with a total of 25 cells analysed per treatment. Error
bars represent standard error of the mean, significance determined by one way ANOVA
followed by Tukey’s post-test.
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that not many ↵-adaptin siRNA treated cells migrate into EGF spots and those that do
migrate in a similar manner to control cells and therefore may represent a population of
cells unaﬀected by the siRNA. We decided instead to use a wound healing assay for this
experiment and imaged cells at the edge of the wound since these should be stimulated
to migrate due to loss of contact inhibition by the occurrence of the wound. Focal adhe-
sions labelled with paxillin-mRFP were circled and fluorescence intensity was measured
over time. The time from when the focal adhesions were the brightest to when this de-
creased to match background fluorescence was recorded as a measure of focal adhesion
disassembly time, a strategy previously used (Fletcher et al., 2012). In this experimental
system we found no diﬀerence in focal adhesion disassembly time between control and
siRNA treated cells (Figure 4.7), providing further evidence for a lack of necessity for
clathrin in focal adhesion dynamics in migrating MDA-MB-231 cells. However, adding
complexity to this result we also examined the eﬀect ↵-adaptin siRNA had on wound
closure in MDA-MB-231 cells. Interestingly we saw no significant inhibition of wound
closure compared to control cells when measuring distance closed over time (Figure 4.8).
4.3 Discussion
Other groups have previously reported a role for clathrin in focal adhesion dynamics of
migrating cells (Chao and Kunz, 2009; Ezratty et al., 2009), however this observation is
not seen in all cases (Gu et al., 2011; Fletcher et al., 2012). We had previously seen a
phenotype of less migratory but more elongated cells upon treatment with the dynamin
inhibitor Dynasore (Figure 3.6). Perhaps the observed phenotype was as a result of
inability of the cells to undergo focal adhesion disassembly meaning that the rear or the
cells remained attached rather than retracting as in a normal migrating cell. This led
us to postulate whether there might be a role for clathrin-mediated endocytosis in the
turnover of focal adhesions in our system. In this current study we therefore investi-
gated whether a role for clathrin in focal adhesion disassembly could be found in cells
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Figure 4.7: ↵-adaptin siRNA does not inhibit focal adhesion disassembly in wound
healing MDA-MB-231 cells. A) Representative image of paxillin-mRFP disappearing
over time in cells treated with NSC or ↵-adaptin siRNA. B) Graph showing mean focal
adhesion disassembly time for cells treated with NSC and ↵-adaptin siRNA. n = 3
experiments with a total of 100 focal adhesions analysed per treatment. Error bars
represent standard error of the mean, significance determined by two-tailed unpaired
student’s t-test, ‘ns’ denotes p-value   0.05. Collaborative work with Emma Jenner is
acknowledged image analysis contributing to this figure.
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Figure 4.8: Wound healing assay with ↵-adaptin knock-down in MDA-MB-231 cells. A)
Representative images of wounds at time 0 and after 14 hours. In the images on the
left yellow lines denote the edge of the wound at time 0. In the images on the right
the time 0 lines are shown again and the new lines denote the egde of the wound at
time 14 hours. Distances between cells at time 0 and 14 hours were measured at various
points in each image to give an average distance migrated in NSC and ↵-adaptin siRNA
treated cells (white lines). B) Quantification of distance moved by siRNA treated cells.
n = 3 experiments with a total of 22 fields of view analysed per treatment. Error bars
represent standard error of the mean, significance determined by two-tailed unpaired
student’s t-test, ‘ns’ denotes p-value   0.05. Collaborative work with Emma Jenner is
acknowledged image analysis contributing to this figure.104
migrating towards EGF.
For a number of the studies in this chapter we chose to use  3-integrin-GFP as our
focal adhesion marker. Since there is a link between  1-integrin and EGFR signalling,
using a fluorescent-tagged  1-integrin might have been an apparent choice at this stage
(Caswell et al., 2008b; Morello et al., 2011). However, this construct is known for being
hard to express to detectable levels unless used in cells devoid of the endogenous protein
(Parsons et al., 2008). In addition to this, our lab already had experience using the
 3-integrin-GFP marker in the MDA-MB-231 cell line. We therefore chose to use this
construct ( 3-integrin-GFP) rather than travel the more complicated route of ensuring
protein knockdown before expression of a construct, which would have been the case if
we chose to use  1-integrin-GFP. As with any decision relating to use of single constructs
to investigate a point, there may be details we are missing out on. Given more time
the use of  1-integrin-GFP in addition to  3-integrin-GFP may have proven useful and
delivered more insights into the role of endocytosis in focal adhesion turnover.
We investigated the possibility of clathrin being involved in focal adhesion turnover in a
number of ways. We examined colocalisation between fluorescent labelled clathrin and
either  3-integrin-GFP (as a focal adhesion protein and a potential endocytic membrane
cargo) and paxillin-mRFP (to account for the fact that  3-integrin-GFP might not be
present in all focal adhesions). We found only a very low amount of colocalisation and
the small amount seen most likely represents random migration due to the sheer number
of clathrin spots present these migrating cells (Figures 4.1 & 4.3). Perhaps, however,
the focal adhesion components begin their disassembly prior to the arrival of clathrin
and, as such, have a fluorescence intensity below the limit of our imaging system by the
time of clathrin recruitment. To test this we examined clathrin recruitment to sites of
focal adhesion disassembly in the period of time following their disassembly (Figures 4.2
& 4.3). In the cases of both focal adhesion markers we found no clathrin recruitment,
so this theory appears not to be the case.
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In addition to these colocalisation studies we looked at focal adhesion disassembly time
in cells treated with siRNA to inhibit clathrin-mediated endocytosis. In this case we
used wound healing as the migratory model due to the lack of migration we see in the
agarose spot assay when we employ ↵-adaptin siRNA. We saw no diﬀerence in the time
for focal adhesion disassembly in either control or siRNA treated cells, showing again
that clathrin appears not to be necessary for this process in migrating MDA-MB-231
cells.
The previously mentioned studies that saw a role for clathrin in focal adhesion disas-
sembly were performed in fibroblasts (Chao and Kunz, 2009; Ezratty et al., 2009). Our
results stem both from migration towards a chemoattractant in the agarose spot assay
and from wound healing, adding weight to the lack of necessity for clathrin in focal adhe-
sion dynamics in migrating MDA-MB-231 cells. However, most likely the discrepancies
between our results and those of other groups are due to cell type specific diﬀerences
in the requirement for clathrin in this process. Interestingly, we actually found that ↵-
adaptin siRNA did not inhibit migration during wound healing with MDA-MB-231 cells,
in contrast to our results observed during chemotactic invasion. This further empha-
sises that diﬀerent migratory models require diﬀerent pathways; thus, clathrin-mediated
endocytosis appears to not be necessary for either wound healing or for focal adhesion
disassembly in this cell type, but may be a requirement in other cell types or experi-
mental systems.
If clathrin is not necessary for focal adhesion disassembly or integrin internalisation in
our system then it begs the question, what is? Since caveolar endocytosis wasn’t neces-
sary for cell migration towards EGF in our system we thought it unlikely to be involved
in focal adhesion turnover, however, in the interest of completeness we tested this by
looking at colocalisation between  3-integrin-GFP and caveolin1-mRFP. As expected
we saw no colocalisation between the two and so see this as a highly unlikely route
of integrin internalisation in MDA-MB-231 cells (Figure 4.5). As previously discussed
work by Gu and colleagues found that in PDGF-stimulated fibroblasts CDRs were re-
106
sponsible for focal adhesion disassembly, and that similar results could be observed in
EGF-stimulated MDA-MB-231 cells (Gu et al., 2011). The aforementioned studies by
Ezratty et al. and Chao et al. used wound healing and Transwell migration models,
respectively, without the addition of growth factors (other than those that those that
occur in FCS), perhaps clathrin is necessary for focal adhesion turnover in these cases
but not in growth factor stimulated conditions (Ezratty et al., 2009; Chao and Kunz,
2009). Given more time it would be interesting to investigate whether CDRs have a role
in the internalisation of integrins in our EGF-directed migration assay.
4.4 Key chapter findings
• Focal adhesion markers do not colocalise with clathrin in cells migrating in an
EGF-directed manner.
• Inhibiting endocytosis does not aﬀect focal adhesion number or distribution.
• Clathrin-mediated endocytosis is not necessary for wound closure in MDA-MB-231
cells.
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Chapter 5
Clathrin-mediated endocytosis is
polarised towards the front of
migrating cells and is responsible for
EGFR internalisation in cells
migrating towards EGF
5.1 Introduction
Polarisation is very important to the migrating cell. In order to control directionality of
migration cells must have methods to respond to chemoattractant gradients and polarise
actin-based protrusions to the regions where concentrations of chemoattractant are the
highest. Following the binding of attractant molecules to cell surface receptors, signalling
cascades lead to the activation of Cdc42 and Rac at this region of highest chemoattrac-
tant gradient (Srinivasan et al., 2003). This local activation serves to restrict the area
of actin polymerisation, and therefore lamellipodia and filopodia formation, to this area
and hence denotes the leading edge (Srinivasan et al., 2003). Complex feedback loops
involving both Cdc42 and Rac are in place to ensure sustained activity of both in this
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area (Li et al., 2003). Through one particular feedback loop Rac plays a role in estab-
lishing more focal contacts at the front of the cell, thereby further enhancing the cells
migratory ability (del Pozo et al., 2000; Schwartz and Shattil, 2000). Rho activity is
inhibited at the front of the cell by Rac. Similarly due to low Rac activity at the rear of
the cell Rho is able to build up in this area and so define it as the back (Sander et al.,
1999). Rho prevents the polymerisation of actin at the rear of cells and thus prevents
unwanted lamellipodia formation.
With regards to vesicle traﬃcking the polarisation of pathways is important to ensure
the correct localisation of cell surface proteins such as integrins. Integrins are compo-
nents of focal adhesions which form at the front of cells and are sites of traction to
enable migration to occur (Sheetz et al., 1998). The requirement for their disassembly
and traﬃcking to sites of new focal adhesions at the front of cells is therefore appar-
ent. In certain situations, endocytosis of integrins from disassembling focal adhesions in
the cell rear has been observed (Bretscher and Aguado-Velasco, 1998; Laukaitis et al.,
2001; Lawson and Maxfield, 1995). As well as disassembly of focal adhesions in the rear
of migrating cells, a subset appears to be disassembled just behind the lamellipodium
(Caswell et al., 2009). A study has shown that the alternative clathrin adaptor, Numb,
localises to this region and colocalises with specific integrins (Nishimura and Kaibuchi,
2007). When Numb is inhibited in these cells integrin endocytosis is perturbed, as is
the ability of cells to migrate on particular integrin substrates, pointing to a role for
Numb polarisation in integrin endocytosis during directed cell migration (Nishimura
and Kaibuchi, 2007).
Polarisation of particular vesicle traﬃcking pathways during migration has also been
shown in some cases. Rappoport et al. used live cell TIRF imaging to shown that
clathrin-mediated endocytosis is polarised towards the middle-front regions of migrating
epithelial cells and others have shown that endocytic recycling is polarised back to the
leading edge (Hopkins et al., 1994; Lawson and Maxfield, 1995; Rappoport and Simon,
2003; Strachan and Condic, 2004; Caswell and Norman, 2006). Conversely, caveolar
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endocytosis has been observed to occur at the rear of migrating cells, the significance
of which is largely unknown (Isshiki et al., 2002; Parat et al., 2003; Fletcher and Rap-
poport, 2010). Importantly, these studies only encompass a small selection of cell types
and migratory models; such polarisation may well depend on the cell type and experi-
mental system as well as other factors.
The EGFR receptor is the receptor for the chemoattractant and signalling molecule
EGF. There is evidence that EGFR is able to continue signalling when located on
early endosomes in a fashion that seems distinct from its plasma membrane signalling
(Di Guglielmo et al., 1994; von Zastrow and Sorkin, 2007; Vieira et al., 1996). As such,
there is much interest in studying the internalisation and traﬃcking of this receptor.
The route of internalisation of EGFR is subject to much debate and evidence exists
for both clathrin-dependent and clathrin-independent pathways (Sorkina et al., 2002;
Motley et al., 2003; Hinrichsen et al., 2003; Huang et al., 2004; Sigismund et al., 2005;
Johannessen et al., 2006; Orlichenko et al., 2006; Rappoport and Simon, 2009). Two
studies previously reported a clathrin-independent route by showing that AP2 was dis-
pensable for EGFR endocytosis (Motley et al., 2003; Hinrichsen et al., 2003). Two later
studies, however, found a necessity for clathrin and AP2, respectively (Huang et al.,
2004; Rappoport and Simon, 2009). Importantly, the studies concluding that AP2 was
not necessary for EGFR internalisation were mostly conducted at 4 C which may there-
fore account for the diﬀerences between those and the later studies (Boucrot et al., 2010).
Further to this, groups have reported a possible role of caveolae in EGFR internalisation,
although debate exists over whether this is indeed internalisation or whether caveolae
might represent a method of EGFR sequestration prior to EGF stimulation (Sigismund
et al., 2005; Orlichenko et al., 2006).
We aim here to elucidate the route of EGFR internalisation in a system of directed mi-
gration towards EGF. We also aim to investigate whether this internalisation is polarised
in the context of migration.
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5.2 Results
5.2.1 EGFR colocalises with clathrin but not caveolin1 in mi-
grating MDA-MB-231 cells
Since inhibiting clathrin-mediated endocytosis caused a decrease in the migration of cells
towards EGF we predicted that clathrin-mediated endocytosis could play a role in the
internalisation of EGFR during migration. We examined the potential for colocalisation
between EGFR and clathrin in migrating cells. Notably when we image EGFR in cells
away from EGF spots it appears diﬀuse in the plasma membrane but when imaged in
cells migrating in EGF spots it appears as punctae on the plasma membrane (as seen
in Figures 5.1A, B). Results from Chapter 3 established a lack of a role for caveolin1
in MDA-MB-231 cell migration, therefore we used colocalisation between EGFR and
caveolin1 as a control in this experiment.
We used TIRF microscopy to image only the adherent plasma membrane of cells mi-
grating towards EGF in agarose spots. Cells were transfected with both EGFR-GFP
and clathrin-dsRed and cells migrating into the spot were imaged. During analysis cells
were split into front, middle and back regions using the axis perpendicular to the spot
edge. At least 50 EGFR clusters were circled per cell, split evenly between the three
regions, and the number of these which were also positive for clathrin was noted. As a
control for random colocalisation the circles drawn around EGFR clusters were moved to
regions not containing EGFR and the number of these which were positive for clathrin
was noted. The same analysis was repeated with EGFR-GFP and caveolin1-mRFP. As
can be seen in Figure 5.1B & C there is a much higher degree of colocalisation between
EGFR-GFP and clathrin-dsRed, compared to EGFR-GFP and caveolin1-mRFP. When
control values were accounted for the colocalisation between EGFR-GFP and caveolin1-
mRFP is about 5%, with colocalisation between EGFR-GFP and clathrin-dsRed being
close to 50%, almost 10-fold higher.
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Figure 5.1: Colocalisation between clathrin-dsRed and EGFR-GFP in migrating cells.
A) Imaging of clathrin-dsRed and EGFR-GFP in cells with no EGF stimulation. Scale
bars are 10 µm. n = 1 experiment with 20 cells imaged to ensure consistency. B)
Representative images of EGFR-GFP with clathrin-dsRed or caveolin1-mRFP in cells
migrating towards EGF. Arrows denote the direction of migration. Scale bars are 10 µm.
C) Quantification of colocalisation of EGFR-GFP with clathrin-dsRed and caveolin1-
mRFP. n = 3 experiments with a total of 14 cells analysed for each condition. Error
bars represent standard error of the mean, significance determined by two-tailed unpaired
student’s t-test, ** denotes p-value < 0.01, *** denotes p-value < 0.001.
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We next performed live cell rapid TIRF imaging of EGFR-GFP and clathrin-dsRed in
migrating cells. We found that we could observe instances of both internalising together,
verifying that some of these colocalisation events result in internalisation. Figure 5.2A
and B shows a timecourse of one such internalisation event. Interestingly, we were also
able to observe instances of EGFR without clathrin colocalisation moving in the plane
of the plasma membrane (Figure 5.2C); likely post-endocytic structures or post-Golgi
vesicles. Since we observed such structures quite regularly this could mean that some
EGFR clusters counted in the previous experiment (Figure 5.1) were of this category
and therefore our quantification of colocalisation between clathrin and EGFR on the
plasma membrane may be even higher than originally thought.
We tested whether Dynasore treatment would have any eﬀect on the colocalisation be-
tween EGFR and clathrin. Perhaps if EGFR entry was inhibited we would see an increase
in colocalisation as more clathrin structures contain EGFR trying to internalise, or if
EGFR were to be internalised via an alternative pathway following inhibition perhaps
we would see a decrease in colocalisation. We repeated the above analysis with the addi-
tion of Dynasore or DMSO for the control cells. As can be seen in Figure 5.3, Dynasore
has no eﬀect on the colocalisation between EGFR and clathrin. As an alternative we
also decided to analyse whether inhibiting endocytosis with Dynasore had any eﬀect on
either the size of clathrin clusters or the number present on the plasma membrane of
migrating cells. We performed this analysis on cells as a whole and also broken down
by area to see if there were any region specific eﬀects. For the cluster size analysis cells
were split into front, middle and back regions and 10 clusters per region in each cell were
measured to establish their area. As can be seen in Figure 5.4A, the average apparent
cluster size over the cell as a whole increased by 18% following Dynasore treatment, and
this increase was more pronounced at the front and back of migrating cells, but less so in
the middle (Figure 5.4B). It should be noted that these cluster area measurements were
approaching the resolution limit of a light microscope, therefore numbers might not be
as accurate as intended. However the error bars for this analysis were small meaning
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Figure 5.2: Live cell TIRF imaging of clathrin-dsRed and EGFR-GFP. A) Representative
image to show instance of both markers leaving the TIRF field at the same time. Time
between frames is 2 seconds. Arrows denote the direction of migration. Scale bars are 10
µm. B) Graph shows a quantification of the intensity over time for the clathrin/EGFR
spot identified in (A), the clathrin-dsRed intensity is shown by the red line (circular
points), the EGFR-GFP intensity is shown by the green line (square points). C) An
instance showing directed motility of an EGFR cluster devoid of clathrin. Scale bars are
1 µm.
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Figure 5.3: Colocalisation between clathrin-dsRed and EGFR-GFP in migrating cells
following Dynasore treatment. A) Quantification of the total number of EGFR clusters
that colocalise with clathrin in cells migrating towards EGF treated with either DMSO
or Dynasore. B) Representative images of EGFR-GFP and clathrin-dsRed in cells with
and without Dynasore treatment. n = 3 experiments with a total of 13 cells analysed
per treatment. Error bars represent standard error of the mean, significance determined
by two-tailed unpaired student’s t-test, ‘ns’ denotes p-value   0.05.
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Figure 5.4: Investigating whether any changes occur to the size of clathrin-dsRed clusters
in migrating cells following Dynasore treatment. A) Mean area of clathrin clusters over
the whole cell. Error bars represent standard error of the mean, significance determined
by two-tailed unpaired student’s t-test, *** denotes p-value < 0.001. B) Mean area of
clathrin clusters broken down by region. C) Representative images of clathrin cluster
size analysis. Green circles show clusters analysed for their area. Arrows denote the
direction of migration. Scale bars are 10 µm. n = 3 experiments with   9 cells analysed
per treatment and a minimum of 10 clusters being analysed per cell (total 90 clusters
analysed per treatment). Error bars represent standard error of the mean, significance
determined by one way ANOVA followed by Tukey’s post-test, ‘ns’ denotes p-value  
0.05, * denotes p-value < 0.05, *** denotes p-value < 0.001.
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that whether the actual values were accurate or not there is still likely to be a significant
diﬀerence between the two treatments. No diﬀerences were observed in the number of
clathrin clusters present in these cells, whether analysing the cell as a whole or by region
(Figure 5.5).
We performed the same analysis on EGFR-GFP clusters in these migrating cells treated
with Dynasore. We found no diﬀerences in the average area of EGFR clusters per cell,
nor were there any diﬀerences in the areas in any particular region following Dynasore
treatment (Figure 5.6). The total number of EGFR clusters per cell was also no diﬀerent
following Dynasore treatment (Figure 5.7A) but when analysed by region the number of
EGFR clusters was skewed following Dynasore treatment with there being a slight build
up at the front (Figure 5.7B and C).
5.2.2 Clathrin-mediated endocytosis events occur more frequently
at the front of migrating cells
In order to establish whether endocytosis events were polarised in our model of migration
we imaged clathrin-dsRed in migrating cells. TIRF microscopy was employed again to
rapidly image clathrin at the plasma membrane of migrating cells for one minute time-
lapses. The disappearance of clathrin from the evanescent field was taken to be due to
endocytosis only if it was not due to photobleaching, if it occurred rapidly and if it did
not reappear in the evanescent field for the duration of the time-lapse (Rappoport and
Simon, 2003).
Using the previously established method for denoting the front, middle and back of
migrating cells, the number of endocytosis events within each of these regions during
the one minute time-lapses was analysed (Figure 5.8). After normalising the data to
ensure equal weighting we felt a cut-oﬀ was necessary to ensure that cells with very
low numbers of events would not skew the analysis. For this reason we only counted
cells with three or more internalisation events. It was found that endocytosis occurred
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Figure 5.5: Investigating to number of clathrin-dsRed clusters at the plasma membrane
of migrating cells with Dynasore treatment. A) Overall there is no significant increase
in the number of clusters following Dynasore treatment. Error bars represent stan-
dard error of the mean, significance determined by two-tailed unpaired student’s t-test,
‘ns’ denotes p-value   0.05. B) Quantification of clathrin clusters by cell region with
and without Dynasore treatment, number normalised relative to the area of the region.
C)Representative images of clathrin cluster counts in migrating cells. Arrows denote the
direction of migration. Scale bars are 10 µm. n = 3 experiments with a total of 12 cells
analysed per treatment. Error bars represent standard error of the mean, significance
determined by one way ANOVA followed by Tukey’s post-test, ‘ns’ denotes p-value  
0.05.
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Figure 5.6: Investigating whether any changes occur to the size of EGFR clusters in
migrating cells following Dynasore treatment. A) Mean area of EGFR clusters over the
whole cell. Error bars represent standard error of the mean, significance determined by
two-tailed unpaired student’s t-test, ‘ns’ denotes p-value   0.05. B) Mean area of EGFR
clusters broken down by region. No significant diﬀerences were observed in any case.
C) Representative images of EGFR cluster size analysis. Green circles show clusters
analysed for their area. Arrows denote the direction of migration. Scale bars are 10 µm.
n = 3 experiments with   9 cells analysed per treatment and a minimum of 10 clusters
being analysed per cell (total 90 clusters analysed per treatment). Error bars represent
standard error of the mean, significance determined by one way ANOVA followed by
Tukey’s post-test, ‘ns’ denotes p-value   0.05.
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Figure 5.7: Investigating to number of EGFR clusters at the plasma membrane of mi-
grating cells with Dynasore treatment. A) Overall there is no significant increase in the
number of clusters following Dynasore treatment. Error bars represent standard error of
the mean, significance determined by two-tailed unpaired student’s t-test, ‘ns’ denotes
p-value   0.05. B) Representative images of EGFR cluster counts in migrating cells.
Arrows denote the direction of migration. Scale bars are 10 µm. C) Quantification
of EGFR clusters by cell region with and without Dynasore treatment, numbers nor-
malised relative to the area of the region. n = 3 experiments with 12 cells analysed per
treatment. Error bars represent standard error of the mean, significance determined by
one way ANOVA followed by Tukey’s post-test, ‘ns’ denotes p-value   0.05, * denotes
p-value < 0.05, *** denotes p-value < 0.001.
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Figure 5.8: Clathrin spot disappearance is polarised to the front of migrating cells. A)
Representative images of a clathrin spot disappearing from the TIRF imaging field.
B) Representative image of a clathrin-dsRed expressing migrating cell with arrows to
indicate instances of clathrin disappearance. Arrow denotes the direction of migration.
Scale bars are 10 µm. C) Quantification of clathrin disappearance by cell region. D)
Quantification of clathrin disappearance compared to total number of spots in each
region. For C) and D) cells were used for quantification if they contained 3 or more
internalisation events. n = 4 experiments with a total of 18 cells analysed. Error
bars represent standard error of the mean, significance determined by one way ANOVA
followed by Tukey’s post-test, ‘ns’ denotes p-value   0.05, ** denotes p-value < 0.01,
*** denotes p-value < 0.001.
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significantly more frequently at the front of migrating cells than the middle or the back.
Furthermore, we tested whether the likelihood of occurrence of endocytic events was
increased at the front of the cells and found this not to be the case (Figure 5.8D). Thus
we can conclude that more clathrin-mediated endocytosis is occurring in this region and
so the pathway appears to be polarised towards the front in cells migrating towards
EGF.
5.3 Discussion
As a means to try and establish the route of EGFR internalisation in cells migrating to-
wards EGF we assessed colocalisation of EGFR-GFP with clathrin-dsRed in the agarose
spot assay. Using TIRF microscopy we were able to image only events at or close to the
plasma membrane thereby increasing the probability that clathrin-positive structures
present were potential sites of endocytosis. As a control we also assessed the colocal-
isation between the EGFR-GFP construct and caveolin1-mRFP. After controlling for
random colocalisation the colocalisation between EGFR-GFP and clathrin-dsRed was
almost 10-fold that between EGFR-GFP and caveolin1-mRFP (Figure 5.1). We also
established that by TIRF imaging we could view instances of EGFR-GFP and clathrin-
dsRed internalisation together, although this imaging was not rigorous enough to assess
all internalisation events (Figure 5.2). These results indicate a clathrin-mediated endo-
cytosis route for the EGFR in cells migrating in an EGF-dependent manner.
In the literature there is much support for a clathrin-dependent route of EGFR endo-
cytosis (Sorkina et al., 2002; Huang et al., 2004; Johannessen et al., 2006; Rappoport
and Simon, 2009) but also contrary evidence supporting a clathrin-independent route in
certain situations (Hinrichsen et al., 2003; Motley et al., 2003; Sigismund et al., 2005; Or-
lichenko et al., 2006; Sigismund et al., 2008). In support of our findings, previous work
by Huang et al. and Rappoport et al. demonstrated that in non-migrating cells the
EGFR enters primarily through clathrin-coated pits and not through caveolae (Huang
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et al., 2004; Rappoport and Simon, 2009). To assess whether we could see endocytosis
events happening in real time we undertook TIRF time-lapse experiments of clathrin-
dsRed and EGFR-GFP in migrating cells. We were able to see many instances of both
markers disappearing from the same point together, suggesting that clathrin-mediated
endocytosis is the main route of internalisation of the EGFR in our migratory model.
We investigated whether using Dynasore to inhibit endocytosis in cells migrating in the
spot assay would have any eﬀect on the colocalisation of clathrin-dsRed and EGFR-GFP.
In this case we saw no observed diﬀerences between the control (DMSO) and Dynasore
treated groups (Figure 5.3). Dynasore inhibits dynamin and therefore the stage of en-
docytosis where the vesicle is detached from the membrane, it is therefore likely that
EGFR recruitment to the forming pit was still able to occur prior to endocytosis being
halted at the stage of vesicle fission. However, when we tested the eﬀect of Dynasore on
the area of clathrin structures on the plasma membrane we saw an 18% increase in size in
the Dynasore treated group (Figure 5.4). This could indicate that clathrin is continuing
to be recruited to sites of vesicle formation under circumstances when they are not able
to pinch oﬀ the membrane. The increase in clathrin cluster size was more exaggerated
at the front and rear of migrating cells, although we are unsure of the significance of
this observation. It might also be expected that the number of clathrin clusters present
at the plasma membrane might increase following Dynasore treatment, although in our
system we found this not to be the case (Figure 5.5).
In addition to analysing the eﬀect Dynasore had on clathrin structures on the plasma
membrane of migrating cells, we looked to see if there were any similar eﬀects on EGFR
clusters. Unlike clathrin, the size of EGFR clusters remained the same, which could mean
that after a certain point no further cargo is recruited to the forming pits, although more
clathrin might be (Figure 5.6). Perhaps this lack of further cargo recruitment is due to
the pit being in a closed state with dynamin at the neck ready to pinch oﬀ the mem-
brane, and so no further cargo incorporation can occur.
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An emerging idea is that polarised vesicle traﬃcking is involved in the regulation of
directed cell migration. A link between polarised traﬃcking of cell adhesion components
has been shown in a number of cell types (Nishimura and Kaibuchi, 2007; Caswell et al.,
2009; Ulrich and Heisenberg, 2009; Thapa et al., 2012). The occurrence of polarised
traﬃcking of chemoattractant receptors is less well studied than that of focal adhesions,
but it is becoming more apparent that it may play a role in the regulation of directed
cell migration. A recent study by Assaker et al. found that particular endocytic proteins
were necessary to control the traﬃcking, and hence spatial polarisation, of receptor ty-
rosine kinases during Drosophila border cell migration (Assaker et al., 2010). Another
study by Belleudi et al. found endocytosis and polarised recycling of the keratinocyte
growth factor receptor regulated receptor polarisation at the plasma membrane, and
that this was necessary for keratinocyte migration (Belleudi et al., 2011). In order to
investigate the possibility of polarised receptor traﬃcking during chemotactic invasion
in MDA-MB-231 cells, we tested whether Dynasore treatment produced a redistribution
of EGFR localisation. The results of these studies demonstrated an accumulation of
EGFR towards the front of migrating cells (Figure 5.7). This implies that EGFR inter-
nalisation is polarised to the front of migrating cells, as inhibition of endocytosis caused
a build-up in this region.
We were then led to test whether clathrin-mediated endocytosis is polarised in MDA-
MB-231 cells during EGF direct chemotactic invasion. As expected, we saw an increase
in the number of internalisation events at the front of cells migrating towards EGF
rather than at the middle or back (Figure 5.8). In addition to the necessity for clathrin-
mediated endocytosis for migration in this model, these results imply that polarised
endocytosis of the EGFR is important for migration in this breast cancer cell line.
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5.4 Key chapter findings
• EGFR colocalises with in MDA-MB-231 cells migrating in an EGF-dependent
manner, but does not colocalise with caveolin1.
• When endocytosis is inhibited more EGFR is present at the front of migrating cells
than at the back, as opposed to a uniform distribution under control conditions.
• Clathrin internalisation events are polarised towards the front of EGF-directed
migrating cells.
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Chapter 6
Endosomal recycling and exocytosis
6.1 Introduction
As discussed earlier, the process of endocytosis is important to cell migration as it may
aﬀect signalling from chemoattractant receptors, availability of such receptors and also
the localisation of adhesion molecules. Similarly traﬃcking of receptors and adhesion
molecules to the cell surface must also be important for cell migration. Traﬃcking to
the cell surface can occur either through the biosynthetic secretory route or by pathways
which recycle internalised proteins back to a location on the cell surface.
Traﬃcking of newly synthesised cargo is a process which has been shown to be neces-
sary for cell migration in fibroblasts (Bershadsky and Futerman, 1994; Prigozhina and
Waterman-Storer, 2004). As previously mentioned, using strategies to disrupt post-
Golgi secretion of cargo prevented Swiss 3T3 fibroblasts from polarising in the direction
of migration and inhibited the migration of these cells. The orientation of the Golgi
towards the leading edge of migrating cells also appears to be important for cell mi-
gration (Gotlieb et al., 1981; Yadav et al., 2009). In wound healing experiments Yadav
et al. showed polarised protein secretion from the Golgi, which was abrogated when
Golgi position was disrupted and this led to a failure of these cells to close the wound
(Yadav et al., 2009). These results indicate that the polarised positioning of the Golgi
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is important for polarised protein secretion and consequently for correct cell migration.
Recycling pathways exist to traﬃc internalised cargo back to the plasma membrane.
The Rab4-dependent short-loop recycling pathway traﬃcs cargo directly from the early
endosome back to the plasma membrane (Grant and Donaldson, 2009; Maxfield and
McGraw, 2004). This pathway has been shown to be the major route of transferrin
receptor recycling as well as for some integrins and has been shown to be important
for polarised integrin recycling in fibroblasts as inhibition prevents directional migration
in this system (Woods et al., 2004; Jones et al., 2006; White et al., 2007). The other
major recycling pathway is Rab11-dependent and involves traﬃcking of cargo via the
juxtanuclear PNRC in a long-loop recycling route (Maxfield and McGraw, 2004). This
route is also thought to be necessary for recycling of some integrins which are seen in a
juxtanuclear compartment after internalisation (Jones et al., 2006; Caswell and Norman,
2006). Like the short-loop pathway this Rab-11 dependent route has been implicated in
cell migration; dominant-negative Rab11 expression perturbs migration in various cell
types and migration systems (Mammoto et al., 1999; Prigozhina and Waterman-Storer,
2006).
Since these exocytic pathways have been shown to be necessary for migration in some
cell types we decided to try and deduce which pathway or pathways are important for
EGFR exocytic traﬃcking and whether this traﬃcking was polarised in migrating cells.
6.2 Results
To assess EGFR fusions we used TIRF microscopy to image cells expressing EGFR-
GFP migrating in EGF spots. We imaged every 100 ms for a total of one minute. True
fusions events were validated in two ways. The first method used a line scan where a
line was draw across the fusion region and the fluorescence intensity of each pixel of the
line was measured over the course of the fusion event. As fusion occurs the intensity
should be high and localised in the centre of the line scan and as the fluorescent marker
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diﬀuses laterally in the plasma membrane the intensity should give a lower but wider
peak. A line scan of one fusion event is shown in Figure 6.1. The second method to
validate a fusion event is to measure the area and fluorescence intensity of the fluorescent
marker over the course of a fusion. The fluorescence intensity should firstly increase as
the vesicle approaches and subsequently fuses with the plasma membrane, the intensity
should then remain approximately constant as the area increases as the vesicle contents
diﬀuse laterally in the plane of the plasma membrane. An area/intensity analysis of a
fusion event is shown in Figure 6.2.
Once confident that we could identify and validate fusion events we analysed the TIRF
time-lapses of EGFR-GFP transfected cells migrating in EGF spots to assess the lo-
calisation of fusion events. We split the cells into front, middle and back regions, as
previously described, and normalised the data. As with the clathrin internalisation data
(Figure 5.8) we only counted cells with three or more events to ensure that cells with very
low numbers of events would not skew the analysis. The data shows a trend whereby
the most fusion events occur at the front (48%), followed by the middle (34%) and then
back (18%), however the data is only significant between the front and back regions
(Figure 6.3). This suggests that exocytosis of EGFR is polarised towards the front of
MDA-MB-231 cells migrating in an EGF spot.
Following the investigation of the localisation of fusions events we next sought to test
which pathways played a significant role in EGFR traﬃcking to the plasma membrane.
We decided to investigate the secretory pathway and the long-loop recycling pathways.
Ideally we would have also included the short-loop pathway in this investigation however
time constraints prevented us from doing so. We again utilised NPY-mRFP as a marker
for biosynthetic cargo and undertook TIRF imaging of live cells expressing this construct
migrating in EGF spots. To assess colocalisation we circled all NPY-mRFP clusters in
the migrating cells (this was between 13 and 50 clusters, dependent on the cell) then
switched to the green EGFR-GFP image and counted the number that were positive
for EGFR clusters. To assess the likelihood of colocalisation happening by random
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Figure 6.3: Localisation of EGFR-GFP exocytic fusion events. A) Shows a representative
TIRF image of a cell expressing EGFR-GFP and migrating in an EGF spot. Regions
where fusion events occurred within the one minute time-lapse are indicated by the
arrows. Arrow denotes the direction of migration. Scale bars 10 µm. B) Quantification
of the localisation of EGFR-GFP fusion events in migrating cells normalised to the
area of each region. Cells were used for quantification if they contained 3 or more fusion
events. n = 4 experiments with a total of 22 cells analysed. Error bars represent standard
error of the mean, significance determined by one way ANOVA followed by Tukey’s post-
test, ‘ns’ denotes p-value   0.05, *** denotes p-value < 0.001. Collaborative work with
Robert Lees is acknowledged for performing experiments and imaging which contributed
to this figure.
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chance we took the circled regions in the red channel image and moved them to regions
not containing NPY-mRFP clusters, we then counted how many of these regions were
positive for EGFR in the green channel. For this analysis we found the number of NPY
clusters colocalised with EGFR to be 21% and the amount of random colocalisation
to be 13% (Figure 6.4). The biosynthetic pathway therefore likely counts for a small
portion of the EGFR being traﬃcked to the plasma membrane when cells are migrating
in an EGF-dependent manner.
In order to assess the role of the long-loop recycling pathways in EGFR traﬃcking
we repeated the above colocalisation analysis using Rab11a-mCherry in place of NPY-
mRFP, as the marker for long-loop recycling. When analysing colocalisation we circled
all distinguishable Rab11a-mCherry punctae in the red channel (between 24 and 258
punctae) and counted how many colocalised with EGFR-GFP clusters in the green
channel. We assessed for random colocalisation by the same methods as with NPY-
mRFP. The percentage of Rab11a punctae that colocalised with EGFR was 44% with
6% random colocalisation, meaning that 38% of this was true colocalisation of the two
markers (Figure 6.5). This shows that the Rab11-dependent long-loop recycling pathway
likely accounts for a significant proportion of EGFR present on the plasma membrane
during migration.
6.3 Discussion
As stated previously polarised traﬃcking has long been thought to play a role in di-
rected migration, especially in the context of integrins (Nishimura and Kaibuchi, 2007;
Caswell et al., 2009; Ulrich and Heisenberg, 2009; Thapa et al., 2012). Many studies
have therefore sought to investigate the traﬃcking pathways taken by integrins into and
around the migrating cell. Studies into the traﬃcking of chemoattractant receptors have
mostly taken place in the context of non-migratory cells, although some studies are
emerging that investigate receptor traﬃcking in the context of migration (Caswell et al.,
132
Figure 6.4: Colocalisation between NPY-mRFP and EGFR-GFP. A) Representative
TIRF images of a cell with NPY-mRFP and EGFR-GFP. Arrows denote the direction
of migration. Scale bars are 10 µm. B) Percentage colocalisation of NPY-mRFP clusters
with EGFR-GFP and of random instances of EGFR-GFP colocalisation with regions
devoid of NPY-mRFP. n = 3 experiments with a total of 20 cells analysed. Error bars
represent standard error of the mean, significance determined by two-tailed unpaired
student’s t-test, ** denotes p-value < 0.01. Collaborative work with Robert Lees is
acknowledged for performing experiments and imaging which contributed to this figure.
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Figure 6.5: Colocalisation between Rab11a-mCherry and EGFR-GFP. A) Representa-
tive TIRF images of a cell with Rab11a-mCherry and EGFR-GFP. Arrows denote the
direction of migration. Scale bars are 10 µm. B) Percentage colocalisation of Rab11a-
mCherry clusters with EGFR-GFP and of random instances of EGFR-GFP colocali-
sation with regions devoid of Rab11a-mCherry. n = 3 experiments with a total of 20
cells analysed. Error bars represent standard error of the mean, significance determined
by two-tailed unpaired student’s t-test, *** denotes p-value < 0.001. Collaborative
work with Robert Lees is acknowledged for performing experiments and imaging which
contributed to this figure.
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2008a; Assaker et al., 2010). In Figure 5.8 we showed that endocytosis is polarised in
our chemotactic invasion assay and in Figure 5.7 show that EGFR clusters are uniform
throughout the cell in control conditions. This could point to EGFR exocytosis also
being polarised towards the front to maintain this uniform distribution, we therefore
sought to test this. We used previously established methods for validating exocytic fu-
sions events and used these methods to analyse EGFR fusion events in cells migrating
in EGF spots in the chemotactic invasion assay (Schmoranzer et al. 2000; Figures 6.1 &
6.2). We used these methods to show EGFR exocytosis is in fact polarised towards the
front of migrating cells. This could explain how the cell is able to maintain a uniform
distribution of receptor even though more internalisation is happening at the front of
the cell. This polarised endocytosis will enable the cell to continue sensing directional
cues from its front region during migration.
The Golgi complex is important for maintaining cell polarity during cell migration and
traﬃcking form the Golgi has been shown to be important for maintenance of the lamel-
lipodium (Yadav et al., 2009; Prigozhina and Waterman-Storer, 2004). In addition, re-
cycling pathways, such as the Rab11-dependent long-loop pathway have been proposed
to be important for migration (Jones et al., 2006; Caswell and Norman, 2006; Mammoto
et al., 1999; Prigozhina and Waterman-Storer, 2006). We investigated the contributions
of these two pathways to the traﬃcking of the EGFR in our migratory system. We
showed a small but significant degree of colocalisation between NPY (our marker of the
secretory pathway) and EGFR, suggesting that at least some EGFR on the cell surface
is newly synthesised protein (Figure 6.4). A higher degree of colocalisation was seen
between Rab11a and EGFR, suggesting that the long-loop recycling pathway plays a
larger role than the secretory pathway in delivering EGFR to the plasma membrane
under these conditions (Figure 6.5).
Ubiquitination of EGFR by proteins which bind to phosphorylation sites on the receptor
occurs following ligand binding at the plasma membrane (Levkowitz et al., 1998). This
ubiquitination is shown to have roles in the internalisation of the receptor but also in
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targeting it for degradation. It might be that one cue which decides the fate of the re-
ceptor is whether it remains ligand bound following internalisation. In the case of TGF↵
ligand dissociation occurs once the ligand-receptor complex reaches the early endosome,
this process is followed by deubiquitination of the receptor preventing it from being tar-
geted to the lysosome for degradation (French et al., 1995; Roepstorﬀ et al., 2009). EGF
does not dissociate from the receptor as easily and so the receptor remains targeted for
degradation (French et al., 1995). This research seems to conflict with our results; if
the receptor was being degraded we would most likely see a higher proportion of newly
synthesised receptor travelling from the Golgi to the plasma membrane to replace the
degraded portion, however we see long-loop recycling playing a much large role than the
synthetic pathway. However, the work by the groups of French and Roepstorﬀ was done
in HeLa cells or HeLa-derived cells and therefore the same might not be occurring in
the MDA-MB-231 cells used in this study. Recently, di Fiore’s group have shown that
diﬀerent concentrations of ligand can aﬀect the amount of ubiquitination the receptor
receives, which in turn aﬀects whether the receptor is degraded or recycled (Sigismund
et al., 2013). Taking this research into account it might be that in our system only a
minimal amount of ubiquitination occurs leading to most of the receptor being recycled.
It is also of note that in cases where overexpression of EGFR/ErbB2 dimers occurs in-
creased recycling has been observed (Peschard and Park, 2003). MDA-MB-231 cells have
been reported to overexpress EGFR but have normal levels of ErbB2, however perhaps
this would be enough to account for increased recycling.
The time-lapses used for Figure 6.3 were made using rapid TIRF imaging (every 100
ms) which was achievable due to the construct being bright enough for this speed of
imaging. It was necessary to image this fast for fusion events since they are themselves
a fast event (the fusion event in Figure 6.1 being 600 ms). It would have been preferable
to image the NPY and Rab11a experiments in the same way in order to see whether we
could view fusion events of each pathway marker along with EGFR. As it stands the
switch time between imaging red and green in our imaging system takes approximately
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two seconds, meaning that the vast majority of fusion events would be missed if we
were to image like this. As the next best option we chose to use static TIRF imaging
and assess colocalisation. This allowed us to know that the vesicles were at least in
close proximity to the plasma membrane (approximately 100 nm), meaning that they
could have been in the process of fusing, but without the rapid time-lapse imaging as in
Figure 6.3 we can’t be sure of this. It would be preferable to repeat such experiments
using a microscope set-up cable of simultaneous imaging of two fluorophores. Another
experiment we would have liked to include here would be colocalisation of Rab4 and
EGFR, as this would assess the contribution of the short-loop pathway in replenishing
EGFR at the plasma membrane during migration.
Further to using a better imaging system to view fusions of EGFR vesicles also con-
taining recycling or biosynthetic pathway markers it could be an interesting addition to
see what eﬀect inhibiting these pathways has on migration. We could use dominant-
negative versions of the Rab4 and Rab11a plasmids to inhibit recycling pathways and
dominant-negative PKD to disrupt biosecretory traﬃc. Finally, investigating the eﬀect
of inhibiting long-loop recycling on EGF-directed migration might be fitting to this study
since we propose from the above studies that it plays a significant role in replenishing
EGFR on the plasma membrane.
6.4 Key chapter findings
• We are able to observe and verify exocytic fusion events in cells in our chemotactic
invasion assay.
• More EGFR fusions events occur at the front than the back of migrating MDA-
MB-231 cells.
• Colocalisation of EGFR with a marker of the biosecretory pathway is minimal;
significant colocalisation occurs between EGFR and a marker of the long-loop
recycling pathway.
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Chapter 7
Signalling during chemotactic invasion
7.1 Introduction
Growth factor signalling is a complex, and poorly understood, process. As mentioned
previously, ligand binding causes receptor dimerisation and subsequent transphosphory-
lation (Schlessinger, 2002; Riese et al., 2007; Foley et al., 2010). These phosphorylation
sites can act as binding sites for protein kinases, whose activation leads to signalling
cascades (Normanno et al., 2006). The response of a signalling cascade might be to alter
transcriptional output of the cell, or it might be to initiate a process within the cell.
Growth factor receptor signalling can activate a multitude of pathways leading to a va-
riety of cellular responses. EGFR signalling has been shown to be involved in processes
such as cell diﬀerentiation, proliferation, survival and migration through regulating the
PI3K-AKT and Ras-ERK pathways, among others (Jones and Rappoport, 2014; Men-
doza et al., 2011). The pathways can regulate cell migration by modulating protein
function via phosphorylation as well as altering gene transcription (Jones and Rap-
poport, 2014). EGFR-related signalling pathways can also have structural eﬀects on
the cell which can influence cell migration, including activation of Rho and Rac which
can influence the actin/myosin dynamics in cell migration, and the activation of Src
which can activate FAK and thereby stimulate focal adhesion turnover and cell migra-
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tion (Spiering and Hodgson, 2011; Ray et al., 2012). Having more knowledge about
these and other pathways can lead to more specific targets for future anticancer thera-
pies; however the complexity of these pathways shouldn’t be underestimated. A recent
study looking at chemoattractant directed migration and invasion in just one cell type,
MDA-MB-231, found that the three chemoattractants studied elicited diﬀerent signalling
pathways within the cell to provide the same general outcome (Harrison et al., 2013).
The authors also found that some pathways were dispensable when particular chemoat-
tractants were used; while LPA-stimulated migration and invasion required the MAPK
pathway, EGF-directed migration did not (Harrison et al., 2013). Such studies are nec-
essary to systematically provide information about signalling during migration.
There are many examples of polarised signalling during chemoattractant directed mi-
gration. Such polarisation is necessary to ensure the correct signalling pathways are
stimulated at the proper localisation within the cell for migration with a defined di-
rection and magnitude. In Dictyostelium discoideum binding of a chemoattractant to
GPCRs at the front of the cell stimulates a polarised dissociation of G↵ subunit and
therefore activation of signalling pathways which cause reorganisation of actin only in
this region (van Hemert et al., 2010). The process of axon guidance in neurons has
been shown to involve polarised signalling due to chemoattractant; polarised PIP3 ac-
cumulation and subsequent Akt activation was shown to occur in this system, and this
asymmetric activation of Akt was also shown to be necessary for the process in vivo
(Henle et al., 2011). A similar observation has been made in fibroblasts where polarised
PDGF activation led to a steeper gradient of PIP3 at the front of cells leading to ac-
tivation of Akt in this region (Haugh et al., 2000). The polarised signalling in these
examples is necessary to ensure processes required for migration, such as actin reorgan-
isation, happen only in specified regions of the cell.
In recent years there has been much work on the localisation of EGFR signalling and
what aﬀects this has on outcome within the cell; thereby linking the process of receptor
traﬃcking with signalling outcome. The longstanding view with regards to receptor
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internalisation was that this process led to signal attenuation and degradation of the
receptor. For EGFR in particular, evidence by many groups now points to a role for
endosomes in the continued signalling of the receptor (Miaczynska et al., 2004; von Za-
strow and Sorkin, 2007; Murphy et al., 2009; French et al., 1995; Vieira et al., 1996;
Di Guglielmo et al., 1994; Wu et al., 2012). In some cases this signalling is distinct
from that at the plasma membrane and can result in diﬀerent signalling outcomes (von
Zastrow and Sorkin, 2007; Wu et al., 2012). Roles for signalling from endosomes might
include temporal regulation, increasing the length of time a receptor signals, or spatial
regulation, controlling the subset of signalling molecules with which a receptor interacts
(French et al., 1995; Miaczynska et al., 2004).
The studies mentioned above show the important link between traﬃcking and signalling,
however, such a link has scarcely been studied in the context of migration. This is likely
to be because biochemical signalling assays only allow analysis of signalling from a whole
group of cells. Newly established techniques are emerging for the study of signalling in
single cells in a variety of contexts, from migration in a 2D environment to within a
tumour environment in a living organism. Here we take advance of a FLIM-FRET tech-
nique which allows measurement of the activity of certain signalling proteins and use
this in conjunction with our agarose spot chemotactic invasion assay. This FLIM-FRET
technique has already recently been used in the context of migrating PDAC cells by
Nobis and colleagues who used it to investigate Src signalling in cells migrating in vivo
tumour environments (Nobis et al., 2013).
7.2 Results
Mouse pancreatic ductal adenocarcinoma (PDAC) cells established for use with FLIM-
FRET Biosensors were obtained. The primary aim was to use this cell line in our
EGF-directed chemotactic invasion assay to assess signalling downstream of EGFR,
polarisation in signalling and whether inhibition of receptor traﬃcking altered signalling.
140
To verify that PDAC cells were an appropriate model we conducted preliminary studies
using the agarose spot assay. Figure 7.1 shows that a significantly higher number of
PDAC cells migrated into EGF spots compared to control PBS spots, and that cells
travelled much further into EGF spots than control. Since we wanted to later test
whether signalling downstream of EGFR was aﬀected by inhibition of internalisation we
tested whether treating the PDAC cells with Dynasore gave us the same results as with
MDA-MB-231 cells. Figure 7.2 shows that when treated with Dynasore 69% less cells
migrated than into control spots and those that still migrated travelled significantly less
far than control DMSO treated cells.
As well as verifying that PDAC cells migrate in EGF spots and that this is inhib-
ited when endocytosis is prevented we thought it would be beneficial to verify whether
clathrin-mediated endocytosis is polarised in this cell type as it was in MDA-MB-231
cells (Figure 5.8). As previously, we imaged one minute time-lapses of clathrin-dsRed in
cells migrating in EGF spots. This analysis proved to be diﬀerent to that of the MDA-
MB-231 cells as the clathin in this case was highly dynamic thereby making judgement
of disappearance from the TIRF field diﬃcult. Previous work by Rappoport and col-
leagues has shown clathrin to be either static, laterally mobile or disappearing vertically
into the cell (Rappoport et al., 2003b; Rappoport and Simon, 2003). It has also been
suggested that movement of clathrin along microtubules can occur prior to endocytosis
(Ezratty et al., 2009; Rappoport et al., 2003b). Therefore in the case of PDAC cells
we chose to count the number of dynamic clathrin spots (those moving laterally in the
plane of the membrane as well as those disappearing from the TIRF field). To prevent
re-counting of a clathrin spot that had already been analysed (for example, in the case of
clathrin spots shown to move along microtubules which have been shown to sometimes
curve axially away from the TIRF field and back again (Yang et al., 2011)) we followed
the fate of only those clathrin spots present at the start of the time-lapse. As with the
previous analysis we split the cells into front, middle and back regions for analysis. We
looked at the total number of dynamic clathrin spots compared to the total number of
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Figure 7.1: PDAC cell migration in the agarose spot assay. A) Representative images of
PDAC cells after 14 hours of migration under PBS spots and EGF spots. Line denotes
the edge of the agarose spot. Scale bars are 100 µm. B) Quantification of the total
number of cells which migrated and the distance migrated into PBS and EGF spots. n
= 3 experiments witha   12 fields of view analysed per treatment. Error bars represent
standard error of the mean, significance determined by two-tailed unpaired student’s
t-test, *** denotes p-value < 0.001.
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Figure 7.2: Dynasore inhibits PDAC chemotactic invasion into EGF spots. A) Rep-
resentative images of PDAC cells after 14 hours of migration under EGF spots with
DMSO or Dynasore treatment. Line denotes the edge of the agarose spot. Scale bars
are 100 µm. B) Quantification of number of cells migrated and distance migrated with
DMSO and Dynasore treatment. n = 4 experiments with   12 fields of view analysed
per treatment. Error bars represent standard error of the mean, significance determined
by two-tailed unpaired student’s t-test, *** denotes p-value < 0.001.
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clathrin spots in each region and also the number of dynamic spots normalised to the
total area of each region. In both cases we found significantly more dynamic clathrin
spots at the front of migrating cells than the middle or the back (Figure 7.3A, B). We
also took this opportunity to image both clathrin-dsRed and EGFR-GFP together in
migrating cells and were able to observe instances of colocalisation and disappearance
from the TIRF field together as in Figure 7.3C.
FLIM-FRET imaging allows measurement of the fluorescence lifetime of a Biosensor.
We chose to use previously validated Biosensors: a membrane-bound Akt Biosensor, a
cytosolic Akt Biosensor and a Src Biosensor. Each of the Biosensors had two domains,
one of which would be a FRET donor and one the acceptor. During imaging the fluores-
cence lifetime of the FRET donor would be measured. The Biosensors were engineered
so that in the inactive confirmation the two domains were close enough for FRET to
occur, in this case energy from the donor would be transferred to the acceptor and the
donor fluorescence lifetime would be low. In the active confirmation the two domains
were not close enough for FRET to occur meaning the fluorescence lifetime of the donor
would be comparatively increased (see Figure 7.4 for a diagram).
In the case of the Src Biosensor ECFP and an SH2 domain are joined by a flexible linker
to a Src substrate peptide and YPet (FRET-optimised yellow fluorescent protein). Un-
phosphorylated Biosensor is in a folded conformation bringing the ECFP and YPet close
together resulting in FRET. Following phosphorylation induced by Src, the Src substrate
peptide binds to the SH2 domain causing separation of the fluorophores and thereby de-
creasing FRET and increasing fluorescence lifetime of the donor. For the Akt Biosensors
the mCFP and mYFP fluorophores are separated by a FHA2 phosphothreonine-binding
domain and a PKB phosphorylation sequence. Again, when unphosphorylated the flu-
orophores are in close proximity resulting in FRET; upon phosphorylation of the PKB
consensus sequence this domain binds the FHA2 domain moving the fluorophores fur-
ther apart and minimising FRET and increasing fluorescence lifetime of the donor. The
membrane-bound Akt Biosensor is identical to its cytosolic counterpart except for the
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Figure 7.3: Dynamic clathrin in migrating PDAC cells. A) Graph to show that there
is a higher proportion of dynamic clathrin compared to total clathrin at the front of
migrating PDAC cells compared to the middle or the back. B) Graph to show that
there is more dynamic clathrin at the front of migrating PDAC cells when normalised
to the area of each region. C) Representative images of a clathrin spot disappearing
from the TIRF imaging field. D) Representative image of a clathrin-dsRed expressing
migrating cell. Diﬀerent symbols were used during analysis to catagorise every clathrin
cluster that was present at the start of the timelapse. Arrow denotes the direction of
migration. Scale bars are 10 µm.n = 4 experiments with a total of 12 cells analysed
per treatment. Error bars represent standard error of the mean, significance determined
by one way ANOVA followed by Tukey’s post-test, * denotes p-value <0.05, * denotes
p-value <0.05, ** denotes p-value <0.01, *** denotes p-value <0.001. C) An instance
to show clathrin-dsRed and EGFR-GFP internalising from the TIRF field together.
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Figure 7.4: Diagram to show how the fluorescent lifetime of a Biosensor changes when the
probe is in the inactive of active conformations. When unphosphorylated the Biosensor
is in a closed position bringing the FRET donor and acceptor in close proximity, thereby
allowing FRET to occur. This decreases the fluorescent lifetime of the donor fluorophore.
When phosphorylated by Src the Biosensor adopts an open conformation, preventing
FRET and increasing the fluorescent lifetime of the donor fluorophore.
146
addition of a myristoylation and palmitoylation tag to target it to the membrane.
We made stable cell lines of PDAC cells expressing each of the Biosensors using G418
selection (see Section 2.6). As an initial experiment to test the activity of the Biosensors
in these stable cells lines we imaged fluorescence lifetimes of cells without stimulation,
we then added 100 ng/ml EGF and incubated for 15 minutes before imaging fluorescence
lifetimes again. Using LI-FLIM analysis software we could establish average fluorescence
lifetime for the cells stably transfected with each Biosensor, with and without EGF stim-
ulation. The purpose of this experiment was to define a cut-oﬀ below which we could
say the Biosensor was inactive and above which it would be active (as in Nobis et al.
2013 Figure 1C & D). Unfortunately, as shown in Figure 7.5, no diﬀerence was seen in
average fluorescence lifetime of cells with or without EGF stimulation for any of the
Biosensors used.
Nonetheless, we next used the agarose spot assay to assess signalling in cells migrating in
EGF spots with and without treatment with Dynasore to assess signalling with inhibition
of endocytosis. We firstly analysed these results on a whole cell basis. Figure 7.6 shows
that in the case of each Biosensor fluorescence lifetime, and therefore signalling, was
increased in cells migrating into EGF spots compared to those away from the spots.
This conflicted with results from the previous experiment (Figure 7.5), however it shows
that in our EGF-directed spot assay signalling by Src and Akt is increased compared to
control. When repeated this experiment with the addition of Dynasore to the media to
inhibit endocytosis and therefore perturb migration, we unexpectedly saw a significant
increase in the signalling of each Biosensor (Figure 7.6).
To see if there was any polarisation of signalling during migration in the EGF spots we
split the cells into front, middle and back regions and looked at average fluorescence
lifetimes for these regions. We repeated this analysis in the Dynasore treated cells
to see if inhibiting endocytosis had any eﬀect on polarisation of signalling. As can
be seen in Figure 7.7 neither the cytoplasmic Akt nor the Src Biosensors showed any
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Figure 7.5: Average fluorescence lifetimes of cells stably transfected with each Biosensor
construct. Fluorescence lifetimes were measured with and without 15 minutes stimula-
tion with 100 ng/ml EGF. A) Representative CFP and lifetime map images of cells with
and without EGF treatment. B) Quantification of fluorescence lifetimes of cells with
and without EGF treatment. n = 3 experiments with a total of 60 cells analysed per
condition. Error bars represent standard error of the mean, significance determined by
two-tailed unpaired student’s t-test, ‘ns’ denotes p-value   0.05.
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polarised signalling with or without treatment with Dynasore. Membrane-bound Akt
has significant polarisation of activity towards the front and middle of migrating cells,
which was abrogated with Dynasore treatment.
7.3 Discussion
In this study we were attempting to look at signalling in live cells during the process
of migration. This work was done at the Beatson Institute for Cancer Research using
their FLIM-FRET Biosensors and imaging system. At the time of planning we decided
to use the PDAC cell line that was already set up for use in a mouse model for pan-
creatic cancer using this system. One reason for this choice was that it would facilitate
potential future in vivo work as PDAC cells can be studied in immuno-competant mice,
whereas MDA-MB-231 cells cannot. The initial work verified that the PDAC cell line
behaved as expected form our previous results in MDA-MB-231 cells. In Figure 7.1
we show that more cells migrate into EGF spots than into control PBS spots and we
show that, as with MDA-MB-231 cells, this migration can be inhibited by treatment
with Dynasore (Figure 7.2). These data show that, not only do the PDAC cells migrate
when stimulated with EGF and require dynamin for this migration, but that the agarose
spot assay can give highly reproducible results in another cell line. We also showed that
more dynamic clathrin is present on the plasma membrane at the front of the migrating
cells, rather than the middle or the back (Figure 7.3). This dynamic clathrin includes
clathrin clusters which disappear from the TIRF field, therefore likely to be internalisa-
tion events, and clathrin moving rapidly and directionally in the plane of the membrane,
presumably along microtubules. In some cases this movement along microtubules has
been suggested to occur just prior to endocytosis and we therefore took these clathrin
clusters to represent an endocytosis intermediate (Yang et al., 2011). In this case we
were able to repeat our results from MDA-MB-231 cells to show that in PDAC cells
more endocytic events occur at the front of cells migration in EGF-directed conditions.
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The range of signalling of each Biosensor construct was tested to estimate a threshold
for the inactive and active forms of each Biosensor. Unexpectedly there were no changes
in fluorescence lifetime of any of the Biosensors with and without EGF treatment, as
shown in Figure 7.5. A similar experiment was done by Nobis and colleagues using the
same cell line with the Src construct stably transfected (Nobis et al., 2013). Rather
than stimulate signalling with a growth factor or similar, they chose to inhibit signalling
by using the Src inhibitor Dasatinib and were able to image lifetimes ranging from 1.9
ns to 2.8 ns. Perhaps the reason we saw no diﬀerence was due to the concentration
of EGF chosen or the timepoint used. We used 100 ng/ml, which is considered a high
concentration, but in this case we wanted to elicit a large signalling response to see the
range of the Biosensors, this is also the same concentration as others have used in EGFR
traﬃcking studies (Rappoport and Simon, 2009; Jones et al., 2014). Ideally the experi-
ment would be repeated with a range of EGF concentrations and timepoints post-EGF
addition, however, time prevented this.
Contrary to the aforementioned result, when we imaged cells migrating in EGF spots
and compared their lifetimes to cells away from the spot regions we saw a significant
increase in fluorescence lifetimes for each of the constructs (Figure 7.6). Without fur-
ther study it is diﬃcult to speculate why this result is diﬀerent to the previous, however
it serves to show that during EGF stimulation in our migration assay activity of all
Biosensors is increased over control.
Dyansore treatment inhibits migration of PDAC cells (Figure 7.2); from this we might
expect that Dynasore treatment would yield a decreasing in migration-dependent sig-
nalling. As shown in Figure 7.7 this was not found to be the case and in fact activity
of all three Biosensors was increased during Dynasore treatment. The role traﬃcking
plays in signalling events is very complicated and is only really at the beginning of being
investigated. EGFR has been shown to signal from endosomes and this signalling is dis-
tinct from signalling at the plasma membrane (Miaczynska et al., 2004; von Zastrow and
Sorkin, 2007; Murphy et al., 2009; French et al., 1995; Vieira et al., 1996; Di Guglielmo
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et al., 1994; Wu et al., 2012). Perhaps our results point to a spatially restricted endoso-
mal signalling pathway that is necessary for migration and when we inhibit endocytosis
we see increased Biosensor activity stemming from the plasma membrane due to lack of
receptor internalisation and degradation, but that this signalling is unable to stimulate
migration. The imaging system does not have enough resolution to further analyse sig-
nalling from endosomes in uninhibited cells as a possibility but this would be useful for
further investigation. There are likely other explanations for our results but much more
work would be needed to fully elucidate the reason for the increase in signalling seen
when internalisation is prevented in these migrating cells.
Finally, the polarisation of membrane-bound Akt signalling was interesting as it follows
our result of polarised endocytosis in migrating cells. Perhaps internalisation of EGFR is
necessary for Akt signalling and more EGF is binding in this front-middle region leading
to increased internalisation and therefore signalling in this region. This could explain
why the polarisation is abrogated when Dynasore treatment is applied, but doesn’t ex-
plain why it only occurs for the membrane-bound Akt and not the cytoplasmic version.
Again, more work would be needed before an explanation might become apparent.
7.4 Key chapter findings
• Earlier results can be verified in a PDAC cell line, proving the use of the chemo-
tactic invasion assay in another cell type.
• Signalling of Src and Akt Biosensor probes is increased within migrating cells in
EGF spots, compared to in cells not migrating in these spots.
• Signalling of Src and Akt Biosensor probes is increased further when endocytosis
is inhibited.
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Chapter 8
Discussion
8.1 Final discussion
The aim of my work has been to show a link between directed cell migration and en-
docytic traﬃcking. Firstly we wanted to establish that the agarose spot assay was
suitable for chemoattractant-directed migration studies. Wiggins and Rappoport al-
ready showed that the assay gave highly reproducible results and that migration was
significantly increased into chemoattractant (EGF)-containing agarose spots relative to
those containing PBS as a control (Wiggins and Rappoport, 2010). The results of their
preliminary studies, however, couldn’t rule out the possibility that EGF was increasing
chemokinesis of the cells and wasn’t specific to the cells crawling under the spot. By
investigating the migration of cells under the spot when EGF was present in the media
rather than in the spot and also by analysing migration of cells away from the agarose
spots, we were able to establish that the assay is specific to chemotactic invasion and
not chemokinesis (Figures 3.2 and 3.3). Analysis of the cell trajectories also showed that
cells are migrating in a directed manner into EGF spots (Figure 3.4).
Rappoport and Wiggins also touched upon the use of the assay in multiple imaging
systems; including imaging using a 10 x objective lens on a Nikon TE300 inverted mi-
croscope and looking at the cells crawling under the spot in more detail using Scannning
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Electron Microscopy (SEM). This current study involved imaging using a 10 x objective,
static and live cell TIRF microscopy, FLIM-FRET Biosensor imaging and also studies
using confocal microscopy, finding the system robust under all methods. This multiple
imaging ability of the assay allows us to gain a wide variety of information from which
to build up a model of cell migration in the highly motile MDA-MB-231 cell line. We
have also used the assay for preliminary studies in another cell line, PDAC, and found
results to be highly comparable to those of MDA-MB-231 cells (Figures 7.1, 7.2 and
7.3), thereby confirming reproducible use of the assay in another cell line. In conclusion,
we can say in the agarose spot assay cells migrate in a directed manner towards the
EGF-containing spots and that this assay can be used to analyse EGF-directed migra-
tion under many diﬀerent conditions with a variety of methods.
Using the agarose spot assay we were able to analyse various parameters of the migration
of MDA-MB-231 cells towards EGF, under a number of inhibitory conditions. We used
both a small molecule inhibitor and an RNAi approach to show that both dynamin and
the process of clathrin-mediated endocytosis are necessary for migration of these cells
towards EGF, but that caveolar endocytosis is dispensable in this system (Figures 3.6
and 3.10).
In the cell tracking analysis Dynasore was also found to cause a more elongated pheno-
type of the MDA-MB-231 cells when compared to control (Figure 3.6). This elongation
led us to consider whether focal adhesion dynamics may be aﬀected by inhibiting en-
docytosis. We analysed the colocalisation of clathrin with two focal adhesion markers,
paxillin-mRFP and  3-integrin-GFP, but found no colocalisation in either case (Figures
4.1, 4.2 and 4.3). This was in agreement with work by Fletcher et al. in MDCK cells
where no colocalisation was seen between clathrin and various focal adhesion markers
(Fletcher et al., 2012). The contrast in these results compared to some studies performed
in fibroblasts indicates that eﬀects seen on focal adhesions may be cell type specific and
although there may be a requirement for clathrin in focal adhesion disassembly in fi-
broblasts that does not seem to be the case for all cell lines (Chao and Kunz, 2009;
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Ezratty et al., 2009). Interestingly, we actually found that ↵-adaptin siRNA did not in-
hibit migration during wound healing with MDA-MB-231 cells, in contrast to our results
observed during chemotactic invasion. This further emphasises that diﬀerent migratory
models require diﬀerent pathways; thus, clathrin-mediated endocytosis appears to be
unnecessary for both wound healing and focal adhesion disassembly in this cell type.
Since clathrin-mediated endocytosis was found to be necessary for chemotactic invasion
in our model we wanted to establish whether this was the route of internalisation taken
by EGFR in these cells. We found a high degree of colocalisation between clathrin-
dsRed and EGFR-GFP in migrating cells (Figure 5.1). As a control we also imaged
EGFR-GFP in conjunction with caveolin1-mRFP and found a relative lack of colocali-
sation. Taken together this provides strong evidence for clathrin-mediated endocytosis
of EGFR during EGF-directed chemotactic invasion. Such a result fits with the litera-
ture but conflicts with evidence for clathrin-independent routes of EGFR internalisation
(Sorkina et al., 2002; Motley et al., 2003; Hinrichsen et al., 2003; Huang et al., 2004;
Sigismund et al., 2005; Johannessen et al., 2006; Orlichenko et al., 2006; Rappoport and
Simon, 2009). Ultimately, these results are likely to be dependent on the experimental
system and cell type being studied.
We also assessed whether EGFR localisation was polarised in migrating cells, however
this was not found to be the case. Though, interestingly, when treated with Dynasore
the localisation of the EGFR became skewed with more receptor clusters present at the
front of migrating cells (Figure 5.7). This led to the suggestion that although EGFR lo-
calisation was not polarised under normal conditions, its endocytosis may be polarised,
as seen by a build-up of receptors at the front of the cell when dynamin-dependent
endocytosis is inhibited. In recent years some studies have found a role for polarised
vesicle traﬃcking in directed cell migration (Bailly et al., 2000; Caswell and Norman,
2006; Caswell et al., 2009; Fletcher and Rappoport, 2010). We found a polarisation of
clathrin-dsRed internalisation events at the front of migrating cells. In a separate ex-
periment we were able to image instances of colocalised clathrin-dsRed and EGFR-GFP
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internalising at the same time, but imaging limitations meant we weren’t able to expand
this anaylsis further. Taken together these results suggest that polarised endocytosis of
EGFR is important for migration in this breast cancer cell line and adds to emerging
evidence of the importance of polarised vesicle traﬃcking in directed cell migration.
Since endocytosis was polarised in our migratory model but EGFR remained uniform
on the cell surface during migration, we decided to further investigate EGFR traﬃck-
ing during EGF-directed chemotactic invasion. We found fusion of EGFR-containing
vesicles to be polarised towards the front of migrating cells, perhaps to replenish the
receptor in this region and allow continued sensing of chemoattractant molecules at the
front of the cell (Figure 6.3). We examined colocalisation of EGFR with NPY-mRFP
as a marker for biosecretory traﬃc and Rab11a-GFP as a marker for the long-loop re-
cycling pathway. A low degree of colocalisation was found with NPY but almost 40%
colocalisation with Rab11a was found, perhaps pointing to the proportionate role each
of these pathways plays with regards to replenishing EGFR on the plasma membrane
(Figures 6.4 and 6.5). However, this work is lacking live TIRF time-lapse imaging to see
how many of these colocalised structures result in fusions and also would benefit from
analysis of Rab4 and EGFR to account for the short-loop recycling pathway.
In the final chapter of work we tested a link between our traﬃcking results and signalling
downstream of EGFR. We used a PDAC cell line, established for use with the FLIM-
FRET Biosensors we intended to work with. Our results showed an increase in both
Akt and Src signalling in cells migrating into EGF spots, and this signalling increased
further when Dynasore was used to inhibit dynamin-dependent endocytosis pathways
(Figure 7.6). Since Dynasore inhibits migration we might expect signalling to be de-
creased in these circumstances, however the complexity of signalling pathways means
what we expect might not necessarily be the case. Perhaps by preventing internalisation
we prevented a necessary aspect of signalling which allows migration to occur; signalling
from endosomes has been shown to play a role in EGFR signalling and might be the
case in this instance. Further work is needed before any conclusions can be made from
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these results.
EGFR and EGFR family members are overexpressed in many cancers, most notably in
breast carcinoma (Eccles, 2011; Roskoski Jr, 2004). EGF has been found to physiolog-
ically promote metastasis of these cancer cells by stimulating EGF-directed migration
(Hynes, 2002; Lu and Kang, 2009). This current study utilised an EGF-directed mi-
gration assay to answer questions about the vesicle traﬃcking pathways and signalling
pathways involved in the migration of particular cell lines and the traﬃcking routes
taken by the major cargo proteins involved. We propose that dynamin and clathrin
are both necessary for the migration of MDA-MB-231 cells, but that caveolin1 is not.
We find no role for clathrin in focal adhesion disassembly in our migratory model but
do find it to be the route of internalisation of EGFR. We find that clathrin-mediated
endocytosis and also exocytosis of EGFR to be polarised towards the front of cells mi-
grating towards EGF. Using PDAC cells we find signalling of Src and Akt Biosensors
to be increased following dynamin inhibition; a result which we are unable to explain
at this stage but may leave the door open for future studies. Comparing some of our
results with other studies provides significant evidence of diﬀerences between cell types,
as well as migratory models. Ultimately, until a more systematic approach is taken to
the study of directed cell migration we will be without a thorough picture of what is
really occurring during chemotaxis and metastasis.
8.2 Future work
This thesis is one in only a few studies which has investigated the polarisation of receptor
traﬃcking during chemoattractant-directed cell migration. At various points within the
study there were many other directions the work could have taken, some of which are
discussed below.
Clathrin-mediated endocytosis and caveolar endocytosis represent the two most highly
studied endocytic routes used by cells, however several other less well characterised and
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possibly overlapping pathways exist. These include the CLIC/GEEC pathway, Flotillin-
dependent endocytosis and the Arf-6 dependent pathway (Doherty and McMahon, 2009).
It would be interesting to investigate the contribution each of these pathways has to
EGF-dependent migration in our migratory model. However, most of these additional
pathways don’t have specific markers and/or inhibitors so specifically investigating each
in studies such as these has not yet been practical. Such work would be useful to estab-
lish whether alternative internalisation pathways are necessary for chemotactic invasion
towards EGF.
Our study found that ↵-adaptin, and therefore presumably clathrin-mediated endocyto-
sis was necessary for EGF-dependent migration of MDA-MB-231 cells. Since ↵-adaptin
is necessary for clathrin-mediated endocytosis it does not pose a particularly attractive
target for anti-cancer therapies, as healthy cells also need this process to enable their
survival. However, if we could find a protein specific for the internalisation of EGFR this
might prove a better target for anti-cancer therapies for tumours overexpressing the re-
ceptor; since inhibiting its endocytosis prevented cell migration it might be an option to
prevent metastasis. A large siRNA screen could find targets which inhibit EGF-directed
migration and with comparisons to other endocytic screens in the literature could find
targets not yet studied in this context. Further experiments could include creating fluo-
rescent protein fusions of these target proteins to assess colocalisation with internalising
receptor, or mutations in the target proteins to assess their role in the EGFR endocytic
process.
Further to our work on the route of internalisation of EGFR it would be beneficial to
elucidate the traﬃcking of the receptor once inside the cell. The fate of the internalised
receptor may impact on the signalling stemming from its activation and more knowledge
of this process might open it up to manipulation in future. We began this investiga-
tion in Chapter 6, with experiments designed to see which exocytic routes played a role
in replenishing EGFR at the plasma membrane. In addition to what we achieved in
Chapter 6 it would be beneficial to show live cell TIRF time-lapses of vesicles containing
159
EGFR and a pathway marker fuse with the plasma membrane, and also to use addi-
tional pathway markers than we were able to in Chapter 3, such as a marker for the
Rab4-short loop recycling pathway. Further knowledge about the route of the receptor
immediately after internalisation would also be useful to future researchers. Knowing
what portion of the receptor is recycled compared to the portion degraded and the cues
that control these pathways could be useful to try and increase the proportion targeted
for degradation in the case of some cancers overexpressing the receptor.
Since its publication in 2010 the agarose spot assay for chemotactic invasion has been
used by a number of other groups in their research (Wiggins and Rappoport, 2010;
Chung et al., 2011; Vinader et al., 2011; Al Saleh et al., 2011; Haemmerle et al., 2013;
Cheng et al., 2014). The groups have used a range of diﬀerent cells lines, from the same
MDA-MB-231 cell line that we used to lymphatic endothelial cells, pancreatic cancer
cells lines and mesothelioma cell lines. It iss promising that other groups have started
using such a new assay in their varied fields of research. Another way to ensure its
use in the future could be to investigate its use with a number of diﬀerent cell types
of diﬀerent metastatic and migratory potentials and also with a range of chemoattrac-
tants/chemokines. This type of analysis, in conjunction with its low cost, will hopefully
ensure it is routinely used for chemoattractant-based motility studies in future research.
Our research in Chapter 7 on signalling during migration and how this might relate to
traﬃcking could open doors for a variety of further work. Our results brought up the
role EGFR signalling at endosomes is playing in migration. To investigate this further
higher resolution microscopy would be needed to discern endosomal structures in the
migrating cells and assess the signalling emanating from these regions. Using TIRF
microscopy in combination with the FLIM-FRET system would also help us localise the
signalling events taking place in the migrating cells. Combined use of Biosensors with
siRNAs to silence traﬃcking proteins of interest could resolve how traﬃcking influences
signalling during the process of migration. As advances are made this research could be
widened to include other signalling Biosensors to further build up understanding of the
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migratory process.
In order to take the current results further it would be useful to apply a more physio-
logical approach; this could range from 3D in vitro migration assays up to in vivo whole
animal imaging. An invasion assay called the matrigel plug assay, pioneered by Hannigan
in 2004 and used by a number of other groups, is particularly appealing (Mongroo et al.,
2004; Muller et al., 2009). It involves cells migrating through Transwell membranes and
into Matrigel or other ECM-based derivatives, it then allows for confocal microscopy
to assess 3D migration into the Matrigel. This assay is appealing as it can investigate
many of the parameters of the agarose spot assay but in a 3D setting, thereby improv-
ing the physiological relevance of results. Another interesting 3D migration assay is an
organotypic invasion assay which uses collagen imbedded with fibroblasts to mimic the
in vivo tumour environment (Timpson et al., 2011; Nobis et al., 2013). Using fluorescent
labelled tumour cells and fibroblasts in conjunction with second harmonic imaging to
view the collagen allows detailed imaging of invasion occurring in the 3D environment.
Nobis et al. used this organotypic assay in conjunction with the same Src FLIM-FRET
signalling Biosensor that we used in Chapter 7, thereby providing another possible av-
enue of research following the signalling route (Nobis et al., 2013).
Following successful 3D invasion assays the next stage would likely be in vivo work, to
assess whether the proteins found necessary for chemotactic invasion in earlier work are
also necessary in vivo. Again, a range of systems could be used for this stage of research.
Injecting tumour cells expressing mutated genes of interest into mice before undertak-
ing whole animal imaging in a system such as the Caliper IVIS would allow us to gain
information about their roles in metastasis. We could investigate the number and size
of metastases as well as their locations in the body. To more specifically investigate
the migratory process we could use multiphoton imaging of mice. In this case we would
again inject tumours carrying mutations in our genes of interest and allow them to grow.
We could then image cells in the tumour/stroma interface migrating into the ECM and
towards blood vessels. We would hope this would give us increased information on the
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roles of our genes of interest in cancer metastasis.
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Appendix I
Supplementary methods
1. LB Broth
20 g of LB Broth (Sigma) was dissolved in 1 l distilled H20 and autoclaved at 121 C for
20 minutes.
2. LB agar plates
35 g of LB Agar (Sigma) was dissolved in 1 l distilled H20 and autoclaved at 121 C for
20 minutes. Kanamycin or ampicillin was then added to give a final concentration of 50
µg/ml or 100 µg/ml, respectively. 50 ml was then poured into each 12 cm plastic dish
and allowed to set. Agar plates were stored at 4 C in a sealed bag.
3. Sample buﬀer
3X sample buﬀer was made using 18.8 ml of Tris-HCl (1 M; pH 6.8) 6 g SDS, 15 ml
Beta mercaptoethanol (Sigma) and 30 ml glycerol (Fisher Scientific), this was made up
to 100 ml with distilled H20. A small spatula of bromophenol blue was added before
thorough mixing.
4. Acrylamide gel solutions
50 ml of 4% stacking gel was made up with 30 ml distilled H20, 12.5 ml Tris HCl
(0.5 M, pH 6.8; Fisher Scientific), 6.7 ml acrylamide (Protogel), 0.5 ml 10% sodium
dodecyl sulphate (SDS; Sigma), 500 µl ammonium per sulphate (APS; Sigma) and 75
µl Tetramethylethylenediamine (TEMED; Sigma).
50 ml of 12.5% resolving gel was made up with 16.1 ml distilled H20, 12.5 ml Tris-HCl
(1.5 M, pH 8.8; Fisher Scientific), 20.8 ml acrylamide (Protogel), 0.5 ml 10% SDS, 500
µl APS and 75 µl TEMED.
5. Gel running buﬀer
Running buﬀer was made up with 14.4 g Glycine (Fisher Scientific), 3 g Tris and 0.4 g
SDS made up to 1 l with distilled H20.
6. Gel transfer buﬀer
188
Transfer buﬀer was made up with 14.4 g Glycine, 3 g Tris with 200 ml methanol (Fisher
Scientific) and made up to 1 l with distilled H20.
7. TBST
TBST was made up using 20 ml of Tris-HCl (1 M, pH 7.5), 30 ml NaCl (Fisher Scientific;
5 M) plus 1 ml Tween20 (Sigma) made up to 1 l with distilled H20.
8. Blocking buﬀer
Milk solution (Marvel) was dissolved in TBST (2.5 g in 50 ml).
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Abstract
Directed cell migration is critical for numerous physiological processes
including development and wound healing. However chemotaxis is also
exploited during cancer progression. Recent reports have suggested
links between vesicle trafficking pathways and directed cell migration.
Very little is known about the potential roles of endocytosis pathways
during metastasis. Therefore we performed a series of studies employ-
ing a previously characterised model for chemotactic invasion of can-
cer cells to assess specific hypotheses potentially linking endocytosis to
directed cell migration. Our results demonstrate that clathrin-mediated
endocytosis is indispensable for epidermal growth factor (EGF) directed
chemotactic invasion of MDA-MB-231 cells. Conversely, caveolar endo-
cytosis is not required in this mode of migration. We further found that
chemoattractant receptor (EGFR) trafficking occurs by clathrin-mediated
endocytosis and is polarised towards the front of migrating cells. How-
ever, we found no role for clathrin-mediated endocytosis in focal adhe-
sion disassembly in this migration model. Thus, this study has char-
acterised the role of endocytosis during chemotactic invasion and has
identified functions mechanistically linking clathrin-mediated endocyto-
sis to directed cell motility.
Keywords breast cancer, chemotactic invasion, EGFR, endocytosis,
MDA-MB-231
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Introduction
Directed cell migration underlies many physiological pro-
cesses. Under most circumstances, including embryonic
development, wound repair and immune responses, cell
migration is beneficial to the normal growth and survival
of an organism. However, cell migration can also promote
progression of cancer through angiogenesis and metastasis
and, under these circumstances, has a negative impact on
the survival of the organism. Cancer metastasis is strongly
associated with a poor prognosis and chance of survival; as
such the prevention of metastasis is a key target for thera-
peutic intervention (1).
During the intravasation and extravasation stages
of metastasis, cells migrate towards a source of
chemoattractant in a process called chemotaxis (2).
This process is triggered by the binding of chemoattrac-
tant molecules to cell surface receptors. Epidermal growth
factor (EGF) binding to its receptor (EGFR) has been iden-
tified as a potent chemoattractant stimulus for metastatic
cancer cells (3). Activation of chemoattractant receptors
results in a complex signalling cascade that leads to polar-
isation of the cell in the direction of migration, increased
contractility and subsequent directed motility (4).
In order to control the directionality and magnitude of
migration, the availability of chemoattractant receptors
and cell adhesion molecules on the cell surface must
be carefully regulated. Endocytosis is the first step of
endocytic recycling and, as such, is important for reg-
ulation of receptor signalling, and has also been shown
to be important for migration in a number of differ-
ent systems (5,6). Recently, it has been demonstrated
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that inhibiting endocytosis had a negative effect on
Madin-Darby canine kidney (MDCK) epithelial cell
migration in a wound healing model (7). Similarly, endo-
cytosis has been shown to be important for platelet-derived
growth factor-dependent chemotaxis of fibroblasts in a
Boyden chamber (8).
Polarisation of vesicle trafficking pathways, such as endo-
cytosis, along the migratory axis has been suggested as
important for the promotion of cell migration (9–11).
This area is widely debated due to uncertainty in the pre-
cise vesicle trafficking pathways involved and the specific
membrane domains to which these might be polarised. It
has recently been suggested that during epithelial wound
healing clathrin-mediated endocytosis takes place in the
middle-to-front area of the cell (12). Conversely, in this
same system caveolar endocytosis is polarised towards the
rear of the cell (6,7).This polarisation, however, may vary
in different cell types and experimental systems.
To date there has been limited research into the role of
endocytosis during chemotactic invasion. Potential endo-
cytic cargo which may have a role in migration include
focal adhesion components and chemoattractant recep-
tors. Focal adhesions are involved in connecting cells to
the extra-cellular matrix and providing the traction force
allowing cells to move (13–15).Thus, factors affecting the
disassembly of focal adhesions could have roles in control-
ling the rate and magnitude of migration, and endocyto-
sis of integrin cell adhesion molecules from disassembling
focal adhesions has been proposed to occur in certain sit-
uations (10,11,16,17).
Chemoattractant receptors are utilised to sense the
surrounding gradient of chemoattractant and enable
directionality of cell migration. The EGFR (also known
as ErbB1 and Her1) is linked to many vital cellular pro-
cesses such as cell survival, proliferation, differentiation
and migration (18), and deregulation of EGFR can be
oncogenic. EGFRs are frequently overexpressed in breast
cancer and this overexpression appears to correlate with
increased aggressiveness of the cancer (19).
There is conflicting evidence over which route(s) of inter-
nalisation EGFR employ(s) and what its fate is following
endocytosis. Some groups describe a clathrin-dependent
route for internalisation while others provide evidence
that the route can be clathrin-independent (20–23). Here
we aim to specifically elucidate the route of internali-
sation of the EGFR during chemotactic invasion of the
highly migratory breast cancer cell line MDA-MB-231
and test specific hypotheses mechanistically linking endo-
cytosis to chemotactic invasion. Our results demonstrate
that dynamin-dependent clathrin-mediated endocytosis
is essential for EGF-directed migration. Alternatively we
found caveolar endocytosis to be entirely dispensable.
While we find no role for clathrin-mediated endocytosis
in focal adhesion disassembly during chemotactic inva-
sion, we have demonstrated that clathrin-mediated endo-
cytosis is polarised towards the front of migrating cells
and that EGFR internalises via this route. In summary, we
propose a model where clathrin-mediated endocytosis of
EGFR is polarised towards the front of migrating cells and
this polarised trafficking is necessary for migration in an
EGF-containing environment. Additionallywe suggest that
clathrin-mediated endocytosis does not play a role in focal
adhesion disassembly in this migratory model.
Results
The effect of dynamin inhibition on chemotactic
invasion
In order to investigate potentialmechanistic roles for endo-
cytosis during chemotactic invasion we began by assessing
the effect of inhibiting different endocytic pathways dur-
ing EGF-directed migration in an assay system we recently
developed (24). Briefly, our agarose spot assay for chemo-
tactic invasion suspends chemoattractants (e.g. EGF) in a
small drop of lowmelting point agarose adhered to a cover-
slip. Cells subsequently plated intowells containing agarose
spots exhibit directed chemotactic invasion underneath the
agarose spots, and can be observed through a wide variety
of microscopy techniques.
The GTPase dynamin is known to be involved in both
clathrin-mediated endocytosis and caveolar endocytosis,
as well as having possible roles in other less characterised
endocytosis pathways (5,25,26). Therefore, we utilised
Dynasore, a small module inhibitor of dynamin, to deter-
mine if dynamin-dependent endocytosis is required
for chemotactic invasion (27). In preliminary control
experiments using fluorescent transferrin as a marker for
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Figure 1: Dynasore inhibits MDA-MB-231 chemotactic invasion into EGF spots. A) Representative images treated with
DMSO or Dynasore after 14 h migration into an agarose spot containing EGF. Line denotes edge of the agarose spot. Scale bars
100 μm. B) Results of tracking cells over the course of the timelapses. Parameters analysed include total number of cells migrated,
total path length, distance from origin, average velocity and elliptical factor (found by dividing width of cell by length to give a number
between 0 and 1). n= 36 fields of view per treatment for ‘number of cell migrated’ graph, n= 100 cells per treatment for all other
analyses. C) Dynasore inhibits chemotaxis towards EGF in Transwells. Number of cells migrated per field of view following DMSO and
Dynasore treatment. n≥ 50 fields of view per treatment.
clathrin-mediated endocytosis and fluorescent cholera
toxin B (CTxB) as a marker for caveolar endocytosis
we confirmed that Dynasore inhibits both these routes of
internalisation (Figure S1, Supporting Information).When
we treatedMDA-MB-231 cells in the chemotactic invasion
assay with Dynasore we saw significant differences in a
number of parameters investigated, including an overall
reduction in the total number of cells which migrated
(60% decrease, Figure 1A and B). Investigating the 40%
of cells which still migrated led us to find perturbations
in the total path length travelled (45% decrease), the
distance travelled from their start point (46% decrease)
and their average velocity (50% decrease, Figure 1B). We
next chose to validate these results with conventional
Transwell-based experiments. As depicted in Figure 1C,
Dynasore treatment resulted in a nearly complete inhi-
bition of EGF-directed motility in these studies. Thus,
dynamin-dependent endocytosis plays a major role in
EGF-directed chemotactic invasion inMDA-MB-231 cells.
In order to further expand the applicability of our studies
we analysed a second cell line. Pancreatic ductal adenocar-
cinoma (PDAC) cells derived from a pancreatic tumour,
have been previously characterised and are chemotactic
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and metastatic (28–30). As depicted in Figure 2A, as with
MDA-MB-231 cells, PDACs demonstrate chemotactic
invasion into agarose spots containing EGF. Both the
number of migratory cells, and distance travelled were
significantly greater in EGF spots compared to control
spots containing PBS in place of chemoattractant. Further-
more, as withMDA-MB-231 cells, chemotactic invasion of
PDACs was sensitive to Dynasore treatment (Figure 2B).
Importantly these results are similar to those obtained
following Dynasore treatment in PDACs cells in studies
employing other cell migration models, including EGF
stimulated wound healing (30), and suggest that dynamin
function is required for chemotactic invasion in multiple
cell platforms.
Previously we have shown that activated growth fac-
tor receptors cluster to sites of endocytosis (21,31). As
depicted in Figure 3 when we visualised GFP-tagged
EGFR by total internal reflection fluorescence (TIRF)
microscopy performed on cells undergoing EGF-directed
chemotactic invasion we observed EGFR clusters in the
front, middle and back of the adherent plasma membrane
(32,33). Importantly, in non-stimulated cells not exposed
to EGF this construct does not form clusters in the plasma
membrane of MDA-MB-231 cells (Figure S2). Thus, we
next set out to determine if Dynasore treatment altered the
distribution of EGFR clusters.
As depicted in Figure 3, when comparing the distribution
of EGFR clusters in the adherent plasma membrane of
cells migrating in EGF spots Dynasore treatment caused a
decrease in the proportion of clusters in the middle of the
cell, and an increase in those towards the front, although
only the former was statistically significant. In further
analyses we found that following Dynasore treatment, but
not in untreated control cells, there were more EGFR clus-
ters in the front of the cell relative to the middle and back
of the adherent plasma membrane.Thus, Dynasore treat-
ment causes a redistribution of EGFR clusters, potentially
suggesting that endocytosis of activated EGFR is polarised
during EGF-directed chemotactic invasion. Furthermore,
consistent with our previous work investigating the endo-
cytic trafficking of activated EGFR in non-motile cells,
Dynasore treatment did not increase the total number
of EGFR clusters in the adherent plasma membrane
(Figure 3C); previously we demonstrated that inhibition
B
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Figure 2: Dynasore inhibits PDACs chemotactic invasion
into EGF spots. A) The total number of PDACs cells migrated
into the spot and the distance migrated by cells was significantly
higher in EGF spots compared to control PBS spots. Line denotes
edge of the agarose spot. B) Dynasore treatment caused a
decrease in the number of PDACs cells migrated and distance
migrated into EGF spots. Scale bars are 100 μm. n≥ 12 fields of
view per treatment.
of clathrin-mediated endocytosis with siRNA silencing of
α-adaptin similarly did not increase the number of EGFR
clusters in EGF stimulated cells (21).
One potential role previously suggested for endocytosis
in cell migration is internalisation of integrins from
disassembling focal adhesions, although this phenomenon
has not been universally observed (7,34–36). Thus we
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Figure 3: Dynasore causes redistribution of EGFR during chemotactic invasion. A) Representative images of cells used for
EGFR cluster number counts in migrating cells treated with DMSO and Dynasore. Scale bars 10 μm. B) Quantification of EGFR clusters
by cell region with and without Dynasore treatment. C) Overall there is no significant increase in the number of clusters following
Dynasore treatment. n= 12 cells per treatment.
investigated whether Dynasore treatment causes a sim-
ilar alteration in the distribution of focal adhesions in
migrating MDA-MB-231 cells.
We chose to employ paxillin-mRFP for these studies, which
should be present in all focal adhesions (37). As depicted
in Figure 4, Dynasore treatment did not cause a redistri-
bution of focal adhesions, within each cell region (front,
middle and back), the number of focal adhesions was sim-
ilar with and without Dynasore treatment. Additionally,
Dynasore treatment did not increase the total number of
focal adhesions per cell (Figure 4C).Thus, in contrast with
EGFR, focal adhesion distribution does not seem, in this
model, to depend on dynamin function.
Clathrin-mediated endocytosis of EGFR during
chemotactic invasion
Dynamin functions in multiple endocytosis pathways,
as well as in other cellular processes relevant to cell
migration (5,25,26,38). In order to specifically determine
the endocytosis pathway(s) that might be important
for EGF-directed migration we performed a series of
RNAi studies. We employed previously validated siRNA
sequences to achieve silencing of α-adaptin, a component
of the AP2 complex necessary for clathrin-medicated
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Figure 4: Dynasore does not cause redistribution of focal adhesions during chemotactic invasion. A) Representative
images of paxillin-mRFP in cells migrating towards EGF. Scale bars are 10 μm. B) Quantification of number of focal adhesions in the
front, middle and back regions of migrating cells. C) Overall there is no significant increase in the number of focal adhesions following
Dynasore treatment. n= 25 cells per treatment.
endocytosis, and caveolin1, necessary for caveolar endo-
cytosis (31). Knock-down was confirmed by western
blot (Figure S3A), and inhibition of clathrin-mediated
endocytosis and caveolar endocytosis were validated by
inhibition of transferrin and CTxB uptake, respectively
(Figure S3B). Using siRNA against α-adaptinwe saw a large
decrease in the total number of cells able to migrate into
the agarose spot (65% decrease), conversely, knock-down
of caveolin1 had no effect on cell migration (Figure 5A
and B).Thus these results indicate that there is a require-
ment for clathrin-mediated endocytosis in the process
of EGF-directed chemotactic invasion, but that caveolar
endocytosis is dispensable.
Becausewe had observed a necessity for clathrin-mediated
endocytosis in EGF-directed migration we predicted that
this pathway might be the route of internalisation of
EGFR following ligand binding in this model of migra-
tion.Thus, in the agarose spot assaymigrating cells express-
ing GFP-tagged EGFR and clathrin-dsRed were imaged by
TIRF microscopy and the degree of colocalisation between
the two was quantified. As depicted in Figure 6, sig-
nificant colocalisation between EGFR and clathrin was
observed when compared to ‘control’ regions devoid of
EGFR spots. As clathrin-independent endocytosis, such as
caveolar endocytosis, has been suggested to play a role in
EGFR internalisation in certain situations (20–23) we per-
formed similar analyses assessing the degree of colocali-
sation between EGFR-GFP and caveolin1-mRFP. In stark
contrast to the colocalisation observed between EGFR and
clathrin, only approximately 5% of EGFR clusters colo-
calised with caveolin1, almost 10-fold less than the colo-
calisation seen with clathrin (Figure 6A and B).
Clathrin and EGFR colocalisation during endocytosis was
also validated by live cell TIRF imaging and instances of
both markers simultaneously disappearing from the TIRF
field were observed (Figure 7A and B). However, in these
live-cell studies dynamic EGFR spots devoid of clathrin
were also tracked. As depicted in Figure 7C, laterallymotile
EGFR spots, potentially uncoated endocytic structures or
post-Golgi carriers, were observed. Thus, these data
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Figure 5: siRNA silencing of 훂-adaptin inhibits
MDA-MB-231 migration into EGF spots. A) Repre-
sentative images treated with control siRNA, α-adaptin siRNA
and caveolin1 siRNA after 14 h migration into an agarose spot
containing EGF. Scale bars are 100 μm. B) Quantification of total
number of cells migrated under siRNA conditions. Line denotes
edge of the agarose spot. n= 22 fields of view per treatment.
NSC= non-silencing control siRNA.
suggest that during EGF-directed chemotactic invasion
activated EGFR enters the cell via clathrin-mediated
endocytosis.
Dynasore treatment caused a redistribution of EGFR spots
in migrating cells (Figure 3), suggesting the possibility of
polarised endocytosis in migrating cells. In order to fur-
ther investigate this possibility we imaged clathrin-dsRed
by live-cell TIRF microscopy in cells migrating in the
agarose spot assay. We looked for instances where clathrin
disappeared from the evanescent field to indicate an inter-
nalisation event. The disappearance of clathrin from the
evanescent field was taken to be due to endocytosis only
if it was not due to photobleaching, if it occurred rapidly
(within 10 frames of imaging) and if it did not reappear in
the evanescent field within 10 frames of its disappearance.
It was found that over the course of these timelapses
significantly more clathrin internalisation events occurred
at the front of migrating cells, as opposed to the middle
or the back (Figure 8A–C). Furthermore, although it
seemed that clathrin-coated pits at the front of the cell
are more likely to undergo endocytosis, this effect was not
statistically significant (Figure 8D). Thus, taken together
with the above results, during EGF-directed migration
EGFR is internalised by clathrin-mediated endocytosis
and that this internalisation is polarised towards the front
of migrating cells.
We also tested whether these observations could be reca-
pitulated in PDAC cells. Live-cell TIRF imaging of clathrin
in migrating PDAC cells revealed a very strong prepon-
derance of highly dynamic clathrin. As described in our
previous work, when imaged by TIRFmicroscopy, clathrin
can either be static, laterally mobile or disappear vertically
into the cell (12,39). Furthermore, it has previously been
suggested that movement of clathrin along microtubules
can occur prior or subsequent to the endocytosis event
(35,39). Thus, we quantified the ‘dynamic’ population of
clathrin in migrating PDAC cells, combining those that
disappeared vertically as well as those that moved laterally
in the plane of the plasma membrane. As it has previously
been demonstrated that individual microtubule tracks
near the adherent cell surface can curve axially, potentially
out of the TIRF field (40), we followed each clathrin spot
present in the first image of a 1min TIRF video. As previ-
ously described, we divided the cell into front, middle and
back regions. Within each region we counted the number
of dynamic clathrin spots. Similar to our results obtained
in MDA-MB-231 cells, there were significant differences
between the clathrin in the front of the cell, relative to
the middle or back. When analysed as a fraction of the
total number of spots per region, the front was signif-
icantly more dynamic (Figure 9A). Similarly, when we
normalised to the area of each region, we found the front
contained more dynamic clathrin than the middle or back
(Figure 9B). Additionally, we found that EGFR and clathrin
colocalised in PDACs, including within spots disappearing
from the cell surface (Figure 9C).Thus, we have shown in
bothMDA-MB-231 and PDAC cells that (1) EGF-directed
chemotaxis is dynamin dependant, (2) clathrin dynamics
are polarised to the front of the migrating cell, and (3)
that clathrin and EGFR can colocalise including during
internalisation.
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Figure 6: Colocalisation between clathrin-dsRed and EGFR-GFP. A) Representative images of EGFR-GFP with clathrin-dsRed
or caveolin1-mRFP in cells migrating towards EGF. Scale bars 10μm. B) Quantification of colocalisation of EGFR-GFPwith clathrin-dsRed
and caveolin1-mRFP. n= 14 cells for each experiment.
Clathrin-mediated endocytosis is not involved in focal
adhesion disassembly
The inability of Dynasore treatment to cause redistribution
of focal adhesions in migrating cells suggests that endo-
cytosis is not required for focal adhesion disassembly in
this model. To further test this hypothesis we investigated
whether there was a role for clathrin-mediated endocytosis
in focal adhesion disassembly in migrating MDA-MB-231
cells. Thus, we investigated the potential colocalisation
between clathrin and a previously validated focal adhesion
marker GFP-β3-integrin in cells migrating towards EGF in
the agarose spot assay (37,41).
As depicted in Figure 10, colocalisation of clathrin and
GFP-β3-integrin was not evident. Only approximately 7%
of focal adhesions were positive for clathrin. In addition,
as shown in Figure 9B, a previously published technique
for assessing colocalisation by analysing the effect on
Pearson’s correlation coefficient of shifting one channel
relative to another one pixel at a time confirms the lack
of colocalisation of clathrin and focal adhesions (39,42).
Finally, we performed two colour live-cell TIRF imag-
ing to specifically determine if clathrin was transiently
recruited to disassembling focal adhesions and as depicted
in Figure 10C, this was not observed.
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Figure 7: Live-cell TIRF imaging of clathrin-dsRed and EGFR-GFP. A) Representative image to show an instance of both
markers leaving the TIRF field at the same time. Scale bars are 10 μm. B) Quantification of the disappearance event depicted in (A). C)
Directed motility of an EGFR cluster devoid of clathrin. Scale bars are 1 μm.
We chose to use a fluorescent tagged integrin (in this
case GFP-β3-integrin) as our focal adhesion marker as
it represents a potential endocytic cargo localised to the
sites of focal adhesions, and therefore has the potential
to colocalise with clathrin during endocytosis. However
β3-integrin might not be present in all focal adhesions,
thus we performed similar analyses with paxillin-mRFP.
Importantly in control studies we assessed the colocali-
sation of GFP-β3-integrin and paxillin-mRFP. As can be
seen in Figure S4, all regions of paxillin-mRFP also contain
GFP-β3-integrin.
As with GFP-β3-integrin, no colocalisation was observed
between paxillin-mRFP and clathrin-GFP in either static
images of migrating cells or by analysing whether clathrin
was recruited to regions of disassembling focal adhe-
sions, as in the previous analysis (Figure S5A). Thus,
these results confirm that clathrin-mediated endocytosis
does not contribute directly to focal adhesion disassem-
bly in this system. Similarly, although siRNA silencing
of caveolin1 did not inhibit EGF-directed chemotactic
invasion of MDA-MB-231 cells we also verified that
caveolin1 also did not colocalise with GFP-β3-integrin
(Figure S5B).
As a final means to investigate a potential role for
clathrin-mediated endocytosis in focal adhesion disassem-
bly we assessed whether inhibition of clathrin-mediated
endocytosis with siRNA against α-adaptin altered the rate
of focal adhesion disassembly measured by timelapse TIRF
microscopy ofmRFP-paxillin, a previously employed assay
strategy (7).However, as cells treatedwithα-adaptin siRNA
do not readily migrate into EGF-containing agarose spots
these experiments were performed with MDA-MB-231
cells migrating in a wound healing assay. Consistent with
our colocalisation analysis (Figure 9), we found no differ-
ences in the time taken for focal adhesions to disassemble
in knock-down cells compared to control (Figure 11A and
B), indicating that clathrin is not required for disassembly
of focal adhesions in migrating cells. Furthermore, as
α-adaptin siRNA did not reduce the rate of wound healing
(Figure 11C and D) it may be that EGFR trafficking is the
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Figure 8: Clathrin spot disappearance is polarised to
the front of migrating cells. A) Representative images of
a clathrin spot disappearing from the TIRF imaging field. B)
Representative image of a clathrin-dsRed expressing migrating
cell with instances of clathrin disappearance circled. Scale bars
are 10 μm. C) Quantification of clathrin disappearance by cell
region. D) Quantification of clathrin disappearance compared to
total number of spots in each region. n= 18 cells.
main role of clathrin-mediated endocytosis during chemo-
tactic invasion and during wound healing this pathway is
not required.
Discussion
The role of endocytosis in chemotactic invasion has
not been adequately investigated. It has been suggested
in some models that endocytosis is involved in focal
adhesion disassembly (10,11,16,17). Furthermore, endo-
cytosis can play a role in the modulation of receptor
signalling (5,43–45). Therefore we conducted a series of
studies to determine the role(s) of endocytosis in driv-
ing chemotactic invasion of breast cancer-derived cells.
Increased understanding of how endocytosis regulates
chemotactic invasion may assist in developing therapeutic
interventions that might target tumour cell invasion and
metastasis.
We firstly sought to establish whether endocy-
tosis was important for chemotactic invasion of
MDA-MB-231 cells towards EGF. Using Dynasore to
inhibit dynamin-dependent endocytosis we found that far
fewer cells were able to migrate, and that the migration of
those which could still migrate was significantly impaired
(Figure 1). In addition, we obtained identical results using
an unrelated pancreatic cancer-derived cell line, further
emphasising the reproducibility of the assay used and the
necessity for dynamin-dependent endocytosis in chemo-
tactic invasion (Figure 2). Because Dynasore had such a
profound effect on migration we next investigated whether
this might be as a result of a role involving endocytosis of
receptors (noteably EGFR) or focal adhesion components
(e.g. integrins). We found that Dynasore caused an accu-
mulation of EGFR towards the front of migrating cells,
however did not affect the localisation of focal adhesion
components (Figures 3 and 4).
Because multiple endocytosis pathways are
dynamin-dependent (46–48) we employed an RNAi
approach to inhibit specific routes of endocytosis and
further narrow down the role of endocytosis in chemo-
tactic invasion. Upon inhibition of clathrin-mediated
endocytosis by siRNA against α-adaptin we again saw
a significant reduction in the number of cells able to
migrate, demonstrating this to be a pathway necessary
for migration towards EGF (Figure 5). Conversely, using
siRNA against caveolin1 to inhibit caveolar endocytosis,
we saw no alteration in cell migration.
Aspects of these results are in contrast to those reported
by other groups. In 2012 Urra et al. inhibited caveolin1 in
MDA-MB-231 cells and found this inhibition to decrease
migration of cells in a wound healing model (49). The
authors therefore suggested a role for caveolin1 in enhanc-
ing the metastatic potential of cancer cells. However,
another study found that expression of caveolin1 led to an
inhibition of chemotaxis and chemoinvasion in melanoma
cells and suggested a role for the protein in inhibiting cell
migration (50). Thus controversy remains, with different
groups pointing to a role for caveolin1 in either promoting
or inhibiting migration in some way (49–53). In order
to verify our results we also undertook TIRF imaging of
caveolin1-mRFP in conjunction with GFP-β3-integrin
in cells migrating towards EGF and found no notable
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Figure 9: Active clathrin in
migrating PDAC cells. A) Graph to
show that there is a higher proportion
of active or internalising clathrin
compared to total clathrin at the front
of migrating PDAC cells compared
to the middle or the back. B) Graph
to show that there is more active or
internalising clathrin at the front of
migrating PDAC cells when normalised
to the area of each region. n= 12 cells.
C) An instance to show clathrin-dsRed
and EGFR-GFP internalising from the
TIRF field together.
colocalisation between the two (Figure S5B). We therefore
conclude that caveolar endocytosis is unnecessary for
EGF-directed chemotactic invasion of MDA-MB-231
cells. However, it may be necessary for other modes of
migration.
As clathrin-mediated endocytosis was required for chemo-
tactic invasion towards EGF we tested for colocalisation
between clathrin and EGFR and found a high degree
of colocalisation between the two (Figure 6). When we
tested colocalisation of EGFR with caveolin1 we found
that this was negligible compared to the colocalisa-
tion with clathrin. This indicates a clathrin-dependent
internalisation route for the EGFR in cells migrating
in an EGF-dependent manner. In the literature there is
much support for a clathrin-dependent route of EGFR
endocytosis (20,21,54,55) but also contrary evidence sup-
porting a clathrin-independent route in certain situations
(22,22,23,56,57). In support of our findings, previous work
by Huang et al. and Rappoport and Simon demonstrated
that in non-migrating cells the EGFR enters primarily
through clathrin-coated pits and not through caveolae
(20,21). In addition to assessing colocalisation of clathrin
and EGFR we were able to image instances of both simul-
taneously disappearing from the TIRF field (Figure 7A and
B). During this live-cell imaging we also saw instances of
EGFR clusters devoid of clathrin moving laterally adjacent
to the plasmamembrane, likely to be post-endocytic struc-
tures or post-Golgi vesicles (Figure 7C).This observation
suggests that some EGFR in our analysis in Figure 6 may
be EGFR of this category and therefore the colocalisation
of EGFR clusters with clathrin-coated pits/vesicles on the
plasma membrane could be even higher than originally
thought.
An emerging idea is that polarised vesicle trafficking is
involved in the regulation of directed cell migration (6). A
link between polarised trafficking of cell adhesion compo-
nents has been shown in a number of cell types (11,58–60).
The occurrence of polarised trafficking of chemoattractant
receptors is less well studied than that of focal adhesions,
but may play a role in regulation of directed cell migra-
tion (61). A recent study by Assaker et al. found that
particular endocytic proteins were necessary to control
the trafficking, and hence spatial polarisation, of receptor
tyrosine kinases during Drosophila boarder cell migration
(62). Another study by Belleudi et al. found endocytosis
and polarised recycling of the keratinocyte growth factor
receptor regulated receptor polarisation at the plasma
membrane, and that this was necessary for keratinocyte
migration (63). Upon inhibition of dynamin-dependent
endocytosis we have already shown a redistribution of
EGFR localisation towards the front of migrating cells
(Figure 3). This implies that EGFR internalisation is
polarised to the front of migrating cells, as inhibition
of endocytosis caused a build up endocytosis cargo in
this region.This led us to test whether clathrin-mediated
endocytosis is polarised in MDA-MB-231 cells during
EGF-directed chemotactic invasion. As expected, we
saw an increased number of internalisation events at the
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Figure 10: Clathrin-dsRed does not co-localise with focal adhesions using GFP-훃3-integrin as the focal adhesion
marker. A) Representative images with focal adhesions circled from the GFP-β3-integrin image to assess colocalisation with clathrin.
Scale bars are 10 μm. B) Pearson’s coefficient of GFP-β3-integrin with clathrin-dsRed. n= 30 cells. C) Kymograph to show lack of
co-localisation between clathrin-dsRed and GFP-β3-integrin labelled focal adhesions. A 10 μm line was drawn across two disassembling
focal adhesions and a kymograph across this region demonstrated no co-localisation of clathrin during focal adhesion disassembly.
front of cells migrating towards EGF rather than at the
middle or back (Figure 8). In addition to the necessity
for clathrin-mediated endocytosis for migration in this
model, these results suggest that polarised endocytosis of
the EGFR is important for migration in this breast cancer
cell line.
There has been data reported suggesting a role for
clathrin-mediated endocytosis of integrins from disassem-
bling focal adhesions (34,35).However, in other studies this
has not been observed (7,36). As inhibition of endocytosis
significantly decreased chemotactic invasion, we tested
whether there is a role for clathrin-mediated endocytosis in
focal adhesion disassembly. However, we found no signifi-
cant colocalisation between clathrin and the focal adhesion
markers β3-integrin and paxillin, including specifically
during focal adhesion disassembly (Figure 10 and Figure
S5A). In addition to chemotactic invasion studies we also
undertook wound healing studies using MDA-MB-231
cells where we found knock-down of α-adaptin had no
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Figure 11: siRNA silencing of 훂-adaptin does not inhibit focal adhesion disassembly during wound healing. A)
Disappearance of paxillin-mRFP over time using NSC and α-adaptin siRNA. B) Graph showing mean focal adhesion disassembly time
for cells treated with NSC and α-adaptin siRNA. n≥ 100 focal adhesions from 20 cells per treatment. C) Wound healing assay with
α-adaptin knock-down. Representative images of wounds at time 0 and after 14 h. Lines denote edge of wound at both time points.
Distances between cells at time 0 and 14 h were measured at various points in each image to give an average distance migrated in
NSC and α-adaptin siRNA treated cells. D) Quantification of distance moved by siRNA treated cells. n= 22 fields of view per treatment.
effect on focal adhesion disassembly time. Wound healing
was assessed here because silencing of α-adaptin had such
a profound effect on chemotactic invasion that we could
not perform these analyses in that model.
Our data in MDA-MB-231 wound healing corroborates
with wound healing results from other studies, includ-
ing those from Fletcher et al. in MDCK cells where
they also found no role for endocytosis during focal
adhesion disassembly (7). The contrast in these results
compared to some studies performed in fibroblasts indi-
cates that effects seen on focal adhesions may be cell
type and/or migratory stimulus specific and that while
there may be a requirement for clathrin in focal adhesion
disassembly in fibroblasts, this is not the case during
chemotactic invasion of MDA-MB-231 breast cancer
cells (34,35).
In addition we found that knocking down α-adaptin had
no effect on the wound closure rate of MDA-MB-231.This
indicated that while some pathways may be necessary for
one process they may be dispensable for other, otherwise
similar, phenotypes. Furthermore, this suggests that EGFR
trafficking might be a critical role of clathrin-mediated
endocytosis during chemotactic invasion towards EGF in
MDA-MB-231 cells, but not necessary for wound healing.
Taken together these results suggest a model where
dynamin and clathrin are necessary for chemotactic
invasion in MDA-MB-231 cells, but caveolin1 is not. We
also establish that clathrin-mediated endocytosis is not
necessary for focal adhesion disassembly in this cell line.
We propose that the main route of EGFR internalisa-
tion is clathrin-mediated endocytosis, which is polarised
towards the front of migrating cells. Comparison of these
results with other studies provides significant evidence for
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differences between cell types, as well as migratory models.
Thus, there results suggest that a more systematic and
empirical approach is required before broad conclusions
can be suggested to describe the role(s) of endocytosis in
directed cell motility.
Materials and methods
Cell culture
MDA-MB-231 (ATCC), PDAC and PDACs cells (gift from Kurt Ander-
son, Beatson Institute) were incubated at 37∘C in 5% (v/v) CO2. Cells were
maintained in Dulbecco modified Eagle medium (DMEM, Lonza) sup-
plemented with 10% foetal calf serum (FCS) (Gibco) and 1% Pen-Strep
(Gibco). PDACs cells are stably transfected versions of PDAC cells with
a Src FLIM/FRET probe and, for the purpose of this manuscript, are
referred to as PDACs (rather than PDAC) to denote the difference from
regular PDAC cells.
Transfection and plasmid constructs
cDNA transfections of MDA-MB-231 cells were achieved using Lipofec-
tamine 2000 (Life Technologies). Cells were plated to approximately 80%
confluency 24 h prior to transfection. Assays with these cells were per-
formed 24 or 48 h post transfection (depending on the cDNA construct
and assay being performed).
cDNA transfection of PDAC cells was achieved using electroporation.
Cells were plated 24 h prior to transfection and on the day of transfection
were trypsinised and counted. Per transfectionweused 2.5× 105 cells with
4 μg cDNA, 100 μL electroporation solution (Ingenio) and programme
X-01 on the Lonza Nucleofector 2b device.
The construct encoding clathrin-dsRed was a gift from Thomas
Kirchhausen (Harvard Medical School), GFP-β3-integrin was a gift
from Jonathan Jones (Northwestern University Medical School),
paxillin-mRFP was a gift from Maddy Parsons (King’s Collage London),
Cav1–mRFP was a gift from Ari Helenius (Swiss Federal Institute of
Technology Zurich) and EGFR-GFP was a gift from Alexander Sorkin
(University of Pittsburgh).
siRNA transfections were achieved using DharmaFECT 1 (Thermo
Scientific). siRNA constructs were obtained from Thermo Scien-
tific. Cells were plated to approximately 40% confluency 24 h prior
to transfection. Assays with these cells were performed 72 h post
transfection.
Endocytosis assays
Uptake assays were used to assess the effect of Dynasore treatment,
α-adaptin knock-down and caveolin1 knock-down on endocytosis. 24 h
prior to the assay cells were plated onto sterilised glass cover slips. For
assays with Dynasore each well was rinsed with serum free media (SFM)
before incubation with SFM containing 80 μM Dynasore (Sigma), or
the equivalent volume of dimethyl sulphoxide (DMSO), for 30min. A
10min incubation with just SFM was used for assays utilising siRNA
transfected cells. After this initial incubation cells were then further
incubated for 5min with either transferrin (Alexa Fluor 568 conjugate,
10 μg/mL, Life Technologies) or cholera toxin B subunit (CTxB, Alexa
Fluor 555 conjugate, 1 μg/mL, Life Technologies) diluted in SFM. After
incubation cells incubated with transferrin were washed with acid PBS
twice followed by a PBS wash; cells incubated with CTxB were washed
twice with SFM followed by a PBS wash. Cover slips were fixed in
4% paraformaldehyde (PFA, Electron Microscopy Sciences) for 5min.
Cover slips were fixed to slides using ProLong Gold (Life Technolo-
gies) and imaged using a Nikon TE300 Inverted Epi-fluorescence micro-
scope with a 60× oil objective lens. Random fields of view from each
slide were recorded and the light intensity of 20 random cells per slide
was analysed.
Transwell assays
Chemotaxis assays were carried out using Transwell plates (24mm
diameter polycarbonate inserts with 8 μm pores, Corning Life Sciences).
EGF was used as the chemoattractant at a concentration of 1 μg/mL
EGF. The Dynasore group was treated with 80 μM, and 5× 105 cells
were plated into each insert and Transwells were incubated at 37∘C, 5%
CO2 for 5 h. After incubation, inserts were washed in PBS and fixed
in 4% PFA for 5min. After fixing, membranes were treated with Vec-
tashield mounting medium with DAPI (4′,6-diamidino-2-phenylindole)
(Vector Laboratories) to stain cell nuclei and fixed to slides. Imaging
was done using a Nikon TE300 Inverted Epi-fluorescence micro-
scope with a 40× oil objective lens. Random fields of view from
each slide were recorded and numbers of migrated cells in each field
were counted.
Western blot
Cells were lysed in 1% Triton X-100 (Sigma) in PBS with protease
inhibitors (complete mini EDTA-free protease inhibitor cocktail, Roche).
Proteins were separated by SDS–PAGE and transferred from the gel onto
Immobilon-FL membrane (Millipore). The membrane was blotted with
primary antibody overnight at 4∘C and then with secondary antibody for
2 h at room temperature. Primary antibodies used were polyclonal rabbit
anti-α-adaptin (Life Technologies), polyclonal rabbit anti-caveolin1 (BD
Biosciences) and monoclonal mouse anti-tubulin (Sigma). Secondary
antibodies used were anti-rabbit IRDye 800 and anti-mouse 680 (Li-cor)
for use in Odyssey. Quantification of knock-downs was performed using
Odyssey relative to control tubulin.
Agarose spot assay
A recently developed agarose spot assay was utilised to investigate
chemotactic invasion as described in Wiggins and Rappoport (24). For
TIRF imaging or overnight timelapses cell imaging media [10mMHepes
(Sigma), 9.7 g Hank’s Balanced Salt Solution (Life Technologies) in 1 L
dH2O, pH 7.4] with low serum content (0.1% FCS) was used. For the
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Dynasore treatment assays the low serum media contained Dynasore
at 80 μM and the control group was given the same volume of DMSO
(Sigma).
Imaging and image analysis
Overnight timelapses (for agarose spot assays)were performed on aNikon
eclipse Ti inverted microscope using a 10× air objective lens (Nikon
Instruments). TIRF imaging was carried out using a Nikon A1-R Ti TIRF
system with a 60× oil objective lens (CFI TIRF Apo 60× oil NA 1.49,
Nikon) (Nikon Instruments).
For quantification of fluorescence for the endocytosis assays IMAGEJ was
used. For all other image analysis NIS elements (version 3.1) was used.
For cell tracking analysis the manual tracking software in NIS elements
was used.
For colocalisation analysis of clathrin-dsRed or caveolin1-mRFP with
EGFR-GFP 50 clusters of EGFR in the green channel were circled, the
number of these corresponding to a cluster of clathrin/caveolin1 in
the red channel was then recorded. To assess colocalisation by chance, the
same 50 circled regions were moved slightly so that they corresponded
to regions where EGFR-GFP was not present; the number of these
control regions which corresponded to a clathrin/caveolin1 cluster was
recorded as the control value. For assessing colocalisation of clathrin with
β3-integrin or paxillin-mRFP a 10 μm line was drawn across two disas-
sembling focal adhesions and a kymograph across this region over 40min
was made.
For analysis involving splitting the cell into front, middle and back
regions of migrating cells control timelapses (i.e. no inhibition of migra-
tion) were used to establish the overall direction taken by cells within
agarose spots. We calculated the angle of cells from the last point on
the timelapses with respect to a line perpendicular to the edge of the
agarose spot. From this analysis it was found that on average cells migrate
to within 2.80∘ (±2.3∘) to the perpendicular, effectively meaning that
the line perpendicular to the agarose spot edge can be used to estimate
the direction of migration. For analysis involving establishing the front,
middle and back of migrating cells we therefore used a line perpendicular
to the edge of the agarose spot and divided this into three equal lengths.
All analyses were normalised to the area of each region to account for
their different sizes (unless stated otherwise).
Wound healing assay
For focal adhesion disassembly experiments, cells transfected with
α-adaptin siRNA and paxillin-mRFP were plated onto 35-mm
glass-bottomed dishes (MatTek Corporation) 24 h prior to wound-
ing to give a confluent layer of cells. Cells were wounded using a 200 μL
pipette tip. Cells at the edge of the wound were imaged using a Nikon
A1-R Ti TIRF system with a 60× oil objective lens.
For experiments on the effect of α-adaptin knock-down on wound clo-
sure rate, cells were plated onto 35-mm glass-bottomed dishes and trans-
fected with siRNA 72 h prior to wounding with a 200 μL pipette tip.
Wounds were imaged every 15min for 14 h with a Nikon eclipse Ti
inverted microscope using a 10× air objective lens. Images were anal-
ysed using NIS elements (version 3.1) and average distance of migration
was recorded.
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Figure S1 Endocytosis controls forDynasore treatment.A)Representa-
tive images of transferrin uptake (left panels) and cholera toxin B subunit
uptake (right panels) with DMSO (as control) or Dynasore. B) Quantifi-
cation of inhibition of transferrin and cholera toxin B subunit uptake by
Dynasore treatment. Dynasore inhibited transferrin uptake by 60% and
inhibited cholera toxin uptake by 52%. n= 60 cells per treatment.
Figure S2 Imaging of clathrin-dsRed and EGFR-GFP in cells with no
EGF stimulation. Scale bars are 10 μm.
Figure S3Controls for훂-adaptin and caveolin1 siRNA.A)Western blot
analysis of α-adaptin and caveolin1 knock-down in siRNA treated cells.
B) Representative images and quantification of transferrin uptake and
cholera toxin B subunit uptake inhibition in siRNA treated cells. Inhi-
bition of transferrin uptake in α-adaptin siRNA treated cells (45%) and
inhibition of cholera toxin B subunit uptake in caveolin1 siRNA treated
cells (50%). n= 3 for knock-down analysis, n= 60 cells per treatment for
transferring and cholera toxin uptake assays.
Figure S4 Colocalisation analysis of focal adhesionmarkers in migrat-
ing cells. Representative image showing a high degree of colocalisation
between paxillin-mRFP and GFP-β3-integrin.
Figure S5 Lack of colocalisation between endocytosis markers and
focal adhesions. A) Representative images of paxillin-mRFP and
clathrin-GFP in migrating cells. Scale bars are 10 μm. Kymograph
to show lack of colocalisation between paxillin-mRFP labelled focal
adhesions and clathrin-GFP over time. A 10 μm line was drawn across
two disassembling focal adhesions and a kymograph across this region
demonstrated no colocalisation of clathrin during focal adhesion disas-
sembly. B) Representative image showing a lack of colocalisation between
caveolin1-mRFP and GFP-β3-integrin. Scale bars are 10 μm. Arrows
show direction of migration.
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Figure 1: Dynasore inhibits MDA-MB-231 chemotactic invasion into EGF spots. A) Representative images treated with
DMSO or Dynasore after 14 h migration into an agarose spot containing EGF. Line denotes edge of the agarose spot. Scale bars
100 μm. B) Results of tracking cells over the course of the timelapses. Parameters analysed include total number of cells migrated,
total path length, distance from origin, average velocity and elliptical factor (found by dividing width of cell by length to give a number
between 0 and 1). n= 36 fields of view per treatment for ‘number of cell migrated’ graph, n= 100 cells per treatment for all other
analyses. C) Dynasore inhibits chemotaxis towards EGF in Transwells. Number of cells migrated per field of view following DMSO and
Dynasore treatment. n≥ 50 fields of view per treatment.
clathrin-mediated endocytosis and fluorescent cholera
toxin B (CTxB) as a marker for caveolar endocytosis
we confirmed that Dynasore inhibits both these routes of
internalisation (Figure S1, Supporting Information).When
we treatedMDA-MB-231 cells in the chemotactic invasion
assay with Dynasore we saw significant differences in a
number of parameters investigated, including an overall
reduction in the total number of cells which migrated
(60% decrease, Figure 1A and B). Investigating the 40%
of cells which still migrated led us to find perturbations
in the total path length travelled (45% decrease), the
distance travelled from their start point (46% decrease)
and their average velocity (50% decrease, Figure 1B). We
next chose to validate these results with conventional
Transwell-based experiments. As depicted in Figure 1C,
Dynasore treatment resulted in a nearly complete inhi-
bition of EGF-directed motility in these studies. Thus,
dynamin-dependent endocytosis plays a major role in
EGF-directed chemotactic invasion inMDA-MB-231 cells.
In order to further expand the applicability of our studies
we analysed a second cell line. Pancreatic ductal adenocar-
cinoma (PDAC) cells derived from a pancreatic tumour,
have been previously characterised and are chemotactic
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and metastatic (28–30). As depicted in Figure 2A, as with
MDA-MB-231 cells, PDACs demonstrate chemotactic
invasion into agarose spots containing EGF. Both the
number of migratory cells, and distance travelled were
significantly greater in EGF spots compared to control
spots containing PBS in place of chemoattractant. Further-
more, as withMDA-MB-231 cells, chemotactic invasion of
PDACs was sensitive to Dynasore treatment (Figure 2B).
Importantly these results are similar to those obtained
following Dynasore treatment in PDACs cells in studies
employing other cell migration models, including EGF
stimulated wound healing (30), and suggest that dynamin
function is required for chemotactic invasion in multiple
cell platforms.
Previously we have shown that activated growth fac-
tor receptors cluster to sites of endocytosis (21,31). As
depicted in Figure 3 when we visualised GFP-tagged
EGFR by total internal reflection fluorescence (TIRF)
microscopy performed on cells undergoing EGF-directed
chemotactic invasion we observed EGFR clusters in the
front, middle and back of the adherent plasma membrane
(32,33). Importantly, in non-stimulated cells not exposed
to EGF this construct does not form clusters in the plasma
membrane of MDA-MB-231 cells (Figure S2). Thus, we
next set out to determine if Dynasore treatment altered the
distribution of EGFR clusters.
As depicted in Figure 3, when comparing the distribution
of EGFR clusters in the adherent plasma membrane of
cells migrating in EGF spots Dynasore treatment caused a
decrease in the proportion of clusters in the middle of the
cell, and an increase in those towards the front, although
only the former was statistically significant. In further
analyses we found that following Dynasore treatment, but
not in untreated control cells, there were more EGFR clus-
ters in the front of the cell relative to the middle and back
of the adherent plasma membrane.Thus, Dynasore treat-
ment causes a redistribution of EGFR clusters, potentially
suggesting that endocytosis of activated EGFR is polarised
during EGF-directed chemotactic invasion. Furthermore,
consistent with our previous work investigating the endo-
cytic trafficking of activated EGFR in non-motile cells,
Dynasore treatment did not increase the total number
of EGFR clusters in the adherent plasma membrane
(Figure 3C); previously we demonstrated that inhibition
B
A
Figure 2: Dynasore inhibits PDACs chemotactic invasion
into EGF spots. A) The total number of PDACs cells migrated
into the spot and the distance migrated by cells was significantly
higher in EGF spots compared to control PBS spots. Line denotes
edge of the agarose spot. B) Dynasore treatment caused a
decrease in the number of PDACs cells migrated and distance
migrated into EGF spots. Scale bars are 100 μm. n≥ 12 fields of
view per treatment.
of clathrin-mediated endocytosis with siRNA silencing of
α-adaptin similarly did not increase the number of EGFR
clusters in EGF stimulated cells (21).
One potential role previously suggested for endocytosis
in cell migration is internalisation of integrins from
disassembling focal adhesions, although this phenomenon
has not been universally observed (7,34–36). Thus we
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Figure 3: Dynasore causes redistribution of EGFR during chemotactic invasion. A) Representative images of cells used for
EGFR cluster number counts in migrating cells treated with DMSO and Dynasore. Scale bars 10 μm. B) Quantification of EGFR clusters
by cell region with and without Dynasore treatment. C) Overall there is no significant increase in the number of clusters following
Dynasore treatment. n= 12 cells per treatment.
investigated whether Dynasore treatment causes a sim-
ilar alteration in the distribution of focal adhesions in
migrating MDA-MB-231 cells.
We chose to employ paxillin-mRFP for these studies, which
should be present in all focal adhesions (37). As depicted
in Figure 4, Dynasore treatment did not cause a redistri-
bution of focal adhesions, within each cell region (front,
middle and back), the number of focal adhesions was sim-
ilar with and without Dynasore treatment. Additionally,
Dynasore treatment did not increase the total number of
focal adhesions per cell (Figure 4C).Thus, in contrast with
EGFR, focal adhesion distribution does not seem, in this
model, to depend on dynamin function.
Clathrin-mediated endocytosis of EGFR during
chemotactic invasion
Dynamin functions in multiple endocytosis pathways,
as well as in other cellular processes relevant to cell
migration (5,25,26,38). In order to specifically determine
the endocytosis pathway(s) that might be important
for EGF-directed migration we performed a series of
RNAi studies. We employed previously validated siRNA
sequences to achieve silencing of α-adaptin, a component
of the AP2 complex necessary for clathrin-medicated
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Figure 4: Dynasore does not cause redistribution of focal adhesions during chemotactic invasion. A) Representative
images of paxillin-mRFP in cells migrating towards EGF. Scale bars are 10 μm. B) Quantification of number of focal adhesions in the
front, middle and back regions of migrating cells. C) Overall there is no significant increase in the number of focal adhesions following
Dynasore treatment. n= 25 cells per treatment.
endocytosis, and caveolin1, necessary for caveolar endo-
cytosis (31). Knock-down was confirmed by western
blot (Figure S3A), and inhibition of clathrin-mediated
endocytosis and caveolar endocytosis were validated by
inhibition of transferrin and CTxB uptake, respectively
(Figure S3B). Using siRNA against α-adaptinwe saw a large
decrease in the total number of cells able to migrate into
the agarose spot (65% decrease), conversely, knock-down
of caveolin1 had no effect on cell migration (Figure 5A
and B).Thus these results indicate that there is a require-
ment for clathrin-mediated endocytosis in the process
of EGF-directed chemotactic invasion, but that caveolar
endocytosis is dispensable.
Becausewe had observed a necessity for clathrin-mediated
endocytosis in EGF-directed migration we predicted that
this pathway might be the route of internalisation of
EGFR following ligand binding in this model of migra-
tion.Thus, in the agarose spot assaymigrating cells express-
ing GFP-tagged EGFR and clathrin-dsRed were imaged by
TIRFmicroscopy and the degree of colocalisation between
the two was quantified. As depicted in Figure 6, sig-
nificant colocalisation between EGFR and clathrin was
observed when compared to ‘control’ regions devoid of
EGFR spots. As clathrin-independent endocytosis, such as
caveolar endocytosis, has been suggested to play a role in
EGFR internalisation in certain situations (20–23) we per-
formed similar analyses assessing the degree of colocali-
sation between EGFR-GFP and caveolin1-mRFP. In stark
contrast to the colocalisation observed between EGFR and
clathrin, only approximately 5% of EGFR clusters colo-
calised with caveolin1, almost 10-fold less than the colo-
calisation seen with clathrin (Figure 6A and B).
Clathrin and EGFR colocalisation during endocytosis was
also validated by live cell TIRF imaging and instances of
both markers simultaneously disappearing from the TIRF
field were observed (Figure 7A and B). However, in these
live-cell studies dynamic EGFR spots devoid of clathrin
were also tracked. As depicted in Figure 7C, laterallymotile
EGFR spots, potentially uncoated endocytic structures or
post-Golgi carriers, were observed. Thus, these data
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Figure 5: siRNA silencing of 훂-adaptin inhibits
MDA-MB-231 migration into EGF spots. A) Repre-
sentative images treated with control siRNA, α-adaptin siRNA
and caveolin1 siRNA after 14 h migration into an agarose spot
containing EGF. Scale bars are 100 μm. B) Quantification of total
number of cells migrated under siRNA conditions. Line denotes
edge of the agarose spot. n= 22 fields of view per treatment.
NSC= non-silencing control siRNA.
suggest that during EGF-directed chemotactic invasion
activated EGFR enters the cell via clathrin-mediated
endocytosis.
Dynasore treatment caused a redistribution of EGFR spots
in migrating cells (Figure 3), suggesting the possibility of
polarised endocytosis in migrating cells. In order to fur-
ther investigate this possibility we imaged clathrin-dsRed
by live-cell TIRF microscopy in cells migrating in the
agarose spot assay. We looked for instances where clathrin
disappeared from the evanescent field to indicate an inter-
nalisation event. The disappearance of clathrin from the
evanescent field was taken to be due to endocytosis only
if it was not due to photobleaching, if it occurred rapidly
(within 10 frames of imaging) and if it did not reappear in
the evanescent field within 10 frames of its disappearance.
It was found that over the course of these timelapses
significantly more clathrin internalisation events occurred
at the front of migrating cells, as opposed to the middle
or the back (Figure 8A–C). Furthermore, although it
seemed that clathrin-coated pits at the front of the cell
are more likely to undergo endocytosis, this effect was not
statistically significant (Figure 8D). Thus, taken together
with the above results, during EGF-directed migration
EGFR is internalised by clathrin-mediated endocytosis
and that this internalisation is polarised towards the front
of migrating cells.
We also tested whether these observations could be reca-
pitulated in PDAC cells. Live-cell TIRF imaging of clathrin
in migrating PDAC cells revealed a very strong prepon-
derance of highly dynamic clathrin. As described in our
previous work, when imaged by TIRFmicroscopy, clathrin
can either be static, laterally mobile or disappear vertically
into the cell (12,39). Furthermore, it has previously been
suggested that movement of clathrin along microtubules
can occur prior or subsequent to the endocytosis event
(35,39). Thus, we quantified the ‘dynamic’ population of
clathrin in migrating PDAC cells, combining those that
disappeared vertically as well as those that moved laterally
in the plane of the plasma membrane. As it has previously
been demonstrated that individual microtubule tracks
near the adherent cell surface can curve axially, potentially
out of the TIRF field (40), we followed each clathrin spot
present in the first image of a 1min TIRF video. As previ-
ously described, we divided the cell into front, middle and
back regions. Within each region we counted the number
of dynamic clathrin spots. Similar to our results obtained
in MDA-MB-231 cells, there were significant differences
between the clathrin in the front of the cell, relative to
the middle or back. When analysed as a fraction of the
total number of spots per region, the front was signif-
icantly more dynamic (Figure 9A). Similarly, when we
normalised to the area of each region, we found the front
contained more dynamic clathrin than the middle or back
(Figure 9B). Additionally, we found that EGFR and clathrin
colocalised in PDACs, including within spots disappearing
from the cell surface (Figure 9C).Thus, we have shown in
both MDA-MB-231 and PDAC cells that (1) EGF-directed
chemotaxis is dynamin dependant, (2) clathrin dynamics
are polarised to the front of the migrating cell, and (3)
that clathrin and EGFR can colocalise including during
internalisation.
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Figure 6: Colocalisation between clathrin-dsRed and EGFR-GFP. A) Representative images of EGFR-GFP with clathrin-dsRed
or caveolin1-mRFP in cells migrating towards EGF. Scale bars 10 μm. B) Quantification of colocalisation of EGFR-GFPwith clathrin-dsRed
and caveolin1-mRFP. n= 14 cells for each experiment.
Clathrin-mediated endocytosis is not involved in focal
adhesion disassembly
The inability of Dynasore treatment to cause redistribution
of focal adhesions in migrating cells suggests that endo-
cytosis is not required for focal adhesion disassembly in
this model. To further test this hypothesis we investigated
whether there was a role for clathrin-mediated endocytosis
in focal adhesion disassembly in migrating MDA-MB-231
cells. Thus, we investigated the potential colocalisation
between clathrin and a previously validated focal adhesion
marker GFP-β3-integrin in cells migrating towards EGF in
the agarose spot assay (37,41).
As depicted in Figure 10, colocalisation of clathrin and
GFP-β3-integrin was not evident. Only approximately 7%
of focal adhesions were positive for clathrin. In addition,
as shown in Figure 9B, a previously published technique
for assessing colocalisation by analysing the effect on
Pearson’s correlation coefficient of shifting one channel
relative to another one pixel at a time confirms the lack
of colocalisation of clathrin and focal adhesions (39,42).
Finally, we performed two colour live-cell TIRF imag-
ing to specifically determine if clathrin was transiently
recruited to disassembling focal adhesions and as depicted
in Figure 10C, this was not observed.
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Figure 7: Live-cell TIRF imaging of clathrin-dsRed and EGFR-GFP. A) Representative image to show an instance of both
markers leaving the TIRF field at the same time. Scale bars are 10 μm. B) Quantification of the disappearance event depicted in (A). C)
Directed motility of an EGFR cluster devoid of clathrin. Scale bars are 1 μm.
We chose to use a fluorescent tagged integrin (in this
case GFP-β3-integrin) as our focal adhesion marker as
it represents a potential endocytic cargo localised to the
sites of focal adhesions, and therefore has the potential
to colocalise with clathrin during endocytosis. However
β3-integrin might not be present in all focal adhesions,
thus we performed similar analyses with paxillin-mRFP.
Importantly in control studies we assessed the colocali-
sation of GFP-β3-integrin and paxillin-mRFP. As can be
seen in Figure S4, all regions of paxillin-mRFP also contain
GFP-β3-integrin.
As with GFP-β3-integrin, no colocalisation was observed
between paxillin-mRFP and clathrin-GFP in either static
images of migrating cells or by analysing whether clathrin
was recruited to regions of disassembling focal adhe-
sions, as in the previous analysis (Figure S5A). Thus,
these results confirm that clathrin-mediated endocytosis
does not contribute directly to focal adhesion disassem-
bly in this system. Similarly, although siRNA silencing
of caveolin1 did not inhibit EGF-directed chemotactic
invasion of MDA-MB-231 cells we also verified that
caveolin1 also did not colocalise with GFP-β3-integrin
(Figure S5B).
As a final means to investigate a potential role for
clathrin-mediated endocytosis in focal adhesion disassem-
bly we assessed whether inhibition of clathrin-mediated
endocytosis with siRNA against α-adaptin altered the rate
of focal adhesion disassembly measured by timelapse TIRF
microscopy ofmRFP-paxillin, a previously employed assay
strategy (7).However, as cells treatedwith α-adaptin siRNA
do not readily migrate into EGF-containing agarose spots
these experiments were performed with MDA-MB-231
cells migrating in a wound healing assay. Consistent with
our colocalisation analysis (Figure 9), we found no differ-
ences in the time taken for focal adhesions to disassemble
in knock-down cells compared to control (Figure 11A and
B), indicating that clathrin is not required for disassembly
of focal adhesions in migrating cells. Furthermore, as
α-adaptin siRNA did not reduce the rate of wound healing
(Figure 11C and D) it may be that EGFR trafficking is the
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Figure 8: Clathrin spot disappearance is polarised to
the front of migrating cells. A) Representative images of
a clathrin spot disappearing from the TIRF imaging field. B)
Representative image of a clathrin-dsRed expressing migrating
cell with instances of clathrin disappearance circled. Scale bars
are 10 μm. C) Quantification of clathrin disappearance by cell
region. D) Quantification of clathrin disappearance compared to
total number of spots in each region. n= 18 cells.
main role of clathrin-mediated endocytosis during chemo-
tactic invasion and during wound healing this pathway is
not required.
Discussion
The role of endocytosis in chemotactic invasion has
not been adequately investigated. It has been suggested
in some models that endocytosis is involved in focal
adhesion disassembly (10,11,16,17). Furthermore, endo-
cytosis can play a role in the modulation of receptor
signalling (5,43–45). Therefore we conducted a series of
studies to determine the role(s) of endocytosis in driv-
ing chemotactic invasion of breast cancer-derived cells.
Increased understanding of how endocytosis regulates
chemotactic invasion may assist in developing therapeutic
interventions that might target tumour cell invasion and
metastasis.
We firstly sought to establish whether endocy-
tosis was important for chemotactic invasion of
MDA-MB-231 cells towards EGF. Using Dynasore to
inhibit dynamin-dependent endocytosis we found that far
fewer cells were able to migrate, and that the migration of
those which could still migrate was significantly impaired
(Figure 1). In addition, we obtained identical results using
an unrelated pancreatic cancer-derived cell line, further
emphasising the reproducibility of the assay used and the
necessity for dynamin-dependent endocytosis in chemo-
tactic invasion (Figure 2). Because Dynasore had such a
profound effect on migration we next investigated whether
this might be as a result of a role involving endocytosis of
receptors (noteably EGFR) or focal adhesion components
(e.g. integrins). We found that Dynasore caused an accu-
mulation of EGFR towards the front of migrating cells,
however did not affect the localisation of focal adhesion
components (Figures 3 and 4).
Because multiple endocytosis pathways are
dynamin-dependent (46–48) we employed an RNAi
approach to inhibit specific routes of endocytosis and
further narrow down the role of endocytosis in chemo-
tactic invasion. Upon inhibition of clathrin-mediated
endocytosis by siRNA against α-adaptin we again saw
a significant reduction in the number of cells able to
migrate, demonstrating this to be a pathway necessary
for migration towards EGF (Figure 5). Conversely, using
siRNA against caveolin1 to inhibit caveolar endocytosis,
we saw no alteration in cell migration.
Aspects of these results are in contrast to those reported
by other groups. In 2012 Urra et al. inhibited caveolin1 in
MDA-MB-231 cells and found this inhibition to decrease
migration of cells in a wound healing model (49). The
authors therefore suggested a role for caveolin1 in enhanc-
ing the metastatic potential of cancer cells. However,
another study found that expression of caveolin1 led to an
inhibition of chemotaxis and chemoinvasion in melanoma
cells and suggested a role for the protein in inhibiting cell
migration (50). Thus controversy remains, with different
groups pointing to a role for caveolin1 in either promoting
or inhibiting migration in some way (49–53). In order
to verify our results we also undertook TIRF imaging of
caveolin1-mRFP in conjunction with GFP-β3-integrin
in cells migrating towards EGF and found no notable
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Figure 9: Active clathrin in
migrating PDAC cells. A) Graph to
show that there is a higher proportion
of active or internalising clathrin
compared to total clathrin at the front
of migrating PDAC cells compared
to the middle or the back. B) Graph
to show that there is more active or
internalising clathrin at the front of
migrating PDAC cells when normalised
to the area of each region. n= 12 cells.
C) An instance to show clathrin-dsRed
and EGFR-GFP internalising from the
TIRF field together.
colocalisation between the two (Figure S5B). We therefore
conclude that caveolar endocytosis is unnecessary for
EGF-directed chemotactic invasion of MDA-MB-231
cells. However, it may be necessary for other modes of
migration.
As clathrin-mediated endocytosis was required for chemo-
tactic invasion towards EGF we tested for colocalisation
between clathrin and EGFR and found a high degree
of colocalisation between the two (Figure 6). When we
tested colocalisation of EGFR with caveolin1 we found
that this was negligible compared to the colocalisa-
tion with clathrin. This indicates a clathrin-dependent
internalisation route for the EGFR in cells migrating
in an EGF-dependent manner. In the literature there is
much support for a clathrin-dependent route of EGFR
endocytosis (20,21,54,55) but also contrary evidence sup-
porting a clathrin-independent route in certain situations
(22,22,23,56,57). In support of our findings, previous work
by Huang et al. and Rappoport and Simon demonstrated
that in non-migrating cells the EGFR enters primarily
through clathrin-coated pits and not through caveolae
(20,21). In addition to assessing colocalisation of clathrin
and EGFR we were able to image instances of both simul-
taneously disappearing from the TIRF field (Figure 7A and
B). During this live-cell imaging we also saw instances of
EGFR clusters devoid of clathrin moving laterally adjacent
to the plasmamembrane, likely to be post-endocytic struc-
tures or post-Golgi vesicles (Figure 7C).This observation
suggests that some EGFR in our analysis in Figure 6 may
be EGFR of this category and therefore the colocalisation
of EGFR clusters with clathrin-coated pits/vesicles on the
plasma membrane could be even higher than originally
thought.
An emerging idea is that polarised vesicle trafficking is
involved in the regulation of directed cell migration (6). A
link between polarised trafficking of cell adhesion compo-
nents has been shown in a number of cell types (11,58–60).
The occurrence of polarised trafficking of chemoattractant
receptors is less well studied than that of focal adhesions,
but may play a role in regulation of directed cell migra-
tion (61). A recent study by Assaker et al. found that
particular endocytic proteins were necessary to control
the trafficking, and hence spatial polarisation, of receptor
tyrosine kinases during Drosophila boarder cell migration
(62). Another study by Belleudi et al. found endocytosis
and polarised recycling of the keratinocyte growth factor
receptor regulated receptor polarisation at the plasma
membrane, and that this was necessary for keratinocyte
migration (63). Upon inhibition of dynamin-dependent
endocytosis we have already shown a redistribution of
EGFR localisation towards the front of migrating cells
(Figure 3). This implies that EGFR internalisation is
polarised to the front of migrating cells, as inhibition
of endocytosis caused a build up endocytosis cargo in
this region.This led us to test whether clathrin-mediated
endocytosis is polarised in MDA-MB-231 cells during
EGF-directed chemotactic invasion. As expected, we
saw an increased number of internalisation events at the
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Figure 10: Clathrin-dsRed does not co-localise with focal adhesions using GFP-훃3-integrin as the focal adhesion
marker. A) Representative images with focal adhesions circled from the GFP-β3-integrin image to assess colocalisation with clathrin.
Scale bars are 10 μm. B) Pearson’s coefficient of GFP-β3-integrin with clathrin-dsRed. n= 30 cells. C) Kymograph to show lack of
co-localisation between clathrin-dsRed and GFP-β3-integrin labelled focal adhesions. A 10 μm line was drawn across two disassembling
focal adhesions and a kymograph across this region demonstrated no co-localisation of clathrin during focal adhesion disassembly.
front of cells migrating towards EGF rather than at the
middle or back (Figure 8). In addition to the necessity
for clathrin-mediated endocytosis for migration in this
model, these results suggest that polarised endocytosis of
the EGFR is important for migration in this breast cancer
cell line.
There has been data reported suggesting a role for
clathrin-mediated endocytosis of integrins from disassem-
bling focal adhesions (34,35).However, in other studies this
has not been observed (7,36). As inhibition of endocytosis
significantly decreased chemotactic invasion, we tested
whether there is a role for clathrin-mediated endocytosis in
focal adhesion disassembly. However, we found no signifi-
cant colocalisation between clathrin and the focal adhesion
markers β3-integrin and paxillin, including specifically
during focal adhesion disassembly (Figure 10 and Figure
S5A). In addition to chemotactic invasion studies we also
undertook wound healing studies using MDA-MB-231
cells where we found knock-down of α-adaptin had no
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Figure 11: siRNA silencing of 훂-adaptin does not inhibit focal adhesion disassembly during wound healing. A)
Disappearance of paxillin-mRFP over time using NSC and α-adaptin siRNA. B) Graph showing mean focal adhesion disassembly time
for cells treated with NSC and α-adaptin siRNA. n≥ 100 focal adhesions from 20 cells per treatment. C) Wound healing assay with
α-adaptin knock-down. Representative images of wounds at time 0 and after 14 h. Lines denote edge of wound at both time points.
Distances between cells at time 0 and 14 h were measured at various points in each image to give an average distance migrated in
NSC and α-adaptin siRNA treated cells. D) Quantification of distance moved by siRNA treated cells. n= 22 fields of view per treatment.
effect on focal adhesion disassembly time. Wound healing
was assessed here because silencing of α-adaptin had such
a profound effect on chemotactic invasion that we could
not perform these analyses in that model.
Our data in MDA-MB-231 wound healing corroborates
with wound healing results from other studies, includ-
ing those from Fletcher et al. in MDCK cells where
they also found no role for endocytosis during focal
adhesion disassembly (7). The contrast in these results
compared to some studies performed in fibroblasts indi-
cates that effects seen on focal adhesions may be cell
type and/or migratory stimulus specific and that while
there may be a requirement for clathrin in focal adhesion
disassembly in fibroblasts, this is not the case during
chemotactic invasion of MDA-MB-231 breast cancer
cells (34,35).
In addition we found that knocking down α-adaptin had
no effect on the wound closure rate of MDA-MB-231.This
indicated that while some pathways may be necessary for
one process they may be dispensable for other, otherwise
similar, phenotypes. Furthermore, this suggests that EGFR
trafficking might be a critical role of clathrin-mediated
endocytosis during chemotactic invasion towards EGF in
MDA-MB-231 cells, but not necessary for wound healing.
Taken together these results suggest a model where
dynamin and clathrin are necessary for chemotactic
invasion in MDA-MB-231 cells, but caveolin1 is not. We
also establish that clathrin-mediated endocytosis is not
necessary for focal adhesion disassembly in this cell line.
We propose that the main route of EGFR internalisa-
tion is clathrin-mediated endocytosis, which is polarised
towards the front of migrating cells. Comparison of these
results with other studies provides significant evidence for
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